"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type"
"CHEMBL583842";"";"None";"428.44";"1";"5.14";"rac-9";"CN1C2=C(C(c3ccc(F)cc3)Oc3ccccc32)C(c2ccc(F)cc2)n2ncnc21";"IC50";"'='";"14800.0";"nM";"4.83";"";"";"UO_0000065";"11.27";"0.21";"-0.31";"11.19";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL568530";"";"None";"550.25";"2";"6.39";"rac-11";"CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"1170.0";"nM";"5.93";"";"";"UO_0000065";"10.78";"0.25";"-0.46";"13.74";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL433949";"";"None";"359.85";"0";"3.81";"2r";"CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccc(Cl)cc1";"IC50";"'='";"16400.0";"nM";"4.79";"";"";"UO_0000065";"13.30";"0.26";"0.98";"9.61";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL361630";"";"None";"579.77";"None";"None";"2x";"CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"118000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL362410";"";"None";"627.81";"None";"None";"2v";"COc1cc(COC2(c3ccc(OCOCC[Si](C)(C)C)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O";"IC50";"'='";"257000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL583626";"";"None";"594.31";"2";"6.79";"rac-24";"CCOc1cccc2c1C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"10.16";"0.24";"-0.75";"11.53";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL361733";"";"None";"560.78";"1";"4.78";"14";"O=C1Nc2ccc(I)cc2C(=O)N([C@@H](Cc2ccccc2)C(=O)O)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"8.77";"0.21";"0.14";"5.68";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL180897";"";"None";"356.47";"0";"4.54";"1a";"CCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'~'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL180799";"";"None";"602.86";"2";"6.20";"17";"CC(C)(C)c1ccc([C@@H](C(=O)O)N2C(=O)c3cc(I)ccc3NC(=O)[C@@H]2c2ccc(Cl)cc2)cc1";"IC50";"'='";"2270.0";"nM";"5.64";"";"";"UO_0000065";"9.36";"0.22";"-0.56";"6.51";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3962088";"";"None";"622.52";"2";"7.41";"BDBM236302";"COc1ccc(C(=O)N2CCOCC2)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.287";"nM";"9.54";"";"411687";"UO_0000065";"15.33";"0.30";"2.13";"14.91";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3979783";"";"None";"479.02";"1";"6.25";"BDBM236310";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"8.132";"nM";"8.09";"";"411694";"UO_0000065";"16.89";"0.32";"1.84";"14.79";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962264";"";"None";"553.45";"2";"5.33";"BDBM236319";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.295";"nM";"9.53";"";"411703";"UO_0000065";"17.22";"0.34";"4.20";"10.11";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3893972";"";"None";"549.45";"2";"7.81";"BDBM236336";"COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.08";"nM";"10.10";"";"411720";"UO_0000065";"18.38";"0.36";"2.29";"14.07";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"4.1";"nM";"8.39";"";"";"UO_0000065";"14.42";"0.29";"2.50";"10.05";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3220696";"";"None";"651.33";"2";"7.14";"31";"C[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2N(CCCCC(=O)O)C(=O)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"12.28";"0.30";"0.86";"10.27";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3220697";"";"None";"675.63";"2";"5.67";"32";"CC(C)C1=C(C(=O)N2C[C@H](F)C[C@H]2C(=O)N2CCNC3(CC3)C2)SC2=N[C@@](C)(c3ccc(Cl)nc3)[C@@H](c3ccc(Cl)c(F)c3)N21";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"12.66";"0.26";"2.88";"10.54";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3305317";"";"None";"724.70";"2";"5.30";"2";"COCCOc1ccccc1N1CCN(C(=O)[C@]2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)[C@@H]2CCO)CC1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"10.51";"0.20";"2.32";"7.28";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL384798";"";"None";"501.63";"2";"6.29";"37";"Cc1cccc(N(CCC#N)CCOC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)c1";"IC50";"'='";"243000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217831";"";"None";"451.52";"1";"5.34";"32";"O=C1c2ccccc2C(OCCOc2ccccc2O)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"221000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL178215";"";"None";"559.82";"None";"None";"84";"CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"464000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL361354";"";"None";"491.03";"1";"5.65";"82";"CC(=O)NCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(Cl)cc1";"IC50";"'='";"91400.0";"nM";"4.04";"";"";"UO_0000065";"8.23";"0.16";"-1.61";"6.89";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL361115";"";"None";"454.96";"1";"5.85";"77";"O=C1c2ccccc2C(OCCc2ccccn2)(c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"26200.0";"nM";"4.58";"";"";"UO_0000065";"10.07";"0.19";"-1.27";"10.80";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL362452";"";"None";"433.50";"0";"4.69";"71";"CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccccc1";"IC50";"'='";"82000.0";"nM";"4.09";"";"";"UO_0000065";"9.43";"0.17";"-0.60";"5.99";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL439349";"";"None";"431.54";"1";"6.27";"S3";"O=C1c2ccccc2C(OC/C=C/c2ccccc2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"334000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL214430";"";"None";"419.52";"1";"5.80";"S6";"O=C1c2ccccc2C(OCCc2ccccc2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL385829";"";"None";"400.48";"0";"3.70";"S20";"COC(=O)CCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL216139";"";"None";"367.45";"0";"4.05";"S23";"N#CCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"190000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL360160";"";"None";"309.41";"0";"4.18";"7";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1CCC";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3604661";"";"None";"479.02";"1";"6.27";"4";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"14.45";"0.28";"0.65";"16.47";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL211045";"";"None";"581.50";"2";"5.89";"Nutlin-3";"COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"11.97";"0.24";"1.07";"8.34";"0";"CHEMBL3136590";"Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132800";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2385336";"";"None";"439.37";"1";"7.22";"MCL0527-4";"Nc1sc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)c1C(=O)Nc1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136590";"Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132800";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2385518";"";"None";"403.33";"1";"5.86";"MCL0527-2";"Nc1sc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)c1C(=O)NC1CC1";"IC50";"'='";"2080.0";"nM";"5.68";"";"";"UO_0000065";"14.09";"0.30";"-0.18";"10.31";"0";"CHEMBL3136590";"Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132800";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3329612";"";"None";"525.48";"2";"7.47";"13";"CCC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"13.39";"0.27";"-0.43";"9.98";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL4217905";"";"None";"574.52";"2";"5.55";"Rac-4a'";"CC(C)(C)C[C@@H]1C=C(C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"33.03";"nM";"7.48";"";"";"UO_0000065";"13.02";"0.26";"1.93";"10.59";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3112822";"";"None";"649.54";"2";"5.57";"14h";"Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(C(=O)C2(c3ccc(Cl)cc3)CC2)C1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"9.33";"0.18";"0.15";"8.67";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112821";"";"None";"555.04";"1";"4.24";"14g";"CC(C)(C)C(=O)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl";"IC50";"'='";"22000.0";"nM";"4.66";"";"";"UO_0000065";"8.98";"0.17";"0.42";"7.06";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL1834380";"";"None";"557.83";"2";"5.66";"10l";"O=C1c2cc(Br)ccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"1030.0";"nM";"5.99";"";"";"UO_0000065";"10.73";"0.23";"0.33";"6.44";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1933132";"";"None";"1726.07";"None";"None";"7";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)[C@@H](C)O";"IC50";"'='";"102.0";"nM";"6.99";"";"";"UO_0000065";"4.05";"None";"None";"None";"0";"CHEMBL1936335";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1933030";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL361770";"";"None";"615.64";"2";"6.21";"33";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)c(Cl)cc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"10.00";"0.25";"-0.06";"7.10";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL361589";"";"None";"512.35";"1";"4.91";"36";"CC(=O)Nc1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2";"IC50";"'>'";"125000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL359897";"";"None";"479.32";"0";"4.94";"38";"C#Cc1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2";"IC50";"'='";"870.0";"nM";"6.06";"";"";"UO_0000065";"12.64";"0.25";"1.12";"6.99";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL180179";"";"None";"586.77";"1";"4.78";"43";"O=C(O)[C@H](c1ccc(Cl)nc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1cc2ccccc2[nH]1";"IC50";"'='";"7900.0";"nM";"5.10";"";"";"UO_0000065";"8.70";"0.20";"0.32";"4.42";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL2371818";"";"None";"1476.69";"None";"None";"QETFSDLWKLLP";"CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O";"IC50";"'='";"12900.0";"nM";"4.89";"";"";"UO_0000065";"3.31";"None";"None";"None";"0";"CHEMBL831913";"In vitro inhibitory concentration against p53-mdm2 interaction; Range = 9.6 to 14 uM";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137206";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";""
"CHEMBL181688";"";"None";"461.61";"1";"7.06";"2d";"CC(C)(C)c1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1";"IC50";"'='";"92000.0";"nM";"4.04";"";"";"UO_0000065";"8.74";"0.16";"-3.02";"13.66";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL179114";"";"None";"464.57";"0";"4.88";"6";"COc1ccc(C(O)CNC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1";"IC50";"'='";"70000.0";"nM";"4.16";"";"";"UO_0000065";"8.94";"0.16";"-0.73";"6.72";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL360944";"";"None";"467.95";"1";"5.35";"2q";"CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(Cl)cc1";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"11.27";"0.22";"-0.07";"7.73";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL362614";"";"None";"406.91";"1";"5.06";"2s";"CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccc(Cl)cc1";"IC50";"'='";"57000.0";"nM";"4.24";"";"";"UO_0000065";"10.43";"0.20";"-0.82";"10.00";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL179339";"";"None";"510.97";"1";"4.07";"2u";"COc1cc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2CCNC(C)=O)cc(OC)c1O";"IC50";"'='";"76000.0";"nM";"4.12";"";"";"UO_0000065";"8.06";"0.16";"0.05";"4.23";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL4211645";"";"None";"581.47";"2";"7.44";"Rac-4d'";"CC(C)(C)C[C@@H]1C=C(C(=O)Nc2ccc(C(=O)O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"349.5";"nM";"6.46";"";"";"UO_0000065";"11.10";"0.22";"-0.98";"6.76";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4209483";"";"None";"559.51";"2";"6.52";"(+)-4c'";"CC(C)(C)CC1C=C(C(=O)NC2CCC(O)CC2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"303.5";"nM";"6.52";"";"";"UO_0000065";"11.65";"0.23";"0.00";"8.31";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4203529";"";"None";"462.35";"1";"6.18";"(+)-8'";"CC(C)(C)CC1C=C(C(=O)O)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"18.40";"0.37";"2.33";"12.81";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3955672";"";"None";"583.48";"2";"5.14";"BDBM238920";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C(=O)N2";"IC50";"'='";"587.0";"nM";"6.23";"";"417052";"UO_0000065";"10.68";"0.21";"1.09";"5.64";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966790";"";"None";"601.47";"2";"5.28";"BDBM238922";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C(=O)N2";"IC50";"'='";"748.0";"nM";"6.13";"";"417054";"UO_0000065";"10.19";"0.20";"0.85";"5.55";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177194";"";"None";"362.30";"1";"5.85";"5";"CCCN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"15.79";"0.33";"-0.13";"28.17";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3219401";"";"None";"590.56";"2";"5.32";"96b";"CN1CCN(CCNC(=O)[C@H]2c3ccccc3C(=O)N(Cc3ccc(Cl)cc3)[C@@H]2c2c[nH]c3cc(Cl)ccc23)CC1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"8.81";"0.17";"-0.12";"7.26";"0";"CHEMBL3222408";"Inhibition of Mdm2-p53 interaction in human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL3219402";"";"None";"410.30";"1";"6.05";"97";"O=C1C(O)=C(c2ccccc2)C(c2ccc(Cl)cc2)N1Cc1ccc(Cl)cc1";"IC50";"'='";"12200.0";"nM";"4.91";"";"";"UO_0000065";"11.98";"0.24";"-1.14";"12.12";"0";"CHEMBL3222408";"Inhibition of Mdm2-p53 interaction in human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL3806040";"";"None";"728.71";"2";"6.22";"17";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC(=O)O)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"11.94";"0.24";"2.48";"7.73";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3805870";"";"None";"770.79";"2";"7.39";"24";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCCCC(=O)O)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"10.58";"0.21";"0.76";"7.25";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3329618";"";"None";"469.37";"1";"6.13";"20";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccccn2)C1=O";"IC50";"'='";"122.0";"nM";"6.91";"";"";"UO_0000065";"14.73";"0.30";"0.78";"9.81";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329608";"";"None";"511.45";"2";"7.08";"9";"CC[C@@H](c1cccnc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"13.82";"0.28";"-0.01";"10.03";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329606";"";"None";"512.44";"2";"6.47";"7";"CC[C@@H](c1ncccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"14.25";"0.28";"0.83";"8.76";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329613";"";"None";"545.89";"2";"7.73";"15";"CC[C@@H](c1cccc(Cl)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"16.77";"0.35";"1.42";"12.99";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329610";"";"None";"525.48";"2";"7.32";"11";"CC(C)[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.55";"0.33";"1.38";"12.34";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329609";"";"None";"497.42";"1";"6.69";"10";"C[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"16.08";"0.32";"1.31";"11.35";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329605";"";"None";"511.45";"2";"7.08";"6";"CC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.66";"0.33";"1.44";"12.09";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3310319";"";"None";"600.52";"2";"5.89";"23";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(OCCO)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.58";"0.27";"2.26";"8.18";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3220698";"";"None";"616.63";"1";"4.03";"34";"COc1cc(C(=O)N(C)[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCN(c3ccc([N+](=O)[O-])cc3)CC2)c([N+](=O)[O-])cc1OC";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"12.20";"0.23";"3.49";"4.58";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL1945124";"";"None";"638.60";"2";"5.82";"8e";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCN(C)CC2)c(OC(C)C)c1";"IC50";"'='";"20650.0";"nM";"4.68";"";"";"UO_0000065";"7.34";"0.15";"-1.13";"5.40";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL3908421";"";"None";"618.56";"2";"7.58";"BDBM236275";"COc1ccc(C(=O)N2CCOCC2)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.106";"nM";"9.97";"";"411660";"UO_0000065";"16.13";"0.32";"2.39";"15.58";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926314";"";"None";"535.47";"2";"7.60";"BDBM236258";"COc1ccc(CO)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.113";"nM";"9.95";"";"411643";"UO_0000065";"18.58";"0.37";"2.35";"18.18";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3925866";"";"None";"594.60";"2";"6.91";"BDBM215380";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C(C)(C)C)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378763";"UO_0000065";"16.31";"0.34";"2.79";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL361575";"";"None";"540.36";"1";"4.82";"5";"CCc1ccc([C@H]2C(=O)Nc3ccc(I)cc3C(=O)N2[C@H](C(=O)O)c2ccccc2)cc1";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"9.48";"0.22";"0.30";"5.91";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL180579";"";"None";"413.56";"1";"6.27";"2j";"CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL361103";"";"None";"581.19";"2";"5.56";"20";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"10.97";"0.27";"0.82";"7.35";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3917871";"";"None";"506.43";"2";"7.50";"BDBM236260";"COc1ccncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.176";"nM";"9.75";"";"411645";"UO_0000065";"19.26";"0.38";"2.25";"20.60";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966894";"";"None";"574.55";"2";"5.47";"BDBM215146";"CC[C@@H](CN1CCN(C(C)=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378425";"UO_0000065";"13.92";"0.28";"2.53";"9.86";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926199";"";"None";"557.44";"2";"6.56";"BDBM215153";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H]2CCCN(CC(F)(F)F)C2)C1=O";"IC50";"'='";"1090.0";"nM";"5.96";"";"378433";"UO_0000065";"10.70";"0.22";"-0.60";"9.80";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109214";"";"None";"463.40";"1";"6.12";"BDBM215172";"CCC(CC)N1C(=O)[C@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1";"IC50";"'='";"920.0";"nM";"6.04";"";"378451";"UO_0000065";"13.03";"0.27";"-0.08";"8.56";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955489";"";"None";"490.43";"1";"6.29";"BDBM215177";"CC[C@@H](CC(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378456";"UO_0000065";"16.31";"0.33";"1.71";"10.71";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111736";"";"None";"531.48";"2";"6.52";"BDBM215222";"CC[C@@H](C1=NC(C)(C)CO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378486";"UO_0000065";"13.92";"0.28";"0.88";"9.34";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904755";"";"None";"587.47";"2";"6.72";"BDBM215223";"CC[C@@H](CN(CC(F)(F)F)C(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378487";"UO_0000065";"12.81";"0.26";"0.80";"9.65";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107897";"";"None";"567.54";"2";"8.29";"BDBM215265";"CC[C@H](c1nc2ccccc2s1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"90.0";"nM";"7.05";"";"378508";"UO_0000065";"12.41";"0.25";"-1.24";"9.99";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3976132";"";"None";"547.48";"2";"5.20";"BDBM215066";"CC[C@@H](COCC1(C(N)=O)CC1)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"378345";"UO_0000065";"12.09";"0.24";"1.42";"6.02";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113762";"";"None";"502.40";"2";"5.98";"BDBM215083";"CC[C@@H](c1nnc(C)o1)N1C(=O)[C@@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"710.0";"nM";"6.15";"";"378362";"UO_0000065";"12.24";"0.25";"0.17";"6.37";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3775815";"";"None";"195.29";"0";"2.57";"1b";"CC(C)C(=O)Nc1ccccc1S";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL3752931";"";"None";"1381.94";"None";"None";"4";"CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccc(Cl)cc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC1=O";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"4.96";"None";"None";"None";"0";"CHEMBL3754930";"Inhibition of p53-HDM2 (unknown origin) interaction";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3751840";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL379173";"";"None";"577.53";"1";"4.33";"MI-63";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"13.93";"0.28";"3.72";"9.73";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3947519";"";"None";"544.02";"1";"4.55";"BDBM236377";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.076";"nM";"8.97";"";"411761";"UO_0000065";"16.49";"0.31";"4.42";"7.60";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3910791";"";"None";"558.04";"1";"4.57";"BDBM236378";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.295";"nM";"9.53";"";"411762";"UO_0000065";"17.08";"0.33";"4.96";"8.72";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962752";"";"None";"553.45";"2";"5.18";"BDBM236395";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.592";"nM";"9.23";"";"411779";"UO_0000065";"16.67";"0.33";"4.05";"8.52";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3973707";"";"None";"553.45";"2";"5.20";"BDBM236397";"COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.254";"nM";"9.60";"";"411781";"UO_0000065";"17.34";"0.34";"4.40";"12.23";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110741";"";"None";"568.46";"2";"5.47";"BDBM236410";"COc1ncc(-c2cc3c(n2C(C)C)[C@@](C)(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"42.73";"nM";"7.37";"";"411794";"UO_0000065";"12.96";"0.26";"1.90";"8.06";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115066";"";"None";"516.96";"2";"5.53";"BDBM236419";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"115.01";"nM";"6.94";"";"411803";"UO_0000065";"13.42";"0.26";"1.41";"6.30";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3891351";"";"None";"497.56";"0";"4.21";"BDBM236426";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(C)nn2C)C3=O)c(OC)n1";"IC50";"'='";"3.462";"nM";"8.46";"";"411810";"UO_0000065";"17.00";"0.31";"4.25";"7.62";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3914063";"";"None";"545.00";"1";"4.52";"BDBM236433";"COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.108";"nM";"9.97";"";"411817";"UO_0000065";"18.29";"0.35";"5.45";"8.65";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110257";"";"None";"545.00";"1";"4.52";"BDBM236434";"COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"143.8";"nM";"6.84";"";"411818";"UO_0000065";"12.55";"0.24";"2.32";"5.94";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107940";"";"None";"500.60";"1";"4.20";"BDBM236438";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(C1CCOCC1)C2=O";"IC50";"'='";"279.88";"nM";"6.55";"";"411822";"UO_0000065";"13.09";"0.24";"2.35";"6.79";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3953073";"";"None";"572.42";"2";"5.44";"BDBM236439";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.128";"nM";"9.89";"";"411823";"UO_0000065";"17.28";"0.35";"4.45";"10.81";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329615";"";"None";"525.48";"2";"7.39";"17";"CC[C@@H](c1ccc(C)cn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"123.0";"nM";"6.91";"";"";"UO_0000065";"13.15";"0.26";"-0.48";"9.80";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329614";"";"None";"551.51";"2";"7.96";"16";"CC[C@@H](c1cccc(C2CC2)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"228.0";"nM";"6.64";"";"";"UO_0000065";"12.04";"0.24";"-1.32";"9.42";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329611";"";"None";"523.46";"2";"7.08";"12";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](c2ccccn2)C2CC2)C1=O";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"14.75";"0.29";"0.64";"10.95";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329609";"";"None";"497.42";"1";"6.69";"10";"C[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"14.49";"0.29";"0.52";"10.22";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329604";"";"None";"517.48";"2";"7.14";"5";"CC[C@@H](c1nccs1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"13.88";"0.29";"0.04";"10.19";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329620";"";"None";"434.36";"1";"5.94";"23";"CC(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"119.0";"nM";"6.92";"";"";"UO_0000065";"15.94";"0.33";"0.98";"12.02";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3220692";"";"None";"554.47";"1";"4.45";"24";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC[C@H](O)CO)[C@@H](c2cc(F)cc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1F";"IC50";"'='";"165.0";"nM";"6.78";"";"";"UO_0000065";"12.23";"0.25";"2.33";"6.44";"0";"CHEMBL3223364";"Inhibition of p53 interaction to MDM2 (unknown origin) by HTRF assay in presence of 0.02% bovine serum albumin";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3310186";"";"None";"613.52";"2";"5.63";"21";"COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(N)=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.53";"0.27";"2.67";"6.77";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310321";"";"None";"631.51";"2";"5.77";"25";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)cc(F)c32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.14";"0.26";"2.53";"6.77";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3112812";"";"None";"771.20";"2";"5.80";"12i";"CN(C)CCCC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"1080.0";"nM";"5.97";"";"";"UO_0000065";"8.12";"0.16";"0.17";"6.07";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112794";"";"None";"608.97";"1";"3.86";"11e";"CC(=O)N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"7.76";"0.15";"0.58";"5.35";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3904825";"";"None";"525.41";"2";"7.73";"BDBM238899";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C(=O)N2";"IC50";"'='";"882.0";"nM";"6.05";"";"417035";"UO_0000065";"11.52";"0.23";"-1.68";"10.19";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329619";"";"None";"468.38";"1";"6.74";"21";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccccc2)C1=O";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"15.50";"0.31";"0.52";"12.60";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329613";"";"None";"545.89";"2";"7.73";"15";"CC[C@@H](c1cccc(Cl)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"13.99";"0.29";"-0.09";"10.83";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2177190";"";"None";"462.42";"1";"6.72";"22";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"18.43";"0.38";"1.80";"14.79";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329619";"";"None";"468.38";"1";"6.74";"21";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccccc2)C1=O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"17.93";"0.36";"1.66";"14.58";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329604";"";"None";"517.48";"2";"7.14";"5";"CC[C@@H](c1nccs1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"15.89";"0.33";"1.08";"11.66";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3937960";"";"None";"525.05";"2";"5.35";"BDBM236350";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N([C@H]2CC[C@H](O)CC2)C3=O)c(OC)n1";"IC50";"'='";"20.7";"nM";"7.68";"";"411604";"UO_0000065";"14.63";"0.28";"2.33";"8.57";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3954030";"";"None";"555.52";"2";"5.20";"BDBM215180";"CC[C@@H](CN(C)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378460";"UO_0000065";"14.40";"0.30";"2.80";"8.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125513";"";"None";"583.58";"2";"6.03";"BDBM50448944";"CC[C@@H](CNS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378604";"UO_0000065";"14.91";"0.31";"2.67";"8.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107164";"";"None";"607.60";"2";"6.12";"BDBM215293";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CN(C)S(=O)(=O)C2CC2)C2CC2)C1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"378661";"UO_0000065";"14.81";"0.31";"2.88";"9.47";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111710";"";"None";"490.43";"1";"5.69";"BDBM215296";"C[C@@H](O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378665";"UO_0000065";"18.35";"0.37";"3.31";"11.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111867";"";"None";"656.05";"2";"7.00";"BDBM215304";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)c2ccc(Cl)s2)C2CC2)C1=O";"IC50";"'='";"0.5";"nM";"9.30";"";"378673";"UO_0000065";"14.18";"0.31";"2.30";"8.96";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113321";"";"None";"645.60";"2";"6.96";"BDBM215306";"CC(C)(C)S(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(F)F";"IC50";"'='";"0.3";"nM";"9.52";"";"378675";"UO_0000065";"14.75";"0.31";"2.56";"10.03";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108939";"";"None";"569.55";"2";"5.50";"BDBM215334";"CCS(=O)(=O)NC[C@H](C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"16.1";"nM";"7.79";"";"378702";"UO_0000065";"13.68";"0.29";"2.29";"7.51";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110659";"";"None";"554.54";"2";"6.14";"BDBM215368";"CCC(CS(=O)(=O)CC)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"378748";"UO_0000065";"16.95";"0.36";"3.26";"10.24";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3952401";"";"None";"582.59";"2";"6.91";"BDBM215370";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378750";"UO_0000065";"17.16";"0.36";"3.09";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3964670";"";"None";"534.48";"2";"6.65";"BDBM215116";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378395";"UO_0000065";"14.40";"0.29";"1.05";"9.18";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114447";"";"None";"490.46";"1";"5.85";"BDBM215134";"CC(C)N1C(=O)[C@@](C)(Cc2nsc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1980.0";"nM";"5.70";"";"378413";"UO_0000065";"11.63";"0.24";"-0.15";"8.63";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109614";"";"None";"463.41";"1";"5.79";"BDBM215441";"CCN(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378533";"UO_0000065";"17.26";"0.35";"2.21";"13.15";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3964670";"";"None";"534.48";"2";"6.65";"BDBM215116";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378540";"UO_0000065";"16.28";"0.33";"2.05";"10.37";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3922286";"";"None";"567.54";"2";"5.34";"BDBM215175";"CCC(CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"12.0";"nM";"7.92";"";"378556";"UO_0000065";"13.96";"0.29";"2.58";"8.34";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3944731";"";"None";"581.56";"2";"5.59";"BDBM215176";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@H](C(C)C(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378557";"UO_0000065";"13.24";"0.28";"2.11";"8.11";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3952928";"";"None";"492.44";"1";"6.08";"BDBM215190";"CC[C@@H](CC(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378574";"UO_0000065";"17.05";"0.35";"2.32";"10.79";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112746";"";"None";"478.42";"1";"5.69";"BDBM215198";"CC[C@@H]([C@@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378582";"UO_0000065";"18.18";"0.37";"3.01";"11.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980916";"";"None";"509.01";"1";"3.94";"BDBM236355";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCC(=O)N(C)C1)C2=O";"IC50";"'='";"3.698";"nM";"8.43";"";"411739";"UO_0000065";"16.57";"0.32";"4.49";"7.91";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918527";"";"None";"579.44";"2";"5.17";"BDBM236367";"COc1ncc(-c2c(C#N)c3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.167";"nM";"9.78";"";"411751";"UO_0000065";"16.87";"0.33";"4.61";"8.48";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108456";"";"None";"554.43";"2";"5.30";"BDBM236369";"COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"28.32";"nM";"7.55";"";"411849";"UO_0000065";"13.61";"0.27";"2.25";"8.25";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3948248";"";"None";"611.49";"2";"5.05";"BDBM236470";"COc1nc(N(C)C)ncc1-c1c(C(=O)O)c2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.132";"nM";"9.88";"";"411856";"UO_0000065";"16.16";"0.32";"4.83";"8.05";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3310188";"";"None";"689.62";"2";"7.30";"4";"COc1cc(C(N)=O)ccc1-c1ccccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"12.04";"0.24";"1.00";"6.77";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310184";"";"None";"614.50";"2";"6.23";"19";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.51";"0.27";"2.07";"7.11";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3604664";"";"None";"556.11";"2";"7.24";"8";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3cccnc3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"14.07";"0.27";"0.58";"14.25";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3220687";"";"None";"704.39";"2";"6.22";"19";"CC(=O)N1CCC(Oc2ccc(I)cc2[C@@H]2NC(=O)C[C@H](c3cccc(Cl)c3)[C@@]23C(=O)Nc2cc(Cl)ccc23)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"10.60";"0.25";"1.25";"8.51";"0";"CHEMBL3223363";"Inhibition of p53 interaction to GST-tagged MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL2315850";"";"None";"626.61";"2";"5.19";"23b";"CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N2CCNC(=O)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"11.33";"0.23";"1.91";"8.32";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3329602";"";"None";"504.45";"2";"6.49";"3";"CC[C@@H]([C@@H]1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"17.84";"0.36";"2.51";"13.46";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3966333";"";"None";"575.40";"2";"6.66";"BDBM238913";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2ccc(F)c(Cl)c2)C(=O)N3)c(OC)n1";"IC50";"'='";"451.0";"nM";"6.35";"";"417045";"UO_0000065";"11.03";"0.22";"-0.31";"6.72";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906849";"";"None";"588.43";"2";"5.22";"BDBM238915";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C(=O)N3)c(OC)n1";"IC50";"'='";"1668.0";"nM";"5.78";"";"417047";"UO_0000065";"9.82";"0.20";"0.56";"4.96";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329607";"";"None";"511.45";"2";"7.08";"8";"CC[C@@H](c1ccncc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"14.68";"0.29";"0.43";"10.65";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3896443";"";"None";"580.49";"2";"7.61";"BDBM236249";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"2.9";"nM";"8.54";"";"411592";"UO_0000065";"14.71";"0.29";"0.93";"13.43";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895404";"";"None";"554.43";"2";"5.30";"BDBM236368";"COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.6";"nM";"9.22";"";"411608";"UO_0000065";"16.63";"0.33";"3.92";"10.08";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3976234";"";"None";"516.96";"2";"5.53";"BDBM236288";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.349";"nM";"9.46";"";"411673";"UO_0000065";"18.29";"0.35";"3.93";"8.59";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895110";"";"None";"496.01";"0";"4.62";"BDBM236315";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"12.6";"nM";"7.90";"";"411600";"UO_0000065";"15.93";"0.31";"3.28";"7.42";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114597";"";"None";"537.45";"2";"6.91";"BDBM236271";"COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"29.59";"nM";"7.53";"";"411656";"UO_0000065";"14.01";"0.28";"0.62";"10.84";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3931214";"";"None";"535.47";"2";"8.12";"BDBM236285";"COc1ccc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)c1";"IC50";"'='";"0.444";"nM";"9.35";"";"411670";"UO_0000065";"17.47";"0.35";"1.23";"21.40";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3220703";"";"None";"570.45";"2";"5.72";"50";"Cc1ccc(F)cc1[C@@H]1NC(=O)C[C@H](c2cc(Cl)cnc2CC(C)(C)C(=O)O)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"145.0";"nM";"6.84";"";"";"UO_0000065";"11.99";"0.24";"1.12";"6.31";"0";"CHEMBL3223364";"Inhibition of p53 interaction to MDM2 (unknown origin) by HTRF assay in presence of 0.02% bovine serum albumin";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL4112795";"";"None";"647.60";"2";"6.92";"BDBM215311";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(c2ccccc2F)S(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378680";"UO_0000065";"14.98";"0.31";"2.78";"10.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109111";"";"None";"621.63";"2";"6.56";"BDBM215332";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C2CCCC2)C2CC2)C1=O";"IC50";"'='";"0.7";"nM";"9.15";"";"378699";"UO_0000065";"14.73";"0.30";"2.59";"8.82";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125701";"";"None";"538.49";"2";"5.35";"BDBM50448955";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"378758";"UO_0000065";"18.57";"0.39";"4.65";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918513";"";"None";"446.37";"1";"5.94";"BDBM215092";"O=C(O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CCC2)C1=O";"IC50";"'='";"1970.0";"nM";"5.71";"";"378371";"UO_0000065";"12.78";"0.26";"-0.23";"9.90";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177183";"";"None";"431.36";"0";"4.95";"BDBM215097";"NC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"1370.0";"nM";"5.86";"";"378376";"UO_0000065";"13.59";"0.28";"0.91";"9.25";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955799";"";"None";"438.38";"1";"5.61";"BDBM215113";"O=C(O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)s2)N(CC2CC2)C1=O";"IC50";"'='";"220.0";"nM";"6.66";"";"378392";"UO_0000065";"15.19";"0.32";"1.05";"11.56";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114636";"";"None";"492.40";"0";"4.42";"BDBM215151";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H]2CC[C@@H](O)[C@H]2O)C1=O";"IC50";"'='";"50.0";"nM";"7.30";"";"378430";"UO_0000065";"14.83";"0.30";"2.88";"7.44";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125704";"";"None";"506.47";"2";"6.47";"BDBM50448953";"CC[C@@H](CC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"378457";"UO_0000065";"14.13";"0.29";"0.68";"9.19";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3967671";"";"None";"638.66";"2";"5.15";"BDBM215206";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NCCCO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"53.0";"nM";"7.28";"";"378587";"UO_0000065";"11.39";"0.24";"2.13";"6.80";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950302";"";"None";"610.60";"2";"5.33";"BDBM215209";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NOC)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"44.0";"nM";"7.36";"";"378590";"UO_0000065";"12.05";"0.25";"2.03";"7.66";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3935901";"";"None";"595.59";"2";"6.12";"BDBM215241";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@](C)(CCC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"44.0";"nM";"7.36";"";"378624";"UO_0000065";"12.35";"0.26";"1.24";"7.74";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3949514";"";"None";"597.56";"1";"4.88";"BDBM215393";"CC[C@@H](CS(=O)(=O)NCC1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378778";"UO_0000065";"16.23";"0.34";"4.82";"8.58";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110489";"";"None";"434.36";"1";"5.72";"BDBM215431";"CC(C)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@]1(C)c1ccc(Cl)cc1";"IC50";"'='";"3.4";"nM";"8.47";"";"378814";"UO_0000065";"19.50";"0.40";"2.75";"14.70";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3923124";"";"None";"616.61";"2";"6.21";"BDBM215438";"CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@](C)(Cc2cccc(O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"52.6";"nM";"7.28";"";"378821";"UO_0000065";"11.80";"0.24";"1.07";"8.02";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111077";"";"None";"566.55";"2";"5.22";"BDBM215440";"CCS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.1";"nM";"8.39";"";"378823";"UO_0000065";"14.80";"0.31";"3.17";"9.14";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3967626";"";"None";"508.44";"2";"5.58";"BDBM215064";"CC[C@@H](COCCOC)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"378343";"UO_0000065";"13.02";"0.27";"1.04";"8.70";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108672";"";"None";"446.38";"0";"4.46";"BDBM215100";"NNC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"3060.0";"nM";"5.51";"";"378379";"UO_0000065";"12.35";"0.25";"1.05";"7.31";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2059299";"";"None";"432.35";"1";"5.55";"1";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"2420.0";"nM";"5.62";"";"";"UO_0000065";"12.99";"0.26";"0.07";"9.75";"0";"CHEMBL2060736";"Inhibition of interaction of MDM2-p53 by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2057187";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3112793";"";"None";"649.08";"2";"5.65";"11d";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(C3CCCCC3)CC2)C1";"IC50";"'='";"4200.0";"nM";"5.38";"";"";"UO_0000065";"8.78";"0.17";"-0.27";"8.15";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3134175";"";"None";"456.54";"1";"5.49";"42";"CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OC)nn1CCc1ccccc1";"IC50";"'='";"339200.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134203";"";"None";"514.62";"2";"6.14";"19";"COc1cccc(-c2cc(-c3cc(CC(=O)O)ccc3OCC(C)C)nn2CCc2ccccc2)c1OC";"IC50";"'='";"68320.0";"nM";"4.17";"";"";"UO_0000065";"8.09";"0.15";"-1.97";"5.03";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134191";"";"None";"484.60";"1";"6.59";"6";"CCOc1ccccc1-c1cc(-c2cc(C(=O)O)ccc2OCC(C)C)nn1CCc1ccccc1";"IC50";"'='";"14190.0";"nM";"4.85";"";"";"UO_0000065";"10.00";"0.18";"-1.74";"6.59";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL4760166";"";"None";"671.56";"2";"7.58";"Ib-140";"CCOc1cccc(CN2[C@H]3CCn4c(nc5cc(C(=O)O)ccc54)[C@H]3[C@H](c3cccc(Cl)c3F)[C@]23C(=O)Nc2cc(Cl)ccc23)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"12.95";"0.25";"1.12";"9.00";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3806304";"";"None";"646.73";"2";"5.10";"4";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1cccs1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"8.56";"0.17";"0.44";"5.80";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL182335";"";"None";"526.76";"1";"4.72";"12";"CCCC[C@@H](C(=O)O)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"9.21";"0.23";"0.13";"5.60";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL179879";"";"None";"580.30";"2";"5.27";"10";"O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1cccc(C(F)(F)F)c1";"IC50";"'='";"45000.0";"nM";"4.35";"";"";"UO_0000065";"7.49";"0.17";"-0.92";"5.01";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3905949";"";"None";"432.35";"1";"5.55";"BDBM215090";"O=C(O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"320.0";"nM";"6.50";"";"378369";"UO_0000065";"15.02";"0.31";"0.94";"11.27";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2315837";"";"None";"460.43";"1";"5.98";"10a";"CNC(=O)C1=C(C(C)C)N2C(=NC(C)(c3ccc(Cl)cc3)C2c2ccc(Cl)cc2)S1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"12.94";"0.27";"-0.02";"13.33";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL1771606";"";"None";"628.35";"2";"5.76";"12, Racemic mixture";"CS(=O)(=O)CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"10.01";"0.24";"0.53";"8.14";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1771605";"";"None";"608.29";"2";"6.23";"11, Racemic mixture";"O=C(O)CCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"510.0";"nM";"6.29";"";"";"UO_0000065";"10.34";"0.24";"0.06";"7.82";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3112787";"";"None";"606.05";"1";"3.91";"9j";"COc1ccc(OC2(C(=O)N3CCN(c4ccccn4)CC3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)cc1.Cl";"IC50";"'='";"33000.0";"nM";"4.48";"";"";"UO_0000065";"7.87";"0.15";"0.57";"5.09";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3310323";"";"None";"631.51";"2";"5.77";"27";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3c2ccc(Cl)c3F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"12.39";"0.25";"2.05";"6.38";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3A";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.76";"0.27";"2.11";"9.58";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3805720";"";"None";"742.78";"2";"6.90";"15";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OC(C)(C)CO)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"10.23";"0.20";"0.70";"7.97";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL4299644";"";"None";"784.82";"2";"7.63";"22";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCC(C)(C)C(=O)O)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"10.19";"0.20";"0.37";"7.11";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3112809";"";"None";"730.11";"2";"5.11";"12f";"COCC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"9.04";"0.17";"1.16";"6.01";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112824";"";"None";"679.08";"2";"5.07";"14j";"Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(S(=O)(=O)c2ccccc2C(F)(F)F)C1";"IC50";"'='";"41000.0";"nM";"4.39";"";"";"UO_0000065";"6.83";"0.14";"-0.68";"5.28";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112786";"";"None";"652.12";"2";"5.57";"9i";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(-c3ccccc3)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"48000.0";"nM";"4.32";"";"";"UO_0000065";"7.01";"0.13";"-1.25";"5.48";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112783";"";"None";"672.91";"1";"4.80";"9f";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(Br)c(F)c2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"8.70";"0.18";"0.74";"7.02";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL584303";"";"None";"536.23";"2";"6.36";"rac-1";"Brc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3)cc1";"IC50";"'='";"3880.0";"nM";"5.41";"";"";"UO_0000065";"10.09";"0.24";"-0.95";"10.41";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL584576";"";"None";"499.41";"1";"6.19";"rac-18";"CCc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3C)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL565262";"";"None";"568.24";"2";"6.53";"rac-22";"CN1C2=C(C(c3ccc(Br)cc3)Oc3cccc(F)c32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"1720.0";"nM";"5.76";"";"";"UO_0000065";"10.14";"0.24";"-0.77";"13.35";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3112777";"";"None";"607.50";"2";"6.19";"3";"Cl.O=C(NCCc1ccccc1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(C(=O)C2(c3ccc(Cl)cc3)CC2)C1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.25";"0.20";"-0.34";"9.98";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112817";"";"None";"513.00";"0";"4.07";"14c";"CCCN1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"10.88";"0.21";"1.12";"10.61";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112796";"";"None";"657.06";"2";"5.52";"11g";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(Cc3ccccc3)CC2)C1";"IC50";"'='";"39000.0";"nM";"4.41";"";"";"UO_0000065";"7.10";"0.14";"-1.11";"6.68";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112828";"";"None";"610.46";"1";"4.55";"9a";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccccc2Cl)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"21000.0";"nM";"4.68";"";"";"UO_0000065";"8.15";"0.16";"0.13";"5.93";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL179820";"";"None";"526.33";"1";"4.56";"4";"Cc1ccc([C@H]2C(=O)Nc3ccc(I)cc3C(=O)N2[C@H](C(=O)O)c2ccccc2)cc1";"IC50";"'='";"13300.0";"nM";"4.88";"";"";"UO_0000065";"9.26";"0.21";"0.32";"5.62";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3112785";"";"None";"647.12";"1";"4.82";"9h";"Cc1nc2cc(OC3(C(=O)N4CCN(c5ccccn5)CC4)CCCN(C(=O)c4cnccc4C(F)(F)F)C3)ccc2s1.Cl";"IC50";"'='";"41000.0";"nM";"4.39";"";"";"UO_0000065";"7.18";"0.14";"-0.43";"4.78";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL178301";"";"None";"614.75";"2";"5.92";"18";"O=C(O)[C@H](c1ccc(C(F)(F)F)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"10.04";"0.24";"0.25";"7.12";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3601317";"";"None";"556.11";"2";"7.24";"3";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)[C@H]2c1ccc(Cl)cc1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"15.53";"0.29";"1.40";"15.73";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601321";"";"None";"604.24";"2";"7.76";"7";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.11";"0.27";"0.76";"18.84";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3134174";"";"None";"486.57";"1";"5.70";"41";"CCCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"328600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134215";"";"None";"500.60";"2";"5.94";"31";"COc1cccc(-c2cc(-c3cc(CC(=O)O)ccc3OCC(C)C)nn2Cc2ccccc2)c1OC";"IC50";"'='";"120000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134214";"";"None";"500.60";"2";"6.09";"30";"CCCCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"117700.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL178661";"";"None";"512.30";"1";"4.25";"3";"O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccccc1";"IC50";"'='";"38000.0";"nM";"4.42";"";"";"UO_0000065";"8.63";"0.20";"0.17";"5.10";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL4212404";"";"None";"545.48";"2";"6.13";"Rac-4b'";"CC(C)(C)C[C@@H]1C=C(C(=O)N[C@H]2C[C@@](C)(O)C2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"1257.0";"nM";"5.90";"";"";"UO_0000065";"10.82";"0.22";"-0.23";"7.52";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4212066";"";"None";"559.51";"2";"6.52";"Rac-4c'";"CC(C)(C)C[C@@H]1C=C(C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"619.0";"nM";"6.21";"";"";"UO_0000065";"11.10";"0.22";"-0.31";"7.92";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL1771610";"";"None";"594.26";"2";"5.84";"19, Racemic mixture";"O=C(O)CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"10.17";"0.24";"0.20";"7.51";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL362474";"";"None";"552.80";"2";"5.11";"11";"O=C1Nc2ccc(I)cc2C(=O)N([C@H](C(=O)O)C2CCCCC2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"64000.0";"nM";"4.19";"";"";"UO_0000065";"7.59";"0.18";"-0.92";"4.84";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3112826";"";"None";"645.53";"1";"4.70";"14l";"Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(S(=O)(=O)c2ccc(Cl)cc2)C1";"IC50";"'='";"50000.0";"nM";"4.30";"";"";"UO_0000065";"7.06";"0.14";"-0.40";"5.18";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112801";"";"None";"601.98";"2";"5.53";"11l";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)NCCc2ccccc2)C1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"9.65";"0.19";"-0.07";"7.63";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112798";"";"None";"629.00";"2";"5.58";"11i";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCC(c3ccccn3)C2)C1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"9.17";"0.18";"-0.15";"7.18";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL2315848";"";"None";"613.61";"2";"6.09";"21b";"CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N2CCOCC2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"12.36";"0.25";"1.50";"11.59";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2315839";"";"None";"474.46";"1";"6.32";"11b";"CC(C)C1=C(C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"15.99";"0.33";"1.27";"21.12";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL359846";"";"None";"485.32";"0";"4.45";"34";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(CO)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"11.29";"0.23";"1.03";"5.13";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL180205";"";"None";"582.18";"1";"4.95";"40";"O=C(O)[C@H](c1ccc(Cl)nc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"1470.0";"nM";"5.83";"";"";"UO_0000065";"10.02";"0.25";"0.88";"5.86";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL568499";"";"None";"496.37";"1";"5.50";"rac-21";"CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(C#N)cc2)n2ncnc21";"IC50";"'='";"5840.0";"nM";"5.23";"";"";"UO_0000065";"10.54";"0.22";"-0.27";"7.81";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3112815";"";"None";"643.03";"2";"5.52";"14a";"Cl.O=C(c1ccccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"8.55";"0.16";"-0.33";"7.86";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112813";"";"None";"781.15";"2";"6.00";"12j";"Cc1cc(CC(=O)Nc2ccccc2N2CCN(C(=O)C3(Oc4ccc(C(F)(F)F)cc4)CCCN(C(=O)c4cnccc4C(F)(F)F)C3)CC2)on1.Cl";"IC50";"'='";"630.0";"nM";"6.20";"";"";"UO_0000065";"8.33";"0.16";"0.20";"5.12";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112804";"";"None";"673.05";"2";"5.53";"11o";"COc1ccc(N2CCN(C(=O)C3(Oc4ccc(C(F)(F)F)cc4)CCCN(C(=O)c4cnccc4C(F)(F)F)C3)CC2)cc1.Cl";"IC50";"'='";"23000.0";"nM";"4.64";"";"";"UO_0000065";"7.29";"0.14";"-0.89";"6.17";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112795";"";"None";"580.96";"1";"3.95";"11f";"CN1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"9.04";"0.18";"0.97";"7.46";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL179662";"";"None";"449.59";"1";"5.03";"4";"OCC(NC1(c2ccccc2)c2ccccc2CC1Cc1ccccc1)C(O)c1ccccc1";"IC50";"'='";"85000.0";"nM";"4.07";"";"";"UO_0000065";"9.05";"0.16";"-0.96";"7.75";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL368017";"";"None";"420.51";"1";"5.20";"2i";"O=C1c2ccccc2C(OCCc2ccccn2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"206000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL361354";"";"None";"491.03";"1";"5.65";"2t";"CC(=O)NCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(Cl)cc1";"IC50";"'='";"91400.0";"nM";"4.04";"";"";"UO_0000065";"8.23";"0.16";"-1.61";"6.89";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL1834287";"";"None";"547.28";"2";"6.40";"(-)-10b";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"137.0";"nM";"6.86";"";"";"UO_0000065";"12.54";"0.28";"0.46";"13.79";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2315851";"";"None";"626.65";"2";"6.00";"24b";"CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N2CCN(C)CC2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"12.19";"0.25";"1.64";"12.85";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2315843";"";"None";"571.57";"2";"6.32";"14b";"CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"9.2";"nM";"8.04";"";"";"UO_0000065";"14.06";"0.29";"1.72";"14.29";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2177203";"";"None";"432.35";"1";"5.55";"14";"O=C(O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"1110.0";"nM";"5.96";"";"";"UO_0000065";"13.77";"0.28";"0.40";"10.34";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177198";"";"None";"434.36";"1";"5.78";"9";"CCOC(=O)[C@H](CC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"18700.0";"nM";"4.73";"";"";"UO_0000065";"10.89";"0.22";"-1.05";"10.14";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177186";"";"None";"492.40";"1";"5.48";"22";"CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"16.49";"0.34";"2.64";"9.68";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177202";"";"None";"392.28";"0";"4.61";"13";"COC(=O)CN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"13.41";"0.28";"0.65";"11.28";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL361115";"";"None";"454.96";"1";"5.85";"2f";"O=C1c2ccccc2C(OCCc2ccccn2)(c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"26200.0";"nM";"4.58";"";"";"UO_0000065";"10.07";"0.19";"-1.27";"10.80";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL178106";"";"None";"481.55";"1";"5.48";"2g";"COc1cc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O";"IC50";"'='";"17900.0";"nM";"4.75";"";"";"UO_0000065";"9.86";"0.18";"-0.73";"6.96";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL1771728";"";"None";"593.28";"2";"5.24";"24, Racemic mixture";"NC(=O)CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"10.56";"0.24";"1.03";"7.27";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL360160";"";"None";"309.41";"0";"4.18";"2b";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1CCC";"IC50";"'~'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL439183";"";"None";"434.54";"1";"5.67";"36";"O=C1c2ccccc2C(OCCNc2ccccc2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"116000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL264505";"";"None";"417.55";"1";"5.30";"63";"CCCN1C(=O)c2ccccc2C1(OCc1[nH]cnc1C)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"64300.0";"nM";"4.19";"";"";"UO_0000065";"10.04";"0.18";"-1.11";"7.20";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL213917";"";"None";"489.52";"0";"3.41";"51";"COC(=O)C(Cc1ccc(O)cc1)N1C(=O)c2ccccc2C1(OCCOC(C)=O)c1ccccc1";"IC50";"'='";"380000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3112779";"";"None";"610.46";"1";"4.55";"9b";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2cccc(Cl)c2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"5200.0";"nM";"5.28";"";"";"UO_0000065";"9.21";"0.18";"0.73";"6.70";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL4107088";"";"None";"476.40";"1";"5.45";"BDBM215155";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CC[C@@H](O)C2)C1=O";"IC50";"'='";"190.0";"nM";"6.72";"";"378434";"UO_0000065";"14.11";"0.29";"1.27";"8.63";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113101";"";"None";"470.42";"1";"5.50";"BDBM215169";"CC(C)N1[C@H](c2ccc(Cl)cc2)[C@@H](c2cccc(Cl)c2)C[C@@](C)(CC(=O)O)S1(=O)=O";"IC50";"'='";"560.0";"nM";"6.25";"";"378448";"UO_0000065";"13.29";"0.28";"0.75";"8.37";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892703";"";"None";"546.41";"2";"6.62";"BDBM215188";"CC[C@@H](CC(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378470";"UO_0000065";"13.54";"0.28";"0.78";"9.50";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114935";"";"None";"504.45";"2";"6.49";"BDBM215261";"CC[C@@H](C1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378506";"UO_0000065";"15.86";"0.32";"1.51";"11.97";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329606";"";"None";"512.44";"2";"6.47";"BDBM215275";"CC[C@@H](c1ncccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"378516";"UO_0000065";"14.09";"0.28";"0.75";"8.66";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108536";"";"None";"435.35";"1";"5.01";"BDBM215442";"CN(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378534";"UO_0000065";"17.68";"0.36";"2.69";"12.65";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111829";"";"None";"520.45";"2";"6.26";"BDBM215050";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378535";"UO_0000065";"16.14";"0.33";"2.14";"10.01";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892703";"";"None";"546.41";"2";"6.62";"BDBM215188";"CC[C@@H](CC(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"14.0";"nM";"7.85";"";"378572";"UO_0000065";"14.37";"0.30";"1.23";"10.09";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108351";"";"None";"605.58";"2";"5.78";"BDBM215309";"C[C@]1(C2(C(=O)O)CC2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C2CC2)C2CC2)C1=O";"IC50";"'='";"5.5";"nM";"8.26";"";"378678";"UO_0000065";"13.64";"0.28";"2.48";"7.96";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112350";"";"None";"655.64";"2";"7.31";"BDBM215312";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(c2ccccc2)S(=O)(=O)C2CC2)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378681";"UO_0000065";"14.79";"0.30";"2.39";"10.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112224";"";"None";"649.66";"2";"6.83";"BDBM215321";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(Cc2cccs2)S(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"0.7";"nM";"9.15";"";"378690";"UO_0000065";"14.09";"0.30";"2.32";"9.64";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125518";"";"None";"595.59";"2";"5.98";"BDBM50448970";"CC(C)[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"378700";"UO_0000065";"14.68";"0.31";"2.76";"9.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961423";"";"None";"581.56";"2";"5.78";"BDBM215335";"CC[C@@H](CNS(=O)(=O)C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"378703";"UO_0000065";"15.28";"0.32";"3.11";"8.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3942755";"";"None";"568.56";"2";"6.38";"BDBM215338";"CC[C@@H](CS(=O)(=O)CC(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"378707";"UO_0000065";"16.36";"0.34";"2.92";"10.14";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3893885";"";"None";"596.57";"2";"5.90";"BDBM215341";"CC[C@@H](CS(=O)(=O)C1CCOCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378713";"UO_0000065";"16.26";"0.34";"3.80";"9.60";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929623";"";"None";"620.64";"2";"7.45";"BDBM215366";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CCCCC2)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"378738";"UO_0000065";"16.11";"0.33";"2.55";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3977180";"";"None";"594.60";"2";"6.91";"BDBM215376";"CCC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"378759";"UO_0000065";"15.51";"0.32";"2.31";"10.05";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3134201";"";"None";"553.06";"2";"7.52";"17";"CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OCc2cccc(Cl)c2)nn1Cc1ccccc1";"IC50";"'='";"54390.0";"nM";"4.26";"";"";"UO_0000065";"7.71";"0.15";"-3.26";"5.80";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.44";"0";"CHEMBL2321368";"Inhibition of human p53/MDM2 interaction";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2315845";"";"None";"585.60";"2";"6.71";"16a";"CC(C)C1=C(C(=O)N2CCCC[C@H]2C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"11.56";"0.24";"0.06";"12.04";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2315844";"";"None";"571.57";"2";"6.32";"15a";"CC(C)C1=C(C(=O)N2CCC[C@@H]2C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"740.0";"nM";"6.13";"";"";"UO_0000065";"10.73";"0.22";"-0.19";"10.90";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3774508";"";"None";"265.38";"0";"3.56";"1c; K-178";"CC(C)C(=O)Nc1ccccc1SC(=O)C(C)C";"IC50";"'='";"13100.0";"nM";"4.88";"";"";"UO_0000065";"18.40";"0.37";"1.32";"10.58";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL4110383";"";"None";"549.45";"2";"7.81";"BDBM236337";"COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"6.21";"nM";"8.21";"";"411721";"UO_0000065";"14.94";"0.29";"0.40";"11.44";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3909065";"";"None";"573.48";"2";"7.03";"BDBM236344";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C#N)C3=O)c1";"IC50";"'='";"0.378";"nM";"9.42";"";"411728";"UO_0000065";"16.43";"0.32";"2.39";"10.79";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3112816";"";"None";"629.05";"2";"5.88";"14b";"Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(Cc2ccccc2C(F)(F)F)C1";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"8.19";"0.16";"-1.03";"9.92";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3220704";"";"None";"398.29";"1";"5.48";"Pageno254, R14C2";"COc1cccc([C@]2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc32)c1";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"16.45";"0.33";"1.07";"17.10";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL361559";"";"None";"540.78";"1";"4.97";"13";"CC(C)CC[C@@H](C(=O)O)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"12000.0";"nM";"4.92";"";"";"UO_0000065";"9.10";"0.22";"-0.05";"5.68";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL181252";"";"None";"614.75";"2";"5.92";"22";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(C(F)(F)F)cc1";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"10.10";"0.24";"0.29";"7.16";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL4299674";"";"None";"708.70";"2";"6.06";"3";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1ccc(C(F)(F)F)cc1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"10.44";"0.20";"1.34";"7.75";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"12.30";"0.24";"1.26";"8.57";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3601397";"";"None";"645.24";"2";"6.24";"12";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCNC(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"13.63";"0.26";"2.56";"11.83";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601324";"";"None";"632.25";"2";"7.73";"10";"CCC(=O)N[C@H]1CC[C@H](CN(C)c2ccc(N3C(=O)Cc4cc(OC)c(O[C@H](C)CC)cc4[C@@H]3c3ccc(Cl)cc3)cc2)CC1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"12.18";"0.23";"-0.03";"10.83";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL2024321";"";"None";"363.89";"1";"6.40";"3";"CC(C)CCn1cnc(-c2ccccc2)c1-c1c[nH]c2cc(Cl)ccc12";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"16.61";"0.32";"-0.35";"17.99";"0";"CHEMBL2027062";"Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2021844";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.76";"0.27";"2.11";"9.58";"0";"CHEMBL2027062";"Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2021844";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4299646";"";"None";"764.74";"2";"6.76";"11";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"9.94";"0.20";"0.84";"7.97";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3601317";"";"None";"556.11";"2";"7.24";"11";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)[C@H]2c1ccc(Cl)cc1";"IC50";"'='";"2.3";"nM";"8.64";"";"";"UO_0000065";"15.53";"0.29";"1.40";"15.73";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3604658";"";"None";"451.95";"1";"5.82";"1";"CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(OC)cc1)C(=O)C2";"IC50";"'='";"540.0";"nM";"6.27";"";"";"UO_0000065";"13.87";"0.27";"0.45";"13.06";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL361676";"";"None";"597.65";"1";"4.36";"1";"CC(C)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(NN=C3C(=O)N(c4ccccc4)N(c4ccccc4)C3=O)cc2)cc1";"IC50";"'='";"31800.0";"nM";"4.50";"";"";"UO_0000065";"7.53";"0.14";"0.14";"3.27";"0";"CHEMBL832457";"In vitro inhibitory concentration against p53-mdm2 interaction";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137206";"1";"Scientific Literature";"J Med Chem";"2004";"None";"";""
"CHEMBL2177185";"";"None";"456.38";"0";"4.83";"BDBM215104";"O=C1[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"90.0";"nM";"7.05";"";"378383";"UO_0000065";"15.44";"0.31";"2.22";"9.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115245";"";"None";"529.51";"2";"6.41";"BDBM215118";"O=C(O)C[C@@]1(CCN2CCCC2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"60.0";"nM";"7.22";"";"378397";"UO_0000065";"13.64";"0.27";"0.81";"11.87";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111833";"";"None";"462.42";"1";"6.72";"BDBM215120";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378542";"UO_0000065";"18.43";"0.38";"1.80";"14.79";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966894";"";"None";"574.55";"2";"5.47";"BDBM215146";"CC[C@@H](CN1CCN(C(C)=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378549";"UO_0000065";"15.14";"0.30";"3.23";"10.72";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177189";"";"None";"558.51";"2";"5.93";"BDBM50397774";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378558";"UO_0000065";"16.11";"0.32";"3.07";"8.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3977905";"";"None";"574.47";"2";"7.40";"BDBM215183";"CC[C@@H](CCC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378566";"UO_0000065";"15.14";"0.31";"1.30";"11.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962770";"";"None";"581.56";"2";"5.73";"BDBM215186";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378569";"UO_0000065";"15.48";"0.32";"3.27";"9.47";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961625";"";"None";"623.52";"2";"6.13";"BDBM215192";"CC[C@@H](CN(CC(F)(F)F)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378575";"UO_0000065";"13.95";"0.30";"2.57";"9.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941572";"";"None";"624.63";"1";"4.76";"BDBM215207";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NCCO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"49.0";"nM";"7.31";"";"378588";"UO_0000065";"11.70";"0.24";"2.55";"6.83";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112746";"";"None";"478.42";"1";"5.69";"BDBM215198";"CC[C@@H]([C@@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378479";"UO_0000065";"16.72";"0.34";"2.31";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115158";"";"None";"492.44";"1";"6.08";"BDBM215201";"CC[C@@H](O)[C@H](CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378481";"UO_0000065";"16.25";"0.33";"1.92";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329605";"";"None";"511.45";"2";"7.08";"BDBM215270";"CC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378511";"UO_0000065";"14.71";"0.29";"0.44";"10.67";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3930864";"";"None";"518.48";"2";"6.74";"BDBM215117";"CC[C@@H](COCC1CC1)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378541";"UO_0000065";"16.78";"0.34";"1.96";"13.01";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115408";"";"None";"567.54";"2";"5.35";"BDBM215193";"CCC(CN1CCCS1(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378576";"UO_0000065";"15.86";"0.33";"3.65";"9.47";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3968058";"";"None";"605.59";"2";"5.25";"BDBM215212";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NC#N)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378593";"UO_0000065";"14.36";"0.30";"3.45";"7.87";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921531";"";"None";"554.54";"2";"6.14";"BDBM215245";"CC[C@@H](CCS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378628";"UO_0000065";"16.23";"0.34";"2.86";"9.81";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3951659";"";"None";"609.47";"2";"7.19";"BDBM215259";"CC[C@@H](Cn1cc(C(F)(F)F)ccc1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"12.0";"nM";"7.92";"";"378641";"UO_0000065";"13.00";"0.26";"0.73";"9.95";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329605";"";"None";"511.45";"2";"7.08";"BDBM215270";"CC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378648";"UO_0000065";"15.64";"0.31";"0.92";"11.35";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895235";"";"None";"512.44";"2";"6.47";"BDBM215274";"CC[C@@H](c1cnccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"378649";"UO_0000065";"15.53";"0.31";"1.49";"9.54";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3959155";"";"None";"614.59";"2";"7.17";"BDBM215357";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2)C2CC2)C1=O";"IC50";"'='";"1.6";"nM";"8.80";"";"378729";"UO_0000065";"14.31";"0.29";"1.63";"9.59";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3924621";"";"None";"538.54";"2";"6.47";"BDBM215386";"CC[C@@H](C[S@@+]([O-])C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.6";"nM";"8.59";"";"378771";"UO_0000065";"15.94";"0.33";"2.12";"10.64";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3925643";"";"None";"490.00";"1";"5.99";"BDBM236324";"COc1ccc(C#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O";"IC50";"'='";"1.509";"nM";"8.82";"";"411708";"UO_0000065";"18.00";"0.34";"2.83";"13.07";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3916949";"";"None";"481.98";"0";"4.49";"BDBM236325";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O";"IC50";"'='";"5.081";"nM";"8.29";"";"411709";"UO_0000065";"17.21";"0.33";"3.80";"8.68";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3985001";"";"None";"529.99";"1";"4.54";"BDBM236375";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.527";"nM";"9.28";"";"411759";"UO_0000065";"17.51";"0.33";"4.74";"7.20";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3949558";"";"None";"525.05";"2";"5.70";"BDBM236390";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N([C@H]2CC[C@H](OC)CC2)C3=O)c(OC)n1";"IC50";"'='";"1.688";"nM";"8.77";"";"411774";"UO_0000065";"16.71";"0.32";"3.07";"11.15";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3964391";"";"None";"545.00";"1";"4.52";"BDBM236400";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.422";"nM";"9.38";"";"411784";"UO_0000065";"17.20";"0.33";"4.85";"8.13";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3900233";"";"None";"506.01";"1";"4.89";"BDBM236425";"COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nn1C)C2=O";"IC50";"'='";"1.074";"nM";"8.97";"";"411809";"UO_0000065";"17.72";"0.34";"4.08";"12.07";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3805828";"";"None";"726.82";"2";"6.63";"7";"C=CC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1cc(C2CC2)cs1)C(=O)N1CCN(c2ccccc2OCCCC(=O)O)CC1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"7.51";"0.15";"-1.17";"4.85";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3805082";"";"None";"728.76";"2";"6.43";"12";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1C)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"9.93";"0.20";"0.81";"7.58";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3774671";"";"None";"179.22";"0";"1.99";"1d";"CC(C)C(=O)Nc1ccccc1O";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL2177183";"";"None";"431.36";"0";"4.95";"19";"NC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"15.23";"0.31";"1.62";"10.36";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL384251";"";"None";"484.94";"1";"6.32";"31";"O=C1c2ccccc2C(OCc2ccc(Cl)c([N+](=O)[O-])c2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"206000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL385387";"";"None";"427.55";"0";"3.47";"28";"O=C1c2ccccc2C(OCCN2CCNCC2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"315000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL214459";"";"None";"421.50";"1";"5.47";"24";"O=C1c2ccccc2C(OCc2ccc(O)cc2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"79000.0";"nM";"4.10";"";"";"UO_0000065";"9.73";"0.18";"-1.37";"8.24";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217054";"";"None";"413.47";"0";"4.29";"21";"C=CC(=O)OCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"439000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL214623";"";"None";"486.57";"0";"3.15";"67";"C=C(C)C(=O)OCCN1C(=O)c2ccccc2C1(N[C@@H](CO)[C@@H](O)c1ccccc1)c1ccccc1";"IC50";"'='";"103000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL386911";"";"None";"311.38";"0";"2.76";"53";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1CCO";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL361345";"";"None";"448.01";"1";"6.92";"78";"CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(Cl)cc1";"IC50";"'='";"187000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL178504";"";"None";"372.47";"0";"4.41";"73";"CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccccc1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"10.74";"0.20";"-0.41";"9.43";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL386814";"";"None";"464.52";"1";"5.98";"39";"Cc1ccc([N+](=O)[O-])c(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)c1";"IC50";"'='";"232000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL2177201";"";"None";"420.34";"1";"5.39";"12";"CCOC(=O)[C@H](C)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"13.73";"0.28";"0.38";"12.38";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177193";"";"None";"374.31";"1";"5.85";"(5S,6R)-4";"O=C1CC[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL584501";"";"None";"495.38";"1";"5.61";"rac-16";"C#Cc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3C)cc1";"IC50";"'='";"2470.0";"nM";"5.61";"";"";"UO_0000065";"11.32";"0.23";"0.00";"12.99";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL567435";"";"None";"568.24";"2";"6.53";"rac-30";"CN1C2=C(C(c3ccc(Br)cc3)Oc3cc(F)ccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"10.57";"0.25";"-0.53";"13.91";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL583427";"";"None";"536.23";"2";"6.36";"1d";"Brc1ccc([C@H]2Oc3ccccc3C3=C2[C@@H](c2ccc(Br)cc2)n2ncnc2N3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL4299661";"";"None";"714.73";"2";"6.12";"6";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1cc(C(F)(F)F)cs1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"9.47";"0.19";"0.65";"7.09";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL4299637";"";"None";"712.69";"1";"4.80";"9";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1cc(C(F)(F)F)n(C)n1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"7.30";"0.14";"0.40";"4.59";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL2398243";"";"None";"696.74";"2";"7.08";"36";"CC[C@@H]1CC[C@@H](C(=O)N2CCN(C(C)=O)[C@@H](C)C2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"10.38";"0.21";"0.15";"9.45";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2398238";"";"None";"682.72";"2";"6.69";"31";"CC(=O)N1CCN(C(=O)[C@@H]2CC[C@@H](C)N2C(=O)C2=C(C(C)C)N3C(=N[C@@](C)(c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)C[C@@H]1C";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"10.89";"0.22";"0.74";"9.71";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3329616";"";"None";"525.48";"2";"7.39";"18";"CC[C@@H](c1cc(C)ccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"13.74";"0.27";"-0.17";"10.24";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329603";"";"None";"501.41";"2";"6.67";"4";"CC[C@@H](c1cnco1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"14.85";"0.30";"0.77";"8.90";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329620";"";"None";"434.36";"1";"5.94";"23";"CC(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"18.52";"0.38";"2.11";"13.97";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329614";"";"None";"551.51";"2";"7.96";"16";"CC[C@@H](c1cccc(C2CC2)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.05";"0.30";"0.34";"11.77";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329606";"";"None";"512.44";"2";"6.47";"7";"CC[C@@H](c1ncccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"15.91";"0.32";"1.68";"9.78";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329601";"";"None";"492.44";"1";"6.35";"2";"CC[C@@H]([C@H](C)OC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"17.67";"0.36";"2.35";"13.01";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2398344";"";"None";"640.68";"2";"6.39";"23";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCN(C)CC2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"12.17";"0.25";"1.41";"13.11";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL1933130";"";"None";"1512.78";"None";"None";"5";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CS)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"5.21";"None";"None";"None";"0";"CHEMBL1936335";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1933030";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL407632";"NUTLIN-2";"None";"686.45";"2";"5.89";"1";"CCOc1cc(OC)ccc1C1=N[C@@H](c2ccc(Br)cc2)[C@@H](c2ccc(Br)cc2)N1C(=O)N1CCN(CCO)CC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"9.98";"0.23";"0.96";"8.81";"0";"CHEMBL3223357";"Inhibition of p53 interaction to MDM2 (unknown origin) by surface plasmon resonance assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3220436";"";"None";"653.66";"2";"5.72";"14";"CC(C)(C)c1ncc(C2=N[C@@](C)(c3ccc(Cl)cc3)[C@@](C)(c3ccc(Cl)cc3)N2C(=O)N2CCN(CCOCCO)CC2)cn1";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"11.49";"0.23";"1.79";"7.95";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3220691";"";"None";"502.49";"2";"5.20";"23";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCCCCO)[C@@H](c2cccc(Cl)c2)[C@@]1(C#N)c1ccc(Cl)cc1";"IC50";"'='";"309.0";"nM";"6.51";"";"";"UO_0000065";"12.96";"0.26";"1.31";"7.65";"0";"CHEMBL3223364";"Inhibition of p53 interaction to MDM2 (unknown origin) by HTRF assay in presence of 0.02% bovine serum albumin";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL1933128";"";"None";"1726.07";"None";"None";"3";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)[C@@H](C)O";"IC50";"'='";"237.0";"nM";"6.62";"";"";"UO_0000065";"3.84";"None";"None";"None";"0";"CHEMBL1936335";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1933030";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3601319";"";"None";"562.15";"2";"6.64";"5";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)CC3CCNCC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.94";"0.29";"1.76";"15.54";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3112788";"";"None";"590.05";"1";"4.21";"2";"Cc1ccc(OC2(C(=O)N3CCN(c4ccccn4)CC3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)cc1.Cl";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"10.52";"0.20";"1.61";"7.38";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112782";"";"None";"654.92";"1";"4.66";"9e";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(Br)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"1900.0";"nM";"5.72";"";"";"UO_0000065";"9.25";"0.20";"1.06";"7.25";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3774514";"";"None";"229.30";"0";"3.23";"3b";"O=C(Nc1ccccc1S)c1ccccc1";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL3134182";"";"None";"416.45";"1";"5.04";"49";"COc1ccc(CC(=O)O)cc1-c1cc(-c2ccc(F)cc2)n(Cc2ccccc2)n1";"IC50";"'='";"594700.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134212";"";"None";"442.52";"1";"5.76";"28";"CCOc1ccc(C(=O)O)cc1-c1cc(-c2ccccc2OCC)n(Cc2ccccc2)n1";"IC50";"'='";"111100.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134211";"";"None";"484.60";"1";"6.27";"27";"CCOc1ccc(CCC(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1";"IC50";"'='";"105400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134195";"";"None";"597.11";"2";"7.73";"10";"COc1cccc(-c2cc(-c3cc(CCC(=O)O)ccc3OCc3cccc(Cl)c3)nn2CCc2ccccc2)c1OC";"IC50";"'='";"34020.0";"nM";"4.47";"";"";"UO_0000065";"7.48";"0.14";"-3.26";"5.40";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134194";"";"None";"583.08";"2";"7.53";"9";"COc1cccc(-c2cc(-c3cc(CCC(=O)O)ccc3OCc3cccc(Cl)c3)nn2Cc2ccccc2)c1OC";"IC50";"'='";"31620.0";"nM";"4.50";"";"";"UO_0000065";"7.72";"0.15";"-3.03";"5.43";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2315852";"";"None";"640.68";"2";"6.44";"25b";"CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N2C[C@@H](C)N[C@@H](C)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"11.60";"0.24";"0.99";"10.89";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2315833";"";"None";"529.49";"2";"5.19";"8a";"CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"12.06";"0.25";"1.20";"9.82";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL1944940";"";"None";"556.45";"2";"6.13";"7a";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)O)c(OC(C)C)c1";"IC50";"'='";"6165.95";"nM";"5.21";"";"";"UO_0000065";"9.36";"0.19";"-0.92";"5.19";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945440";"";"None";"652.62";"2";"6.21";"8j";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@@H](C)C(=O)N2CCN(C)CC2)c(OC(C)C)c1";"IC50";"'='";"6025.6";"nM";"5.22";"";"";"UO_0000065";"8.00";"0.16";"-0.99";"6.02";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL214545";"";"None";"421.50";"1";"5.47";"30";"O=C1c2ccccc2C(OCc2cccc(O)c2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"58000.0";"nM";"4.24";"";"";"UO_0000065";"10.05";"0.18";"-1.23";"8.51";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL178320";"";"None";"325.41";"0";"3.15";"72";"CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL1771604";"";"None";"594.31";"2";"6.14";"10, Racemic mixture";"OCCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"10.71";"0.25";"0.23";"10.04";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1771708";"";"None";"564.28";"2";"6.78";"9, Racemic mixture";"CCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"10.18";"0.24";"-1.04";"13.30";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3112819";"";"None";"567.10";"2";"5.24";"14e";"Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(CC2CCCCC2)C1";"IC50";"'='";"5100.0";"nM";"5.29";"";"";"UO_0000065";"9.97";"0.19";"0.05";"10.82";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112818";"";"None";"555.09";"2";"5.10";"14d";"CC(C)(C)CCN1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"9.95";"0.19";"0.06";"10.55";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112814";"";"None";"798.14";"1";"4.06";"12k";"Cl.O=C(CC1NC(=O)NC1=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"8.62";"0.17";"2.51";"4.29";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112806";"";"None";"687.08";"2";"5.92";"12b";"CCOc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"590.0";"nM";"6.23";"";"";"UO_0000065";"9.57";"0.18";"0.31";"8.28";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112805";"";"None";"659.03";"2";"5.23";"12a";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccc3O)CC2)C1";"IC50";"'='";"970.0";"nM";"6.01";"";"";"UO_0000065";"9.66";"0.19";"0.78";"6.98";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112803";"";"None";"673.05";"2";"5.53";"11n";"COc1cccc(N2CCN(C(=O)C3(Oc4ccc(C(F)(F)F)cc4)CCCN(C(=O)c4cnccc4C(F)(F)F)C3)CC2)c1.Cl";"IC50";"'>'";"50000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112800";"";"None";"622.39";"2";"6.14";"11k";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)NCc2ccc(Cl)cc2)C1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"9.94";"0.20";"-0.32";"8.14";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112792";"";"None";"645.00";"1";"4.31";"11c";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ncccn3)CC2)C1";"IC50";"'='";"35000.0";"nM";"4.46";"";"";"UO_0000065";"7.32";"0.14";"0.15";"4.86";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112789";"";"None";"644.02";"1";"4.92";"1";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"9.28";"0.18";"0.72";"7.15";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112784";"";"None";"628.45";"1";"4.69";"9g";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(Cl)c(F)c2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"9.89";"0.19";"1.16";"7.42";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL217399";"";"None";"435.57";"0";"4.09";"62";"CCCN1C(=O)c2ccccc2C1(OCCN1CCNC1=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"74300.0";"nM";"4.13";"";"";"UO_0000065";"9.48";"0.18";"0.04";"6.67";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL362614";"";"None";"406.91";"1";"5.06";"81";"CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccc(Cl)cc1";"IC50";"'='";"57000.0";"nM";"4.24";"";"";"UO_0000065";"10.43";"0.20";"-0.82";"10.00";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL360944";"";"None";"467.95";"1";"5.35";"79, NU8231";"CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(Cl)cc1";"IC50";"'='";"5300.0";"nM";"5.28";"";"";"UO_0000065";"11.27";"0.22";"-0.07";"7.73";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217044";"";"None";"358.44";"0";"3.13";"S24";"O=C1c2ccccc2C(NCCO)(c2ccccc2)N1Cc1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3112827";"";"None";"577.07";"1";"3.40";"14m";"CC(C)S(=O)(=O)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl";"IC50";"'='";"6900.0";"nM";"5.16";"";"";"UO_0000065";"9.55";"0.19";"1.76";"6.21";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112823";"";"None";"611.09";"1";"4.05";"14i";"Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(S(=O)(=O)c2ccccc2)C1";"IC50";"'='";"26000.0";"nM";"4.58";"";"";"UO_0000065";"7.98";"0.16";"0.54";"5.52";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112811";"";"None";"757.18";"2";"5.41";"12h";"CN(C)CCC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"590.0";"nM";"6.23";"";"";"UO_0000065";"8.64";"0.17";"0.82";"6.34";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112808";"";"None";"714.11";"2";"5.87";"12e";"CCC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"9.49";"0.18";"0.56";"6.76";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112778";"";"None";"717.11";"2";"5.55";"12c";"COCCOc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"330.0";"nM";"6.48";"";"";"UO_0000065";"9.52";"0.18";"0.93";"7.68";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112802";"";"None";"673.05";"2";"5.53";"11m";"COc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"560.0";"nM";"6.25";"";"";"UO_0000065";"9.82";"0.19";"0.72";"8.31";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112797";"";"None";"640.02";"2";"6.49";"11h";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CC=C(c3ccccc3)CC2)C1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"9.70";"0.19";"-0.64";"9.33";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112790";"";"None";"643.03";"2";"5.52";"11a";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccc3)CC2)C1";"IC50";"'='";"2800.0";"nM";"5.55";"";"";"UO_0000065";"9.15";"0.18";"0.03";"8.42";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL217146";"";"None";"479.58";"1";"5.82";"25";"COc1ccc(CCOC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1OC";"IC50";"'='";"311000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217718";"";"None";"429.58";"0";"4.11";"58";"CCCN1C(=O)c2ccccc2C1(OCCS(C)(=O)=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"290000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL384875";"";"None";"502.57";"2";"5.25";"S11";"O=C1c2ccccc2C(=O)N1CCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"189000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL4210216";"";"None";"574.52";"2";"5.55";"Rac-4a''''";"CC(C)(C)C[C@H]1C=C(C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"738.8";"nM";"6.13";"";"";"UO_0000065";"10.67";"0.21";"0.58";"8.68";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL2398237";"";"None";"682.72";"2";"6.69";"30";"CC(=O)N1CCN(C(=O)[C@@H]2CC[C@@H](C)N2C(=O)C2=C(C(C)C)N3C(=N[C@@](C)(c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)C[C@H]1C";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"11.02";"0.22";"0.83";"9.83";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL368244";"";"None";"582.18";"1";"4.95";"41";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)nc1";"IC50";"'='";"7400.0";"nM";"5.13";"";"";"UO_0000065";"8.81";"0.22";"0.18";"5.15";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3927069";"";"None";"604.56";"2";"5.68";"BDBM215239";"CC[C@@H](CNS(=O)(=O)c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378622";"UO_0000065";"14.89";"0.31";"3.32";"7.71";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3970501";"";"None";"600.56";"2";"6.78";"BDBM215347";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2)C2CC2)C1=O";"IC50";"'='";"1.4";"nM";"8.85";"";"378719";"UO_0000065";"14.74";"0.30";"2.07";"9.65";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3968199";"";"None";"606.61";"2";"7.06";"BDBM215365";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CCCC2)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378737";"UO_0000065";"15.99";"0.33";"2.64";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL214180";"";"None";"476.58";"1";"5.51";"38";"CN(CCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)c1ccc(C=O)cc1";"IC50";"'='";"191000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL386804";"";"None";"426.52";"0";"4.18";"20";"O=C1CCCN1CCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"393000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217774";"";"None";"443.59";"1";"6.02";"61";"CCCN1C(=O)c2ccccc2C1(OCCc1ccc(O)cc1)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"69700.0";"nM";"4.16";"";"";"UO_0000065";"9.37";"0.17";"-1.86";"8.35";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL215009";"";"None";"464.57";"0";"4.23";"S22";"O=C1c2ccccc2C(NC(CO)C(O)c2ccccc2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"85000.0";"nM";"4.07";"";"";"UO_0000065";"8.76";"0.16";"-0.16";"5.59";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL1834379";"";"None";"496.92";"1";"5.03";"10k";"O=C1c2cc(F)ccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"852.0";"nM";"6.07";"";"";"UO_0000065";"12.21";"0.24";"1.04";"6.53";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL4788289";"";"None";"577.44";"2";"6.00";"Ia-38";"O=C(O)c1ccc2nn3c(c2c1)C[C@H]1[C@@H]3[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)N1CC1CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.06";"0.30";"2.70";"9.95";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3601402";"";"None";"660.26";"2";"5.98";"16";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cn1)C(=O)C2";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"13.18";"0.25";"2.72";"11.09";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601401";"";"None";"660.26";"2";"5.98";"15";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)nc1)C(=O)C2";"IC50";"'='";"2.5";"nM";"8.60";"";"";"UO_0000065";"13.03";"0.25";"2.62";"10.97";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601318";"";"None";"556.11";"2";"7.24";"4";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)[C@@H]2c1ccc(Cl)cc1";"IC50";"'='";"1171.0";"nM";"5.93";"";"";"UO_0000065";"10.67";"0.20";"-1.31";"10.80";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3134196";"";"None";"458.53";"1";"6.01";"11";"CCOc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(F)cc2)n(CCc2ccccc2)n1";"IC50";"'='";"35780.0";"nM";"4.45";"";"";"UO_0000065";"9.70";"0.18";"-1.56";"6.91";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL179890";"";"None";"489.74";"1";"5.61";"32";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2ccc(Cl)cc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"6300.0";"nM";"5.20";"";"";"UO_0000065";"10.62";"0.22";"-0.41";"6.00";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL2315849";"";"None";"654.66";"2";"5.92";"22b";"CC(=O)N1CCN(C(=O)[C@@H]2CCCN2C(=O)C2=C(C(C)C)N3C(=N[C@@](C)(c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)CC1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"10.97";"0.22";"1.26";"9.38";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2315834";"";"None";"529.49";"2";"5.19";"8b";"CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"92.0";"nM";"7.04";"";"";"UO_0000065";"13.29";"0.27";"1.85";"10.82";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL1834375";"";"None";"492.96";"1";"5.20";"10g";"Cc1ccc2c(c1)C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"492.0";"nM";"6.31";"";"";"UO_0000065";"12.80";"0.25";"1.11";"6.79";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3955006";"";"None";"497.00";"0";"4.92";"BDBM236323";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCOCC2)C3=O)c(OC)n1";"IC50";"'='";"1.64";"nM";"8.79";"";"411707";"UO_0000065";"17.68";"0.34";"3.87";"11.16";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892862";"";"None";"563.48";"2";"7.74";"BDBM236338";"COc1ccc(CC(=O)O)cc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.061";"nM";"10.21";"";"411722";"UO_0000065";"18.13";"0.36";"2.47";"14.23";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3914272";"";"None";"496.01";"0";"4.49";"BDBM236353";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCNCC2)C3=O)c(OC)n1";"IC50";"'='";"904.2";"nM";"6.04";"";"411737";"UO_0000065";"12.18";"0.24";"1.55";"7.41";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3922357";"";"None";"544.02";"1";"4.56";"BDBM236383";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"0.131";"nM";"9.88";"";"411767";"UO_0000065";"18.17";"0.35";"5.32";"8.23";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3949094";"";"None";"525.40";"1";"4.86";"BDBM236385";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"0.341";"nM";"9.47";"";"411769";"UO_0000065";"18.02";"0.36";"4.61";"7.95";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895549";"";"None";"538.09";"2";"5.76";"BDBM236389";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](OC)CC1)C2=O";"IC50";"'='";"0.74";"nM";"9.13";"";"411773";"UO_0000065";"16.97";"0.33";"3.37";"12.56";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919420";"";"None";"510.60";"1";"4.26";"BDBM236427";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(C)nn1C)C2=O";"IC50";"'='";"0.647";"nM";"9.19";"";"411811";"UO_0000065";"18.00";"0.33";"4.93";"8.74";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111792";"";"None";"547.48";"2";"5.20";"BDBM215065";"CC[C@@H](COCC1(C(N)=O)CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"378344";"UO_0000065";"13.07";"0.26";"1.95";"6.51";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110652";"";"None";"473.40";"1";"6.22";"BDBM215079";"CC[C@@H](CCC#N)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378537";"UO_0000065";"17.74";"0.36";"2.18";"10.32";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113368";"";"None";"432.35";"1";"5.55";"BDBM215084";"O=C(O)C[C@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"30.0";"nM";"7.52";"";"378538";"UO_0000065";"17.40";"0.35";"1.97";"13.06";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904550";"";"None";"610.60";"1";"4.89";"BDBM215145";"CC[C@@H](CN1CCN(S(C)(=O)=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"378548";"UO_0000065";"13.26";"0.28";"3.21";"8.24";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110280";"";"None";"486.44";"1";"6.72";"BDBM215164";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C(C2CC2)C2CC2)C1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"378553";"UO_0000065";"18.50";"0.37";"2.28";"15.62";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3948736";"";"None";"562.41";"2";"5.94";"BDBM215182";"CC[C@@H](CC(O)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378565";"UO_0000065";"15.47";"0.32";"2.76";"8.87";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107867";"";"None";"547.52";"2";"6.47";"BDBM215221";"CC[C@@H](C(=O)NCC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"378602";"UO_0000065";"15.02";"0.30";"1.75";"9.48";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3947049";"";"None";"595.47";"2";"5.75";"BDBM215226";"CC[C@@H](CNS(=O)(=O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"378609";"UO_0000065";"13.69";"0.29";"2.40";"7.86";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108550";"";"None";"472.37";"1";"5.47";"BDBM215158";"Cn1cc(N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)cn1";"IC50";"'='";"300.0";"nM";"6.52";"";"378437";"UO_0000065";"13.81";"0.28";"1.05";"8.65";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107479";"";"None";"470.36";"1";"5.53";"BDBM215161";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ncccn2)C1=O";"IC50";"'='";"230.0";"nM";"6.64";"";"378440";"UO_0000065";"14.11";"0.28";"1.11";"7.96";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3902756";"";"None";"534.52";"2";"7.25";"BDBM215185";"CC[C@@H](CCCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378466";"UO_0000065";"14.97";"0.30";"0.75";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3952928";"";"None";"492.44";"1";"6.08";"BDBM215190";"CC[C@@H](CC(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378472";"UO_0000065";"16.25";"0.33";"1.92";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941874";"";"None";"561.55";"2";"6.42";"BDBM215254";"CC[C@@H](CN1CCOCC1(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378498";"UO_0000065";"13.71";"0.28";"1.28";"10.99";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3938935";"";"None";"537.49";"2";"7.47";"BDBM215272";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](CC2CC2)c2ccccn2)C1=O";"IC50";"'='";"80.0";"nM";"7.10";"";"378513";"UO_0000065";"13.20";"0.26";"-0.37";"10.07";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329607";"";"None";"511.45";"2";"7.08";"BDBM215277";"CC[C@@H](c1ccncc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378518";"UO_0000065";"14.46";"0.29";"0.32";"10.49";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114388";"";"None";"551.51";"2";"7.96";"BDBM215282";"CC[C@H](c1cccc(C2CC2)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378521";"UO_0000065";"13.64";"0.27";"-0.44";"10.67";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108869";"";"None";"492.44";"1";"5.94";"BDBM215197";"CC[C@@H]([C@H](C)CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378581";"UO_0000065";"17.67";"0.36";"2.76";"11.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108608";"";"None";"658.67";"1";"4.73";"BDBM215205";"CCC(CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NS(C)(=O)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"378586";"UO_0000065";"12.48";"0.27";"3.49";"6.80";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3981404";"";"None";"595.59";"2";"5.98";"BDBM215216";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(C(C)C(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"378597";"UO_0000065";"13.14";"0.27";"1.84";"8.24";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3924685";"";"None";"518.48";"2";"6.88";"BDBM215264";"CC[C@@H](C1CCCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378645";"UO_0000065";"17.36";"0.35";"2.12";"13.46";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110212";"";"None";"553.51";"1";"4.86";"BDBM215327";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"0.3";"nM";"9.52";"";"378696";"UO_0000065";"17.20";"0.36";"4.66";"9.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3923259";"";"None";"501.97";"1";"4.70";"BDBM236485";"COc1ncc(-c2cc3c(n2C2CC2)C(c2ccc(Cl)cc2)N(c2cc(C)c(=O)n(C)c2)C3=O)cn1";"IC50";"'='";"3916.8";"nM";"5.41";"";"411611";"UO_0000065";"10.77";"0.21";"0.71";"6.57";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975972";"";"None";"524.42";"2";"7.64";"BDBM236253";"COc1ccncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.172";"nM";"9.76";"";"411638";"UO_0000065";"18.62";"0.37";"2.12";"20.62";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL565706";"";"None";"536.23";"2";"6.36";"1b";"Brc1ccc([C@@H]2Oc3ccccc3C3=C2[C@@H](c2ccc(Br)cc2)n2ncnc2N3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL584088";"";"None";"536.23";"2";"6.36";"1c";"Brc1ccc([C@@H]2Oc3ccccc3C3=C2[C@H](c2ccc(Br)cc2)n2ncnc2N3)cc1";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL584512";"";"None";"582.27";"2";"6.83";"rac-34";"Cc1cc2c(cc1F)OC(c1ccc(Br)cc1)C1=C2N(C)c2ncnn2C1c1ccc(Br)cc1";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"10.85";"0.25";"-0.51";"14.63";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL2398245";"";"None";"641.66";"2";"6.86";"27";"CC[C@@H]1CC[C@@H](C(=O)N2CCOCC2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"68.0";"nM";"7.17";"";"";"UO_0000065";"11.17";"0.23";"0.31";"10.95";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2315838";"";"None";"474.46";"1";"6.32";"11a";"CC(C)C1=C(C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"15.55";"0.32";"1.06";"20.54";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2315836";"";"None";"446.40";"1";"5.72";"9a";"CC(C)C1=C(C(N)=O)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"780.0";"nM";"6.11";"";"";"UO_0000065";"13.68";"0.29";"0.39";"10.41";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3134177";"";"None";"472.54";"1";"5.31";"44";"CCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"348200.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134216";"";"None";"386.43";"1";"5.30";"32";"O=C(O)c1ccc(-c2cc(-c3ccc(F)cc3)n(CCc3ccccc3)n2)cc1";"IC50";"'='";"127900.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134204";"";"None";"456.54";"1";"6.15";"20";"CCCOc1ccc(C(=O)O)cc1-c1cc(-c2ccccc2OCC)n(Cc2ccccc2)n1";"IC50";"'='";"68750.0";"nM";"4.16";"";"";"UO_0000065";"9.12";"0.17";"-1.99";"5.66";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134200";"";"None";"498.62";"1";"6.66";"16";"CCCCOc1ccc(CC(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1";"IC50";"'='";"54060.0";"nM";"4.27";"";"";"UO_0000065";"8.56";"0.16";"-2.39";"5.80";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3805140";"";"None";"770.79";"2";"7.24";"20";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC(C)(C)C(=O)O)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"10.90";"0.22";"1.16";"7.46";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL1818538";"";"None";"609.55";"2";"6.62";"Nutlin-1";"COc1ccc(C2=NC(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N2C(=O)N2CCN(C(C)=O)CC2)c(OC(C)C)c1";"IC50";"'='";"4780.0";"nM";"5.32";"";"";"UO_0000065";"8.73";"0.17";"-1.30";"7.12";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945123";"";"None";"666.61";"2";"5.73";"8d";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCN(C(C)=O)CC2)c(OC(C)C)c1";"IC50";"'='";"5430.0";"nM";"5.26";"";"";"UO_0000065";"7.90";"0.16";"-0.46";"5.07";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1944937";"";"None";"598.53";"2";"7.00";"6c";"CCOC(=O)[C@@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"588.84";"nM";"6.23";"";"";"UO_0000065";"10.41";"0.21";"-0.77";"6.96";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL2177186";"";"None";"492.40";"1";"5.48";"22";"CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"14.35";"0.29";"1.59";"8.42";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2398342";"";"None";"585.60";"2";"6.70";"21";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.41";"0.28";"1.15";"13.97";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL1834288";"";"None";"493.39";"1";"5.51";"(+)-10c";"N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"4077.0";"nM";"5.39";"";"";"UO_0000065";"10.92";"0.22";"-0.12";"7.33";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3983285";"";"None";"524.07";"2";"5.10";"BDBM236316";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"0.777";"nM";"9.11";"";"411700";"UO_0000065";"17.38";"0.34";"4.01";"10.88";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3953706";"";"None";"510.04";"1";"4.98";"BDBM236326";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O";"IC50";"'='";"0.423";"nM";"9.37";"";"411710";"UO_0000065";"18.38";"0.36";"4.39";"12.89";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3984231";"";"None";"516.43";"2";"7.67";"BDBM236343";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C#N)C2=O";"IC50";"'='";"1.949";"nM";"8.71";"";"411727";"UO_0000065";"16.87";"0.33";"1.04";"14.95";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955785";"";"None";"568.46";"2";"5.47";"BDBM236364";"COc1ncc(-c2cc3c(n2C(C)C)C(C)(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.208";"nM";"9.68";"";"411748";"UO_0000065";"17.03";"0.34";"4.21";"10.58";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966525";"";"None";"540.41";"2";"5.29";"BDBM236386";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.266";"nM";"9.57";"";"411770";"UO_0000065";"17.72";"0.35";"4.29";"9.36";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3900015";"";"None";"533.42";"2";"6.05";"BDBM236346";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C#N)C2=O";"IC50";"'='";"1.441";"nM";"8.84";"";"411730";"UO_0000065";"16.57";"0.33";"2.79";"8.03";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3907520";"";"None";"516.96";"2";"5.53";"BDBM236401";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.328";"nM";"9.48";"";"411785";"UO_0000065";"18.35";"0.35";"3.95";"8.62";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114205";"";"None";"516.96";"2";"5.53";"BDBM236402";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"43.01";"nM";"7.37";"";"411786";"UO_0000065";"14.25";"0.27";"1.84";"6.69";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3915879";"";"None";"568.46";"2";"5.61";"BDBM236407";"COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.144";"nM";"9.84";"";"411791";"UO_0000065";"17.31";"0.34";"4.23";"10.76";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929867";"";"None";"545.02";"2";"6.01";"BDBM236416";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.357";"nM";"9.45";"";"411800";"UO_0000065";"17.33";"0.33";"3.44";"10.82";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3948860";"";"None";"None";"None";"None";"BDBM238903";"";"IC50";"'='";"120.0";"nM";"6.92";"";"417028";"UO_0000065";"";"";"";"";"0";"CHEMBL3888805";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 μM (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3903662";"";"None";"585.47";"2";"5.50";"BDBM236440";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.139";"nM";"9.86";"";"411824";"UO_0000065";"16.84";"0.34";"4.36";"11.53";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3949589";"";"None";"576.03";"1";"4.71";"BDBM236441";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.194";"nM";"9.71";"";"411825";"UO_0000065";"16.86";"0.32";"5.00";"8.89";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3909197";"";"None";"562.99";"1";"4.66";"BDBM236442";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.252";"nM";"9.60";"";"411826";"UO_0000065";"17.05";"0.33";"4.94";"8.33";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112735";"";"None";"529.46";"2";"6.24";"BDBM215061";"CC[C@@H](COCC1(C#N)CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378340";"UO_0000065";"13.97";"0.28";"1.16";"8.16";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329613";"";"None";"545.89";"2";"7.73";"BDBM215269";"CC[C@@H](c1cccc(Cl)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378647";"UO_0000065";"16.49";"0.34";"1.27";"12.77";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3984190";"";"None";"680.70";"2";"5.44";"BDBM215420";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](CCN2CCOCC2)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.5";"nM";"8.46";"";"378806";"UO_0000065";"12.42";"0.26";"3.02";"7.87";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109170";"";"None";"727.78";"1";"4.24";"BDBM215425";"CCC(CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](CCN2CCS(=O)(=O)CC2)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378808";"UO_0000065";"12.37";"0.26";"4.76";"6.51";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3970638";"";"None";"602.58";"2";"5.82";"BDBM215435";"CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@@H](Cc2cccc(O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"23.1";"nM";"7.64";"";"378818";"UO_0000065";"12.67";"0.26";"1.82";"8.41";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3947440";"";"None";"616.61";"2";"6.21";"BDBM215439";"CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@@](C)(Cc2cccc(O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"119.0";"nM";"6.92";"";"378822";"UO_0000065";"11.23";"0.23";"0.71";"7.63";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3931174";"";"None";"493.05";"1";"6.56";"BDBM236348";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"31.86";"nM";"7.50";"";"411732";"UO_0000065";"15.20";"0.29";"0.94";"13.71";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3957542";"";"None";"479.02";"1";"6.43";"BDBM236351";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(C1CCOCC1)C2=O";"IC50";"'='";"15.34";"nM";"7.81";"";"411735";"UO_0000065";"16.31";"0.31";"1.38";"17.88";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3974998";"";"None";"547.06";"2";"5.01";"BDBM236359";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)c(=O)cc1C)C2=O";"IC50";"'='";"0.393";"nM";"9.41";"";"411743";"UO_0000065";"17.19";"0.33";"4.40";"11.00";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895404";"";"None";"554.43";"2";"5.30";"BDBM236368";"COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.087";"nM";"10.06";"";"411752";"UO_0000065";"18.15";"0.36";"4.76";"11.00";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3911501";"";"None";"558.04";"1";"4.57";"BDBM236476";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.069";"nM";"10.16";"";"411862";"UO_0000065";"18.21";"0.35";"5.59";"9.30";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113641";"";"None";"526.48";"2";"5.35";"BDBM215080";"CC[C@@H](CCS(C)(=O)=O)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"378359";"UO_0000065";"13.87";"0.29";"1.95";"7.96";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3978255";"";"None";"460.40";"1";"6.33";"BDBM215087";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CCCC2)C1=O";"IC50";"'='";"190.0";"nM";"6.72";"";"378366";"UO_0000065";"14.60";"0.30";"0.39";"11.67";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904258";"";"None";"474.43";"1";"6.72";"BDBM215089";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CCCCC2)C1=O";"IC50";"'='";"170.0";"nM";"6.77";"";"378368";"UO_0000065";"14.27";"0.29";"0.05";"11.75";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3891537";"";"None";"460.40";"1";"6.33";"BDBM215094";"O=C(O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CCCC2)C1=O";"IC50";"'='";"550.0";"nM";"6.26";"";"378373";"UO_0000065";"13.60";"0.28";"-0.07";"10.87";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109441";"";"None";"447.36";"0";"4.97";"BDBM215101";"O=C(C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O)NO";"IC50";"'='";"1700.0";"nM";"5.77";"";"378380";"UO_0000065";"12.90";"0.26";"0.80";"8.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3963132";"";"None";"581.56";"2";"5.04";"BDBM215251";"CC[C@@H](CN1CCS(=O)(=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378634";"UO_0000065";"14.44";"0.30";"3.36";"8.84";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950605";"";"None";"539.45";"2";"6.26";"BDBM215252";"CC[C@@H](CN1CC(F)(F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"378635";"UO_0000065";"15.39";"0.31";"2.04";"13.64";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932633";"";"None";"579.45";"2";"8.10";"BDBM215278";"CC[C@@H](c1cccc(C(F)(F)F)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378651";"UO_0000065";"15.53";"0.32";"0.90";"12.77";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115203";"";"None";"635.64";"2";"6.69";"BDBM215303";"CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)c1cccs1";"IC50";"'='";"0.3";"nM";"9.52";"";"378672";"UO_0000065";"14.98";"0.32";"2.83";"10.03";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3965232";"";"None";"617.54";"2";"6.18";"BDBM215307";"CCS(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(F)F";"IC50";"'='";"0.1";"nM";"10.00";"";"378676";"UO_0000065";"16.19";"0.34";"3.82";"10.53";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111883";"";"None";"643.63";"2";"7.17";"BDBM215313";"CCS(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)c1ccccc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378682";"UO_0000065";"14.80";"0.30";"2.35";"10.03";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112010";"";"None";"673.66";"2";"6.78";"BDBM215322";"COc1cccc(CN(C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)S(C)(=O)=O)c1";"IC50";"'='";"1.5";"nM";"8.82";"";"378691";"UO_0000065";"13.10";"0.27";"2.04";"8.47";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3960491";"";"None";"609.62";"2";"6.51";"BDBM215336";"CC[C@@H](CN(CC)S(=O)(=O)C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378704";"UO_0000065";"13.12";"0.27";"1.49";"8.42";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125528";"";"None";"566.55";"2";"6.14";"BDBM50448935";"CC[C@@H](CS(=O)(=O)CC1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378708";"UO_0000065";"16.81";"0.35";"3.38";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3986408";"";"None";"608.58";"2";"5.76";"BDBM215346";"CC1(CS(=O)(=O)C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)COC1";"IC50";"'='";"0.1";"nM";"10.00";"";"378718";"UO_0000065";"16.43";"0.34";"4.24";"9.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3915213";"";"None";"580.57";"2";"6.53";"BDBM215362";"CCCS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378734";"UO_0000065";"16.71";"0.35";"3.17";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125524";"";"None";"540.51";"2";"5.74";"BDBM50448939";"CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378743";"UO_0000065";"17.62";"0.37";"3.78";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3318760";"";"None";"581.56";"2";"5.64";"BDBM50053040";"CC(C)NS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378782";"UO_0000065";"17.20";"0.36";"4.36";"9.64";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110956";"";"None";"470.40";"1";"6.01";"BDBM215106";"Cc1nnc(C[C@H]2C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N(CC3CC3)C2=O)o1";"IC50";"'='";"1600.0";"nM";"5.80";"";"378385";"UO_0000065";"12.32";"0.25";"-0.21";"9.79";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3953174";"";"None";"534.48";"2";"6.65";"BDBM215115";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"310.0";"nM";"6.51";"";"378394";"UO_0000065";"12.18";"0.25";"-0.14";"7.76";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3927443";"";"None";"446.37";"1";"5.94";"BDBM215121";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"60.0";"nM";"7.22";"";"378400";"UO_0000065";"16.18";"0.33";"1.28";"12.54";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932275";"";"None";"560.44";"2";"7.01";"BDBM215178";"CC[C@@H](CC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"378458";"UO_0000065";"12.35";"0.26";"-0.09";"8.89";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932275";"";"None";"560.44";"2";"7.01";"BDBM215178";"CC[C@@H](CC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378459";"UO_0000065";"14.27";"0.30";"0.99";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108086";"";"None";"476.40";"1";"5.30";"BDBM215291";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CO)C2CC2)C1=O";"IC50";"'='";"10.0";"nM";"8.00";"";"378528";"UO_0000065";"16.79";"0.34";"2.70";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894082";"";"None";"562.99";"1";"4.66";"BDBM236481";"COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(C#N)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.107";"nM";"9.97";"";"411867";"UO_0000065";"17.71";"0.34";"5.31";"8.65";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3900501";"";"None";"541.41";"2";"6.74";"BDBM236301";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.267";"nM";"9.57";"";"411686";"UO_0000065";"17.68";"0.35";"2.83";"13.78";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3924973";"";"None";"544.02";"1";"4.56";"BDBM236414";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.161";"nM";"9.79";"";"411798";"UO_0000065";"18.00";"0.34";"5.23";"8.15";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895513";"";"None";"514.63";"1";"4.32";"BDBM236421";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"1.666";"nM";"8.78";"";"411805";"UO_0000065";"17.06";"0.32";"4.46";"8.17";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3890144";"";"None";"506.99";"1";"4.99";"BDBM236428";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cn(C)nc2C)C3=O)c(OC)n1";"IC50";"'='";"2.391";"nM";"8.62";"";"411812";"UO_0000065";"17.01";"0.33";"3.63";"9.88";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906793";"";"None";"506.01";"1";"4.89";"BDBM236431";"COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)nc1C)C2=O";"IC50";"'='";"5.599";"nM";"8.25";"";"411815";"UO_0000065";"16.31";"0.31";"3.36";"11.11";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329616";"";"None";"525.48";"2";"7.39";"18";"CC[C@@H](c1cc(C)ccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"16.22";"0.32";"1.13";"12.09";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2177183";"";"None";"431.36";"0";"4.95";"19";"NC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"7630.0";"nM";"5.12";"";"";"UO_0000065";"11.86";"0.24";"0.17";"8.07";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"4600.0";"nM";"5.34";"";"";"UO_0000065";"9.18";"0.18";"-0.55";"6.39";"0";"CHEMBL3222408";"Inhibition of Mdm2-p53 interaction in human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL3310320";"";"None";"630.54";"2";"5.90";"24";"COc1cc(OCCO)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.16";"0.26";"2.40";"7.62";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3112810";"";"None";"743.15";"2";"5.02";"12g";"CN(C)CC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"8.74";"0.17";"1.15";"6.28";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112799";"";"None";"613.99";"2";"5.76";"11j";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCc3ccccc3C2)C1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.14";"0.19";"0.09";"9.33";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL1944936";"";"None";"598.53";"2";"7.00";"6b";"CCOC(=O)CCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"3360.0";"nM";"5.47";"";"";"UO_0000065";"9.15";"0.18";"-1.53";"6.12";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1944937";"";"None";"598.53";"2";"7.00";"6c";"CCOC(=O)[C@@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"590.0";"nM";"6.23";"";"";"UO_0000065";"10.41";"0.21";"-0.77";"6.96";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1944942";"";"None";"570.47";"2";"6.52";"7c";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@H](C)C(=O)O)c(OC(C)C)c1";"IC50";"'='";"3270.0";"nM";"5.49";"";"";"UO_0000065";"9.62";"0.19";"-1.03";"5.46";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945233";"";"None";"625.60";"2";"7.30";"8g";"CCN(CC)C(=O)CCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"9.89";"0.20";"-1.11";"7.41";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945443";"";"None";"639.62";"2";"7.69";"8m";"CCN(CC)C(=O)CCCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"4180.0";"nM";"5.38";"";"";"UO_0000065";"8.41";"0.17";"-2.31";"6.44";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1944939";"";"None";"612.55";"2";"7.39";"6e";"CCOC(=O)CCCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"1659.59";"nM";"5.78";"";"";"UO_0000065";"9.44";"0.19";"-1.61";"6.46";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945119";"";"None";"584.50";"2";"6.91";"7e";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCCC(=O)O)c(OC(C)C)c1";"IC50";"'='";"2041.74";"nM";"5.69";"";"";"UO_0000065";"9.73";"0.19";"-1.22";"5.66";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945123";"";"None";"666.61";"2";"5.73";"8d";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCN(C(C)=O)CC2)c(OC(C)C)c1";"IC50";"'='";"5370.32";"nM";"5.27";"";"";"UO_0000065";"7.91";"0.16";"-0.46";"5.08";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945441";"";"None";"625.60";"2";"7.30";"8k";"CCN(CC)C(=O)[C@@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"5011.87";"nM";"5.30";"";"";"UO_0000065";"8.47";"0.17";"-2.00";"6.35";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL2315842";"";"None";"571.57";"2";"6.32";"14a";"CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N(C)C)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"12.65";"0.26";"0.91";"12.86";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2398239";"";"None";"668.73";"2";"7.17";"32";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCN(C)C(C)(C)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"11.58";"0.24";"0.57";"13.03";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL1771707";"";"None";"576.29";"2";"6.94";"8, Racemic mixture";"C=CCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"9.75";"0.23";"-1.32";"13.01";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2398345";"";"None";"668.69";"2";"6.31";"24";"CC(=O)N1CCN(C(=O)[C@@H]2CC[C@@H](C)N2C(=O)C2=C(C(C)C)N3C(=N[C@@](C)(c4ccc(Cl)cc4)[C@H]3c3ccc(Cl)cc3)S2)CC1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"11.34";"0.23";"1.28";"9.91";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL1688256";"";"None";"445.95";"1";"5.21";"48";"Cc1ccc(CN2C(=O)c3ccccc3C2(O[C@H]2C=C[C@@H](O)C2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"13.13";"0.25";"0.64";"11.76";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3134183";"";"None";"472.54";"1";"5.11";"50";"COc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1";"IC50";"'='";"726800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3687315";"";"None";"593.55";"2";"7.31";"9";"COc1ccccc1-n1nc2c(c1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1OCCN(C)C)C2=O";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"11.60";"0.23";"-0.42";"11.51";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3A";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"13.76";"0.27";"2.11";"9.58";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3954710";"";"None";"548.96";"1";"4.65";"BDBM236447";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)c(F)c2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.37";"nM";"9.43";"";"411831";"UO_0000065";"17.18";"0.33";"4.78";"7.48";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3971176";"";"None";"561.47";"2";"6.53";"BDBM236347";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C#N)C2=O";"IC50";"'='";"0.316";"nM";"9.50";"";"411731";"UO_0000065";"16.92";"0.33";"2.97";"10.88";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3946024";"";"None";"562.99";"1";"4.66";"BDBM236445";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.691";"nM";"9.16";"";"411829";"UO_0000065";"16.27";"0.31";"4.50";"7.95";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966414";"";"None";"504.03";"2";"6.12";"BDBM236314";"COc1ccc(C#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"2.486";"nM";"8.60";"";"411698";"UO_0000065";"17.07";"0.33";"2.48";"10.96";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111895";"";"None";"546.99";"2";"5.16";"BDBM236467";"COC[C@@H](C)n1c(-c2cnc(N)nc2OC)cc2c1C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.631";"nM";"9.20";"";"411853";"UO_0000065";"16.82";"0.32";"4.04";"7.71";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112637";"";"None";"584.46";"1";"4.93";"BDBM236469";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)cc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.277";"nM";"9.56";"";"411855";"UO_0000065";"16.35";"0.33";"4.63";"9.49";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3353231";"";"None";"505.42";"1";"4.65";"1";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)NCC=N)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"15.04";"0.31";"2.95";"8.08";"0";"CHEMBL3372382";"Inhibition of MDM2/P53 (unknown origin) protein interaction";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351271";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3310183";"";"None";"614.50";"2";"6.23";"18";"COc1cc(NC(=O)[C@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@@H]2c2cccc(Cl)c2F)ccc1C(=O)O";"IC50";"'='";"3741.0";"nM";"5.43";"";"";"UO_0000065";"8.83";"0.18";"-0.80";"4.65";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3963943";"";"None";"573.52";"2";"5.09";"BDBM215148";"CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378427";"UO_0000065";"13.95";"0.28";"2.91";"8.73";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3964874";"";"None";"587.47";"2";"5.92";"BDBM215255";"CC[C@@H](CN1CC(O)(C(F)(F)F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378499";"UO_0000065";"12.59";"0.26";"1.48";"9.12";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL1933127";"";"None";"1678.96";"None";"None";"2";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"4.44";"None";"None";"None";"0";"CHEMBL1936335";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1933030";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL4109769";"";"None";"473.36";"0";"4.66";"BDBM215111";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@]2(C(=O)Nc3cc(Cl)ccc32)N(CC2CC2)C1=O";"IC50";"'='";"90.0";"nM";"7.05";"";"378390";"UO_0000065";"14.88";"0.30";"2.39";"8.13";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL447529";"";"None";"471.67";"None";"None";"2y";"CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"476000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL3904160";"";"None";"598.55";"2";"7.02";"BDBM236309";"CNS(=O)(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.169";"nM";"9.77";"";"411693";"UO_0000065";"16.33";"0.33";"2.75";"12.12";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3946895";"";"None";"576.52";"2";"7.40";"BDBM236328";"CNC(=O)Cc1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.148";"nM";"9.83";"";"411712";"UO_0000065";"17.05";"0.34";"2.43";"15.46";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895323";"";"None";"545.02";"2";"6.01";"BDBM236340";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.361";"nM";"9.44";"";"411724";"UO_0000065";"17.33";"0.33";"3.43";"10.82";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3945611";"";"None";"534.02";"1";"4.95";"BDBM236358";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cn(C)c(=O)cc2C)C3=O)c(OC)n1";"IC50";"'='";"1.843";"nM";"8.73";"";"411742";"UO_0000065";"16.36";"0.31";"3.78";"9.55";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3913136";"";"None";"509.97";"1";"4.70";"BDBM236457";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c(F)c(C)nn1C)C2=O";"IC50";"'='";"3.901";"nM";"8.41";"";"411841";"UO_0000065";"16.49";"0.32";"3.71";"8.08";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113499";"";"None";"562.00";"2";"5.58";"BDBM236466";"COC[C@@H](C)n1c(-c2cnc(OC)nc2OC)cc2c1C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.303";"nM";"9.52";"";"411852";"UO_0000065";"16.94";"0.32";"3.94";"9.29";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2385517";"";"None";"378.28";"1";"5.76";"MCL0527";"COC(=O)c1c(N)sc(-c2ccc(Cl)cc2)c1-c1ccc(Cl)cc1";"IC50";"'='";"4230.0";"nM";"5.37";"";"";"UO_0000065";"14.21";"0.31";"-0.39";"10.27";"0";"CHEMBL3136590";"Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132800";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3112778";"";"None";"717.11";"2";"5.55";"12c, active enantiomer";"COCCOc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"9.98";"0.19";"1.25";"8.05";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112820";"";"None";"569.07";"1";"4.63";"14f";"CC(C)(C)CC(=O)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1.Cl";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"10.37";"0.20";"0.89";"8.37";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"474.0";"nM";"6.32";"";"";"UO_0000065";"10.88";"0.22";"0.43";"7.58";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134184";"";"None";"458.51";"0";"4.92";"51";"COc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"967300.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134180";"";"None";"486.57";"1";"5.50";"47";"COc1ccc(CCC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1";"IC50";"'='";"436500.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134168";"";"None";"442.52";"1";"5.57";"35";"CCOc1ccccc1-c1cc(-c2cc(C(=O)O)ccc2OC)nn1CCc1ccccc1";"IC50";"'='";"232500.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134217";"";"None";"527.00";"2";"7.26";"33";"O=C(O)Cc1ccc(OCc2ccccc2Cl)c(-c2cc(-c3ccc(F)cc3)n(Cc3ccccc3)n2)c1";"IC50";"'='";"129800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134213";"";"None";"514.62";"2";"6.28";"29";"CCCCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1";"IC50";"'='";"115600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134210";"";"None";"470.57";"1";"5.88";"26";"CCOc1ccc(CC(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1";"IC50";"'='";"102400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3132875";"";"None";"498.62";"1";"6.52";"14";"CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OCC(C)C)nn1CCc1ccccc1";"IC50";"'='";"48700.0";"nM";"4.31";"";"";"UO_0000065";"8.65";"0.16";"-2.21";"5.86";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134193";"";"None";"430.48";"1";"5.43";"8";"COc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(F)cc2)n(Cc2ccccc2)n1";"IC50";"'='";"16980.0";"nM";"4.77";"";"";"UO_0000065";"11.08";"0.20";"-0.66";"7.41";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3310184";"";"None";"614.50";"2";"6.23";"19";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.51";"0.27";"2.07";"7.11";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310183";"";"None";"614.50";"2";"6.23";"18";"COc1cc(NC(=O)[C@H]2N[C@H](CC(C)(C)C)[C@]3(C(=O)Nc4cc(Cl)ccc43)[C@@H]2c2cccc(Cl)c2F)ccc1C(=O)O";"IC50";"'='";"3089.0";"nM";"5.51";"";"";"UO_0000065";"8.97";"0.18";"-0.72";"4.72";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310182";"";"None";"614.50";"2";"6.23";"18";"COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(=O)O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.67";"0.27";"2.17";"7.19";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310323";"";"None";"631.51";"2";"5.77";"27";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3c2ccc(Cl)c3F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"12.26";"0.25";"1.97";"6.32";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310185";"";"None";"583.49";"2";"5.62";"20";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(N)=O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.23";"0.28";"2.68";"7.33";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL1944939";"";"None";"612.55";"2";"7.39";"6e";"CCOC(=O)CCCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"1660.0";"nM";"5.78";"";"";"UO_0000065";"9.44";"0.19";"-1.61";"6.46";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL2177189";"";"None";"558.51";"2";"5.93";"26";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"14.41";"0.29";"2.12";"7.96";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2398341";"";"None";"599.63";"2";"7.09";"10";"CC[C@H]1CC[C@@H](C(=O)N(C)C)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"12.36";"0.25";"0.32";"13.18";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2398241";"";"None";"668.73";"2";"7.17";"34";"CC[C@@H]1CC[C@@H](C(=O)N2CCN(C)[C@@H](C)C2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"11.25";"0.23";"0.35";"12.65";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2398343";"";"None";"599.63";"2";"7.09";"22";"CC[C@@H]1CC[C@@H](C(=O)N(C)C)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"12.92";"0.26";"0.65";"13.78";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2315840";"";"None";"500.50";"2";"6.86";"12a";"CC(C)C1=C(C(=O)N2CCCC2)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"13.38";"0.28";"-0.16";"18.65";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3134188";"";"None";"456.54";"1";"5.96";"3";"CCOc1ccc(C(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1";"IC50";"'='";"10650.0";"nM";"4.97";"";"";"UO_0000065";"10.89";"0.20";"-0.99";"6.76";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3310188";"";"None";"689.62";"2";"7.30";"4";"COc1cc(C(N)=O)ccc1-c1ccccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"12.04";"0.24";"1.00";"6.77";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL2402737";"IDASANUTLIN";"3.0";"616.49";"2";"6.94";"2, RG7388";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"12.98";"0.26";"1.06";"7.18";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310182";"";"None";"614.50";"2";"6.23";"18";"COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(=O)O";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"13.67";"0.27";"2.17";"7.19";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3354604";"";"None";"417.34";"0";"4.68";"5";"CC(=O)N1CCCC([C@]2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc32)C1";"IC50";"'='";"3900.0";"nM";"5.41";"";"";"UO_0000065";"12.96";"0.26";"0.73";"10.95";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3954185";"";"None";"587.05";"2";"6.66";"BDBM236330";"CCOC(=O)Cc1cnc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"4.163";"nM";"8.38";"";"411714";"UO_0000065";"14.28";"0.27";"1.72";"8.60";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110580";"";"None";"556.43";"2";"5.94";"BDBM236473";"COC[C@@H](C)n1c(-c2cnc(N)nc2OC)cc2c1[C@H](c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.078";"nM";"10.11";"";"411859";"UO_0000065";"18.17";"0.36";"4.17";"10.58";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3220689";"";"None";"467.33";"1";"5.59";"21";"Cc1ccc(F)cc1[C@H]1NC(=O)C=C(c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"15.36";"0.31";"1.59";"12.34";"0";"CHEMBL3223364";"Inhibition of p53 interaction to MDM2 (unknown origin) by HTRF assay in presence of 0.02% bovine serum albumin";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3220693";"";"None";"681.62";"2";"6.34";"26";"CCOC(=O)[C@@]1(c2ccc(Cl)cc2)N=C(c2ccc(OC)cc2OC(C)C)N(C(=O)N2CCN(C(C)=O)CC2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"10.50";"0.21";"0.81";"7.09";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3913154";"";"None";"584.46";"2";"5.39";"BDBM238914";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C(=O)N3)c(OC)n1";"IC50";"'='";"3106.0";"nM";"5.51";"";"417046";"UO_0000065";"9.42";"0.19";"0.12";"4.73";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962110";"";"None";"539.42";"2";"5.32";"BDBM236371";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.185";"nM";"9.73";"";"411755";"UO_0000065";"18.04";"0.36";"4.41";"9.26";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3935262";"";"None";"581.50";"2";"5.66";"BDBM236394";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.164";"nM";"9.79";"";"411778";"UO_0000065";"16.83";"0.33";"4.13";"11.45";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115541";"";"None";"545.00";"1";"4.52";"BDBM236463";"COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"883.0";"nM";"6.05";"";"411847";"UO_0000065";"11.11";"0.21";"1.53";"5.25";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3310319";"";"None";"600.52";"2";"5.89";"23";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(OCCO)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"13.48";"0.27";"2.21";"8.12";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL361220";"";"None";"562.75";"1";"4.61";"19";"O=C(O)[C@H](c1ccc(O)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"16500.0";"nM";"4.78";"";"";"UO_0000065";"8.50";"0.20";"0.17";"4.47";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL181148";"";"None";"625.64";"2";"5.67";"21";"O=C(O)[C@H](c1ccc(Br)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"620.0";"nM";"6.21";"";"";"UO_0000065";"9.92";"0.26";"0.54";"7.16";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL4114935";"";"None";"504.45";"2";"6.49";"BDBM215261";"CC[C@@H](C1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378505";"UO_0000065";"15.26";"0.31";"1.21";"11.52";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107660";"";"None";"533.50";"2";"6.22";"BDBM215150";"CC[C@@H](C(=O)NC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"378552";"UO_0000065";"15.41";"0.31";"2.00";"9.48";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112050";"";"None";"535.47";"2";"6.05";"BDBM215174";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(Cl)ccn2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"378555";"UO_0000065";"15.50";"0.31";"2.25";"8.58";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955489";"";"None";"490.43";"1";"6.29";"BDBM215177";"CC[C@@H](CC(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378560";"UO_0000065";"17.38";"0.35";"2.23";"11.41";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980529";"";"None";"604.56";"2";"5.68";"BDBM215236";"CC[C@@H](CNS(=O)(=O)c1cccnc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'<'";"1.0";"nM";"";"";"378619";"UO_0000065";"";"";"";"";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3913854";"";"None";"628.58";"2";"6.16";"BDBM215237";"CC[C@@H](CNS(=O)(=O)c1ccc(C#N)cc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'<'";"1.0";"nM";"";"";"378620";"UO_0000065";"";"";"";"";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899355";"";"None";"531.48";"2";"5.93";"BDBM215248";"CC[C@@H](CN1CCCC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"378631";"UO_0000065";"15.34";"0.31";"2.22";"10.47";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112794";"";"None";"540.51";"2";"5.74";"BDBM215388";"CC[C@@H]([C@@H](C)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"378773";"UO_0000065";"17.06";"0.36";"3.48";"10.05";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL567426";"";"None";"536.23";"2";"6.02";"1a";"Brc1ccc([C@H]2C3=C(N=C4NC=NN42)c2ccccc2O[C@@H]3c2ccc(Br)cc2)cc1";"IC50";"'='";"1230.0";"nM";"5.91";"";"";"UO_0000065";"11.02";"0.26";"-0.11";"12.01";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL584289";"";"None";"485.39";"1";"5.93";"rac-14";"Cc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3C)cc1";"IC50";"'='";"4630.0";"nM";"5.33";"";"";"UO_0000065";"10.99";"0.23";"-0.60";"12.35";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL582243";"";"None";"509.41";"2";"6.00";"rac-17";"CC#Cc1ccc(C2Oc3ccccc3C3=C2C(c2ccc(Br)cc2)n2ncnc2N3C)cc1";"IC50";"'='";"9070.0";"nM";"5.04";"";"";"UO_0000065";"9.90";"0.20";"-0.96";"11.68";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL568519";"";"None";"485.39";"1";"5.93";"rac-20";"Cc1ccc(C2C3=C(c4ccccc4OC3c3ccc(Br)cc3)N(C)c3ncnn32)cc1";"IC50";"'='";"4740.0";"nM";"5.32";"";"";"UO_0000065";"10.97";"0.23";"-0.61";"12.33";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL566551";"";"None";"575.26";"2";"6.26";"rac-29";"CN1C2=C(C(c3ccc(Br)cc3)Oc3ccc(C#N)cc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"3060.0";"nM";"5.51";"";"";"UO_0000065";"9.59";"0.22";"-0.75";"8.23";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3932419";"";"None";"554.45";"2";"6.80";"BDBM236305";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.458";"nM";"9.34";"";"411689";"UO_0000065";"16.84";"0.34";"2.54";"14.71";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3964492";"";"None";"554.43";"2";"5.30";"BDBM236317";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.235";"nM";"9.63";"";"411701";"UO_0000065";"17.37";"0.35";"4.33";"10.53";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3944419";"";"None";"522.05";"2";"5.48";"BDBM236322";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCOCC2)C3=O)c1";"IC50";"'='";"1.087";"nM";"8.96";"";"411706";"UO_0000065";"17.17";"0.33";"3.48";"12.31";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3920354";"";"None";"511.02";"2";"5.23";"BDBM236352";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(C2CCOCC2)C3=O)c(OC)n1";"IC50";"'='";"14.33";"nM";"7.84";"";"411736";"UO_0000065";"15.35";"0.30";"2.61";"9.97";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921717";"";"None";"500.60";"1";"4.20";"BDBM236405";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(C1CCOCC1)C2=O";"IC50";"'='";"1.344";"nM";"8.87";"";"411789";"UO_0000065";"17.72";"0.33";"4.67";"9.19";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3897997";"";"None";"544.02";"1";"4.55";"BDBM236412";"CNc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.578";"nM";"9.24";"";"411796";"UO_0000065";"16.98";"0.32";"4.69";"7.82";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114518";"";"None";"544.02";"1";"4.55";"BDBM236413";"CNc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"293.2";"nM";"6.53";"";"411797";"UO_0000065";"12.01";"0.23";"1.98";"5.53";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3974644";"";"None";"520.04";"2";"5.05";"BDBM236424";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nn1C)C2=O";"IC50";"'='";"0.514";"nM";"9.29";"";"411808";"UO_0000065";"17.86";"0.34";"4.24";"11.42";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918559";"";"None";"534.02";"1";"4.95";"BDBM236483";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.156";"nM";"8.94";"";"411869";"UO_0000065";"16.74";"0.32";"3.99";"9.77";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3939933";"";"None";"550.49";"2";"6.97";"BDBM236274";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.225";"nM";"9.65";"";"411659";"UO_0000065";"17.53";"0.35";"2.68";"15.20";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961529";"";"None";"576.52";"2";"7.78";"BDBM236278";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.184";"nM";"9.73";"";"411663";"UO_0000065";"16.89";"0.33";"1.96";"15.31";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3902052";"";"None";"528.01";"2";"6.13";"BDBM236291";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.167";"nM";"9.78";"";"411676";"UO_0000065";"18.52";"0.35";"3.65";"10.48";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113368";"";"None";"432.35";"1";"5.55";"BDBM215084";"O=C(O)C[C@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"150.0";"nM";"6.82";"";"378363";"UO_0000065";"15.78";"0.32";"1.27";"11.85";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980672";"";"None";"586.48";"2";"7.40";"BDBM215181";"CC[C@@H](CC(O)(C1CC1)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378461";"UO_0000065";"13.64";"0.28";"0.60";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109962";"";"None";"544.48";"2";"6.41";"BDBM215105";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](Cc2nnco2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1890.0";"nM";"5.72";"";"378384";"UO_0000065";"10.51";"0.21";"-0.69";"6.69";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL179931";"";"None";"581.19";"2";"5.56";"25";"O=C1Nc2ccc(I)cc2C(=O)N([C@H](C(=O)O)c2ccccc2Cl)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20000.0";"nM";"4.70";"";"";"UO_0000065";"8.09";"0.20";"-0.86";"5.42";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3897931";"";"None";"606.49";"2";"6.29";"BDBM215355";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)CC(F)(F)F)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378727";"UO_0000065";"15.99";"0.34";"3.41";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL1944938";"";"None";"598.53";"2";"7.00";"6d";"CCOC(=O)[C@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"10.15";"0.20";"-0.92";"6.79";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL3914415";"";"None";"541.06";"2";"6.18";"BDBM236342";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.194";"nM";"9.71";"";"411726";"UO_0000065";"17.95";"0.34";"3.53";"11.13";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906442";"";"None";"553.06";"1";"4.55";"BDBM236354";"CNC(=O)N1CCC(N2C(=O)c3cc(-c4cnc(OC)nc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"2.692";"nM";"8.57";"";"411738";"UO_0000065";"15.50";"0.30";"4.02";"8.42";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929622";"";"None";"539.04";"1";"4.11";"BDBM236357";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CN(C)C(=O)N(C)C2)C3=O)c(OC)n1";"IC50";"'='";"0.741";"nM";"9.13";"";"411741";"UO_0000065";"16.94";"0.33";"5.02";"9.81";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3945906";"";"None";"583.54";"2";"7.51";"BDBM236361";"COc1ccc(S(C)(=O)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.184";"nM";"9.73";"";"411745";"UO_0000065";"16.68";"0.34";"2.23";"14.19";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3953644";"";"None";"600.52";"2";"5.90";"BDBM236366";"COc1ccc(S(C)(=O)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.168";"nM";"9.78";"";"411750";"UO_0000065";"16.28";"0.33";"3.87";"10.79";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108456";"";"None";"554.43";"2";"5.30";"BDBM236369";"COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"76.87";"nM";"7.11";"";"411753";"UO_0000065";"12.83";"0.26";"1.81";"7.78";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892710";"";"None";"530.97";"1";"4.51";"BDBM236373";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.779";"nM";"9.11";"";"411757";"UO_0000065";"17.15";"0.33";"4.60";"7.22";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975023";"";"None";"529.99";"1";"4.54";"BDBM236384";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.321";"nM";"9.49";"";"411768";"UO_0000065";"17.91";"0.34";"4.95";"7.36";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3986913";"";"None";"568.46";"2";"5.61";"BDBM236393";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.216";"nM";"9.67";"";"411777";"UO_0000065";"17.00";"0.34";"4.06";"10.57";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3971557";"";"None";"539.42";"2";"5.32";"BDBM236399";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.166";"nM";"9.78";"";"411783";"UO_0000065";"18.13";"0.36";"4.46";"9.30";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3956352";"";"None";"572.42";"2";"5.44";"BDBM236403";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2F)C3=O)c(OC)n1";"IC50";"'='";"0.122";"nM";"9.91";"";"411787";"UO_0000065";"17.32";"0.35";"4.47";"10.84";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943828";"";"None";"568.46";"2";"5.47";"BDBM236409";"COc1ncc(-c2cc3c(n2C(C)C)[C@](C)(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"49.02";"nM";"7.31";"";"411793";"UO_0000065";"12.86";"0.26";"1.84";"7.99";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108457";"";"None";"562.99";"1";"4.66";"BDBM236482";"COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(C#N)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"126.14";"nM";"6.90";"";"411868";"UO_0000065";"12.25";"0.24";"2.24";"5.99";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3922073";"";"None";"555.43";"1";"4.66";"BDBM238919";"COc1nc(N)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C(=O)N2";"IC50";"'='";"4298.0";"nM";"5.37";"";"417051";"UO_0000065";"9.66";"0.19";"0.71";"4.03";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980581";"";"None";"501.59";"1";"4.26";"BDBM236420";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N([C@H]2CC[C@H](O)CC2)C3=O)c(OC)n1";"IC50";"'='";"13.64";"nM";"7.87";"";"411804";"UO_0000065";"15.68";"0.29";"3.61";"6.93";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904935";"";"None";"506.99";"1";"4.99";"BDBM236423";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(C)nn2C)C3=O)c(OC)n1";"IC50";"'='";"0.87";"nM";"9.06";"";"411807";"UO_0000065";"17.87";"0.34";"4.07";"10.38";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3922965";"";"None";"598.44";"1";"5.00";"BDBM236465";"COc1ncc(-c2c(C(=O)O)c3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.14";"nM";"9.85";"";"411851";"UO_0000065";"16.47";"0.33";"4.85";"7.65";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114920";"";"None";"571.44";"2";"5.48";"BDBM236472";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"48.68";"nM";"7.31";"";"411858";"UO_0000065";"12.80";"0.26";"1.83";"7.59";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3979827";"";"None";"514.97";"1";"4.51";"BDBM236480";"COc1ncncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"2.98";"nM";"8.53";"";"411866";"UO_0000065";"16.56";"0.31";"4.02";"8.04";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL565896";"";"None";"584.70";"2";"7.04";"rac-26";"CN1C2=C(C(c3ccc(Br)cc3)Oc3ccc(Cl)cc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.01";"0.24";"-1.19";"13.56";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL1834374";"";"None";"496.92";"1";"5.03";"10f";"O=C1c2ccc(F)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"295.0";"nM";"6.53";"";"";"UO_0000065";"13.14";"0.25";"1.50";"7.03";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1834383";"";"None";"411.93";"0";"4.66";"11a";"CC1=C(C)C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N(Cc2ccccc2)C1=O";"IC50";"'='";"3450.0";"nM";"5.46";"";"";"UO_0000065";"13.26";"0.26";"0.80";"10.97";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3601318";"";"None";"556.11";"2";"7.24";"10";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)[C@@H]2c1ccc(Cl)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"10.65";"0.20";"-1.32";"10.78";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3604662";"";"None";"573.11";"2";"7.98";"6";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3cccc(F)c3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"11.81";"0.23";"-1.21";"16.11";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3603849";"";"None";"456.37";"1";"6.47";"3";"CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C(=O)C2";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"12.83";"0.26";"-0.62";"15.10";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL5088618";"";"None";"580.61";"2";"5.77";"27";"C[C@@H](Nc1nc(C(=O)O)nc2nc(N3CCOC[C@H]3c3ccccc3)n(Cc3ccc(C(F)(F)F)cc3)c12)C1CCC1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"15.06";"0.28";"2.97";"8.30";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5076263";"";"None";"572.71";"2";"5.17";"16";"C[C@@H](Nc1nc(-c2noc(=O)[nH]2)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"0.63";"nM";"9.20";"";"";"UO_0000065";"16.07";"0.30";"4.03";"7.25";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5080229";"";"None";"572.71";"2";"5.17";"17";"C[C@@H](Nc1nc(-c2n[nH]c(=O)o2)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.19";"0.28";"3.53";"6.85";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5085709";"";"None";"585.76";"1";"4.92";"36";"C[C@@H](Nc1nc(-c2n[nH]c(=O)n2C)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"990.0";"nM";"6.00";"";"";"UO_0000065";"10.25";"0.19";"1.08";"5.06";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL5080229";"";"None";"572.71";"2";"5.17";"17";"C[C@@H](Nc1nc(-c2n[nH]c(=O)o2)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"11.97";"0.22";"1.68";"5.40";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL5079727";"";"None";"586.10";"2";"5.89";"39";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3nc(-c4noc(=O)[nH]4)nc(-c4cccc(Cl)c4)c32)CC1";"IC50";"'='";"113.0";"nM";"6.95";"";"";"UO_0000065";"11.85";"0.23";"1.06";"6.04";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL3647046";"";"None";"586.10";"2";"5.89";"42";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"12.81";"0.24";"1.62";"6.53";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL1944940";"";"None";"556.45";"2";"6.13";"7a";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)O)c(OC(C)C)c1";"IC50";"'='";"6180.0";"nM";"5.21";"";"";"UO_0000065";"9.36";"0.19";"-0.92";"5.19";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL3904825";"";"None";"525.41";"2";"7.73";"BDBM238899";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C(=O)N2";"IC50";"'='";"2.0";"nM";"8.70";"";"417024";"UO_0000065";"16.56";"0.33";"0.97";"14.65";"0";"CHEMBL3888805";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 μM (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919318";"";"None";"580.57";"2";"6.53";"BDBM215247";"CC[C@@H](CCS(=O)(=O)CC1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378491";"UO_0000065";"12.74";"0.27";"0.87";"8.06";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906565";"";"None";"503.47";"2";"6.02";"BDBM215073";"CC[C@@H](CN1CCCC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"570.0";"nM";"6.24";"";"378352";"UO_0000065";"12.40";"0.25";"0.22";"10.26";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106464";"";"None";"491.42";"1";"5.06";"BDBM215077";"CC[C@@H](CNC(C)=O)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"180.0";"nM";"6.75";"";"378356";"UO_0000065";"13.72";"0.28";"1.68";"7.78";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111743";"";"None";"527.47";"1";"4.47";"BDBM215078";"CC[C@@H](CNS(C)(=O)=O)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378357";"UO_0000065";"14.26";"0.30";"3.05";"7.25";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975518";"";"None";"490.43";"1";"5.69";"BDBM215297";"C[C@H](O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378666";"UO_0000065";"17.74";"0.36";"3.01";"11.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL1945122";"";"None";"609.55";"2";"6.67";"8c";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCCC2)c(OC(C)C)c1";"IC50";"'='";"10350.0";"nM";"4.99";"";"";"UO_0000065";"8.18";"0.16";"-1.68";"5.97";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945122";"";"None";"609.55";"2";"6.67";"8c";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCCC2)c(OC(C)C)c1";"IC50";"'='";"10232.93";"nM";"4.99";"";"";"UO_0000065";"8.19";"0.16";"-1.68";"5.98";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945120";"";"None";"625.55";"2";"5.90";"8a";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCOCC2)c(OC(C)C)c1";"IC50";"'='";"5270.0";"nM";"5.28";"";"";"UO_0000065";"8.44";"0.17";"-0.62";"5.69";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945121";"";"None";"611.57";"2";"6.91";"8b";"CCN(CC)C(=O)CNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"9410.0";"nM";"5.03";"";"";"UO_0000065";"8.22";"0.16";"-1.88";"6.02";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL584299";"";"None";"461.35";"1";"6.17";"rac-10";"CN1C2=C(C(c3ccc(Cl)cc3)Oc3ccccc32)C(c2ccc(Cl)cc2)n2ncnc21";"IC50";"'='";"1210.0";"nM";"5.92";"";"";"UO_0000065";"12.83";"0.25";"-0.25";"13.70";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL1945439";"";"None";"625.60";"2";"7.30";"8i";"CCN(CC)C(=O)[C@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"12589.25";"nM";"4.90";"";"";"UO_0000065";"7.83";"0.16";"-2.40";"5.87";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL362794";"";"None";"554.38";"2";"5.38";"6";"CC(C)c1ccc([C@H]2C(=O)Nc3ccc(I)cc3C(=O)N2[C@H](C(=O)O)c2ccccc2)cc1";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"8.56";"0.20";"-0.64";"5.47";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL359856";"";"None";"596.30";"2";"5.15";"8";"O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1320.0";"nM";"5.88";"";"";"UO_0000065";"9.86";"0.23";"0.73";"6.13";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL180433";"";"None";"567.21";"2";"6.03";"44";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"490.0";"nM";"6.31";"";"";"UO_0000065";"11.12";"0.28";"0.28";"9.06";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL369321";"";"None";"534.19";"2";"5.72";"31";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(Br)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"11.38";"0.26";"0.36";"7.01";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL2385521";"";"None";"445.42";"1";"7.03";"MCL0527-3";"Nc1sc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)c1C(=O)NC1CCCCC1";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"13.57";"0.28";"-0.98";"10.97";"0";"CHEMBL3136590";"Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132800";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2059435";"";"None";"478.42";"1";"5.69";"29, AM-8553";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"17.51";"0.36";"2.69";"10.76";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL178504";"";"None";"372.47";"0";"4.41";"2m";"CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccccc1";"IC50";"'='";"100000.0";"nM";"4.00";"";"";"UO_0000065";"10.74";"0.20";"-0.41";"9.43";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL181083";"";"None";"515.99";"2";"6.14";"2o";"COc1cc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O";"IC50";"'='";"42000.0";"nM";"4.38";"";"";"UO_0000065";"8.48";"0.16";"-1.76";"6.41";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL179549";"";"None";"572.82";"None";"None";"1";"CCCN1C(=O)c2ccccc2C1(NC(=O)c1ccc(C(C)(C)C)cc1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"27000.0";"nM";"4.57";"";"";"UO_0000065";"7.98";"None";"None";"None";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL1834384";"";"None";"363.89";"0";"3.87";"11b";"CCCN1C(=O)C(C)=C(C)C1(OCC1(CO)CC1)c1ccc(Cl)cc1";"IC50";"'='";"8900.0";"nM";"5.05";"";"";"UO_0000065";"13.88";"0.28";"1.18";"10.15";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL367147";"";"None";"580.30";"2";"5.27";"1";"O=C(O)C(c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)C1c1ccc(C(F)(F)F)cc1";"IC50";"'='";"31000.0";"nM";"4.51";"";"";"UO_0000065";"7.77";"0.18";"-0.76";"5.20";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL362222";"";"None";"546.75";"1";"4.91";"7";"O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2500.0";"nM";"5.60";"";"";"UO_0000065";"10.25";"0.25";"0.69";"6.46";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL1945120";"";"None";"625.55";"2";"5.90";"8a";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCC(=O)N2CCOCC2)c(OC(C)C)c1";"IC50";"'='";"5754.4";"nM";"5.24";"";"";"UO_0000065";"8.38";"0.17";"-0.66";"5.65";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1688277";"";"None";"458.95";"0";"4.86";"5";"N#Cc1ccc(CN2C(=O)c3ccccc3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"1800.0";"nM";"5.75";"";"";"UO_0000065";"12.52";"0.24";"0.88";"7.81";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL181688";"";"None";"461.61";"1";"7.06";"2d";"CC(C)(C)c1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1";"IC50";"'='";"92000.0";"nM";"4.04";"";"";"UO_0000065";"8.74";"0.16";"-3.02";"13.66";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL178320";"";"None";"325.41";"0";"3.15";"2l";"CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL567635";"";"None";"489.35";"1";"5.76";"rac-12";"CN1C2=C(C(c3ccc(F)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"6570.0";"nM";"5.18";"";"";"UO_0000065";"10.59";"0.22";"-0.58";"12.00";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL582438";"";"None";"580.28";"2";"6.40";"rac-23";"COc1cccc2c1C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"11.24";"0.26";"0.12";"12.45";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL567403";"";"None";"568.24";"2";"6.53";"rac-25";"CN1C2=C(C(c3ccc(Br)cc3)Oc3ccc(F)cc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"1730.0";"nM";"5.76";"";"";"UO_0000065";"10.14";"0.24";"-0.77";"13.34";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL359676";"";"None";"586.77";"1";"4.78";"42";"O=C(O)[C@H](c1ccc(Cl)nc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1c[nH]c2ccccc12";"IC50";"'='";"55000.0";"nM";"4.26";"";"";"UO_0000065";"7.26";"0.17";"-0.52";"3.69";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL360484";"";"None";"480.31";"0";"4.83";"37";"N#Cc1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2";"IC50";"'='";"14800.0";"nM";"4.83";"";"";"UO_0000065";"10.06";"0.20";"0.00";"4.37";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL3134208";"";"None";"412.49";"1";"5.56";"24";"CCOc1ccccc1-c1cc(-c2ccc(C(=O)O)cc2)nn1CCc1ccccc1";"IC50";"'='";"91220.0";"nM";"4.04";"";"";"UO_0000065";"9.79";"0.18";"-1.52";"6.28";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134207";"";"None";"446.93";"1";"5.94";"23";"COc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(Cl)cc2)n(Cc2ccccc2)n1";"IC50";"'='";"86630.0";"nM";"4.06";"";"";"UO_0000065";"9.09";"0.17";"-1.88";"6.31";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134190";"";"None";"500.60";"2";"6.35";"5";"CCCCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1";"IC50";"'='";"14150.0";"nM";"4.85";"";"";"UO_0000065";"9.69";"0.18";"-1.50";"5.86";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL1834288";"";"None";"493.39";"1";"5.51";"10c";"N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"185.0";"nM";"6.73";"";"";"UO_0000065";"13.65";"0.27";"1.22";"9.15";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1834376";"";"None";"535.04";"2";"6.19";"10h";"CC(C)(C)c1ccc2c(c1)C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"733.0";"nM";"6.13";"";"";"UO_0000065";"11.47";"0.22";"-0.06";"6.60";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1834377";"";"None";"557.83";"2";"5.66";"10i";"O=C1c2ccc(Br)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"902.0";"nM";"6.04";"";"";"UO_0000065";"10.84";"0.24";"0.38";"6.51";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL180335";"";"None";"560.78";"2";"5.21";"15";"Cc1ccc([C@@H](C(=O)O)N2C(=O)c3cc(I)ccc3NC(=O)[C@@H]2c2ccc(Cl)cc2)cc1";"IC50";"'='";"1590.0";"nM";"5.80";"";"";"UO_0000065";"10.34";"0.25";"0.59";"6.69";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL386190";"";"None";"387.44";"0";"3.73";"45";"COC(=O)COC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL1944941";"";"None";"570.47";"2";"6.52";"7b";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCC(=O)O)c(OC(C)C)c1";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"10.47";"0.21";"-0.55";"5.94";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1944943";"";"None";"570.47";"2";"6.52";"7d";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@@H](C)C(=O)O)c(OC(C)C)c1";"IC50";"'='";"3390.0";"nM";"5.47";"";"";"UO_0000065";"9.59";"0.19";"-1.05";"5.44";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945119";"";"None";"584.50";"2";"6.91";"7e";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCCC(=O)O)c(OC(C)C)c1";"IC50";"'='";"2050.0";"nM";"5.69";"";"";"UO_0000065";"9.73";"0.19";"-1.22";"5.66";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945232";"";"None";"639.58";"2";"6.29";"8f";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCC(=O)N2CCOCC2)c(OC(C)C)c1";"IC50";"'='";"2230.0";"nM";"5.65";"";"";"UO_0000065";"8.84";"0.18";"-0.64";"6.10";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945439";"";"None";"625.60";"2";"7.30";"8i";"CCN(CC)C(=O)[C@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"12620.0";"nM";"4.90";"";"";"UO_0000065";"7.83";"0.16";"-2.40";"5.87";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945441";"";"None";"625.60";"2";"7.30";"8k";"CCN(CC)C(=O)[C@@H](C)NC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"5010.0";"nM";"5.30";"";"";"UO_0000065";"8.47";"0.17";"-2.00";"6.35";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945121";"";"None";"611.57";"2";"6.91";"8b";"CCN(CC)C(=O)CNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"9332.54";"nM";"5.03";"";"";"UO_0000065";"8.22";"0.16";"-1.88";"6.03";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945234";"";"None";"652.62";"2";"6.21";"8h";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCC(=O)N2CCN(C)CC2)c(OC(C)C)c1";"IC50";"'='";"5830.0";"nM";"5.23";"";"";"UO_0000065";"8.02";"0.16";"-0.98";"6.04";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL216799";"";"None";"465.60";"1";"5.82";"33";"CC(C)(C)c1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2CCc2c[nH]cn2)cc1";"IC50";"'='";"214000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL180048";"";"None";"357.45";"0";"4.97";"5";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'>'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL360719";"";"None";"407.90";"0";"4.60";"76";"O=C1c2ccccc2C(OCCCO)(c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"15900.0";"nM";"4.80";"";"";"UO_0000065";"11.76";"0.23";"0.20";"9.64";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL1771607";"";"None";"693.44";"2";"7.24";"13, Racemic mixture";"CC(C)(C)C(=O)ONCCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"4400.0";"nM";"5.36";"";"";"UO_0000065";"7.72";"0.17";"-1.88";"6.57";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1834373";"";"None";"492.96";"1";"5.20";"10e";"Cc1cccc2c1C(OCC1(CO)CC1)(c1ccc(Cl)cc1)N(Cc1ccc([N+](=O)[O-])cc1)C2=O";"IC50";"'='";"274.0";"nM";"6.56";"";"";"UO_0000065";"13.31";"0.26";"1.36";"7.06";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1834382";"";"None";"482.96";"1";"5.10";"10n";"O=C1C2=C(CCCC2)C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"3470.0";"nM";"5.46";"";"";"UO_0000065";"11.30";"0.22";"0.36";"5.88";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL361630";"";"None";"579.77";"None";"None";"85";"CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"118000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL179339";"";"None";"510.97";"1";"4.07";"83";"COc1cc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2CCNC(C)=O)cc(OC)c1O";"IC50";"'='";"76000.0";"nM";"4.12";"";"";"UO_0000065";"8.06";"0.16";"0.05";"4.23";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL433949";"";"None";"359.85";"0";"3.81";"80";"CCCN1C(=O)c2ccccc2C1(OCCCO)c1ccc(Cl)cc1";"IC50";"'='";"16400.0";"nM";"4.79";"";"";"UO_0000065";"13.30";"0.26";"0.98";"9.61";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL368017";"";"None";"420.51";"1";"5.20";"69";"O=C1c2ccccc2C(OCCc2ccccn2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"206000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL384376";"";"None";"410.51";"0";"3.44";"S8";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1[C@@H](CCCCN)C(=O)OC";"IC50";"'='";"79000.0";"nM";"4.10";"";"";"UO_0000065";"9.99";"0.19";"0.66";"5.01";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL213918";"";"None";"440.50";"0";"3.71";"S10";"O=C1CCC(=O)N1CCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"284000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL180897";"";"None";"356.47";"0";"4.54";"6";"CCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3601403";"";"None";"661.25";"2";"5.37";"17";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1cnc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cn1)C(=O)C2";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"12.28";"0.24";"2.75";"8.89";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL1834287";"";"None";"547.28";"2";"6.40";"10b";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"169.0";"nM";"6.77";"";"";"UO_0000065";"12.37";"0.28";"0.37";"13.61";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL180048";"";"None";"357.45";"0";"4.97";"2a";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'~'";"200000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL181607";"";"None";"511.40";"2";"6.25";"29";"CC(C)(C)c1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2";"IC50";"'='";"2270.0";"nM";"5.64";"";"";"UO_0000065";"11.04";"0.22";"-0.61";"6.51";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL361168";"";"None";"489.74";"1";"5.61";"30";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(Cl)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"830.0";"nM";"6.08";"";"";"UO_0000065";"12.42";"0.26";"0.47";"7.01";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL1933133";"";"None";"1864.28";"None";"None";"8";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)NCCCNCCCCNCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"4.15";"None";"None";"None";"0";"CHEMBL1936335";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1933030";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1933131";"";"None";"1678.96";"None";"None";"6";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"4.94";"None";"None";"None";"0";"CHEMBL1936335";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1933030";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL566560";"";"None";"496.37";"1";"5.50";"rac-15";"CN1C2=C(C(c3ccc(C#N)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"2080.0";"nM";"5.68";"";"";"UO_0000065";"11.45";"0.24";"0.18";"8.48";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL565916";"";"None";"489.35";"1";"5.76";"rac-19";"CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(F)cc2)n2ncnc21";"IC50";"'='";"1880.0";"nM";"5.73";"";"";"UO_0000065";"11.70";"0.24";"-0.03";"13.26";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL565254";"";"None";"594.31";"2";"6.70";"rac-33";"COc1c(C)ccc2c1C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C";"IC50";"'='";"3940.0";"nM";"5.41";"";"";"UO_0000065";"9.09";"0.21";"-1.30";"10.31";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL568520";"";"None";"619.14";"2";"7.69";"rac-35, (1:3syn/anti)";"CN1C2=C(C(c3ccc(Br)cc3)Oc3c(Cl)cc(Cl)cc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'>'";"100000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL2059300";"";"None";"534.48";"2";"6.65";"25";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"16.20";"0.33";"2.01";"10.32";"0";"CHEMBL2060736";"Inhibition of interaction of MDM2-p53 by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2057187";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL179987";"";"None";"499.35";"0";"4.49";"35";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(CCO)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2400.0";"nM";"5.62";"";"";"UO_0000065";"11.25";"0.23";"1.13";"5.26";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL182052";"";"None";"445.52";"0";"4.26";"3";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1C(Cc1ccc(O)cc1)C(=O)OC";"IC50";"'='";"90000.0";"nM";"4.05";"";"";"UO_0000065";"9.08";"0.17";"-0.21";"5.32";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL360141";"";"None";"456.59";"0";"4.99";"2e";"CC(=O)NCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccccc1";"IC50";"'='";"14000.0";"nM";"4.85";"";"";"UO_0000065";"10.63";"0.19";"-0.14";"8.28";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL4112052";"";"None";"542.46";"2";"6.94";"BDBM215139";"CC[C@H](c1nc(C2CC2)no1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378418";"UO_0000065";"13.64";"0.27";"0.46";"7.66";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921531";"";"None";"554.54";"2";"6.14";"BDBM215245";"CC[C@@H](CCS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378489";"UO_0000065";"14.43";"0.30";"1.86";"8.72";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926559";"";"None";"545.51";"2";"5.78";"BDBM215249";"CC[C@@H](CN1C[C@H]2C[C@@H]1CO2)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"378493";"UO_0000065";"13.12";"0.26";"1.37";"10.21";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3938040";"";"None";"559.53";"2";"6.17";"BDBM215253";"CC[C@@H](CN1CC2CCC(C1)O2)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378497";"UO_0000065";"13.44";"0.27";"1.35";"10.73";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3951659";"";"None";"609.47";"2";"7.19";"BDBM215259";"CC[C@@H](Cn1cc(C(F)(F)F)ccc1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378503";"UO_0000065";"12.34";"0.25";"0.33";"9.45";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114823";"";"None";"450.36";"0";"4.91";"BDBM215056";"CC[C@@H](CO)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"378335";"UO_0000065";"16.21";"0.33";"2.39";"9.38";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3977218";"";"None";"531.40";"2";"6.07";"BDBM215072";"CC[C@@H](CNCC(F)(F)F)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"378351";"UO_0000065";"12.74";"0.26";"0.70";"9.72";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111372";"";"None";"452.35";"1";"6.08";"BDBM215404";"CC(C)N1C(=O)[C@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"123.0";"nM";"6.91";"";"378793";"UO_0000065";"15.28";"0.31";"0.83";"11.99";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941277";"";"None";"573.51";"2";"5.39";"BDBM215405";"CC[C@@H](CNS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.7";"nM";"9.15";"";"378794";"UO_0000065";"15.96";"0.34";"3.76";"8.82";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895410";"";"None";"664.70";"2";"6.20";"BDBM215422";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](CCN2CCCC2)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.6";"nM";"8.59";"";"378807";"UO_0000065";"12.92";"0.27";"2.39";"8.74";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110335";"";"None";"504.45";"2";"6.08";"BDBM215429";"CC[C@@H]([C@H](O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.3";"nM";"8.89";"";"378812";"UO_0000065";"17.62";"0.36";"2.81";"11.42";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2059300";"";"None";"534.48";"2";"6.65";"25";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"19.9";"nM";"7.70";"";"";"UO_0000065";"14.41";"0.29";"1.05";"9.18";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177185";"";"None";"456.38";"0";"4.83";"21";"O=C1[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"190.0";"nM";"6.72";"";"";"UO_0000065";"14.73";"0.30";"1.89";"8.99";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3907629";"";"None";"530.46";"2";"7.98";"BDBM236306";"COc1ccccc1-c1c(C#N)c2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.163";"nM";"9.79";"";"411690";"UO_0000065";"18.45";"0.36";"1.81";"16.80";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3978167";"";"None";"563.48";"2";"7.74";"BDBM236307";"COc1ccc(CC(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.155";"nM";"9.81";"";"411691";"UO_0000065";"17.41";"0.34";"2.07";"13.67";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918896";"";"None";"506.43";"2";"7.50";"BDBM236360";"COc1cccnc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.216";"nM";"9.67";"";"411744";"UO_0000065";"19.09";"0.38";"2.17";"20.41";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940681";"";"None";"555.44";"2";"6.19";"BDBM236478";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cn1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.657";"nM";"9.18";"";"411864";"UO_0000065";"16.53";"0.33";"2.99";"12.02";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177191";"";"None";"464.39";"1";"5.30";"28";"CC[C@@H](CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"18.88";"0.39";"3.47";"11.27";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177195";"";"None";"376.33";"1";"6.10";"6";"CC(C)CN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"14.98";"0.31";"-0.46";"27.76";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177192";"";"None";"374.31";"1";"5.85";"4";"O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"15.56";"0.32";"-0.03";"28.68";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL1834286";"";"None";"513.38";"2";"5.55";"(+)-10a";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"763.0";"nM";"6.12";"";"";"UO_0000065";"11.92";"0.24";"0.57";"6.58";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2177190";"";"None";"462.42";"1";"6.72";"27";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.8";"nM";"8.55";"";"";"UO_0000065";"18.50";"0.38";"1.83";"14.85";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL433753";"";"None";"580.30";"2";"5.27";"9";"O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccccc1C(F)(F)F";"IC50";"'>'";"125000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL567636";"";"None";"505.80";"2";"6.28";"rac-13";"CN1C2=C(C(c3ccc(Cl)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"890.0";"nM";"6.05";"";"";"UO_0000065";"11.96";"0.26";"-0.23";"14.01";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL2315847";"";"None";"615.63";"2";"6.33";"20b";"COCCN(C)C(=O)[C@@H]1CCCN1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"11.92";"0.24";"1.01";"11.21";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL1688274";"";"None";"478.93";"0";"4.89";"3";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"225.0";"nM";"6.65";"";"";"UO_0000065";"13.88";"0.27";"1.76";"7.16";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1834287";"";"None";"547.28";"2";"6.40";"(+)-10b";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"4015.0";"nM";"5.40";"";"";"UO_0000065";"9.86";"0.22";"-1.00";"10.84";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2177187";"";"None";"520.45";"2";"6.26";"23";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"43.3";"nM";"7.36";"";"";"UO_0000065";"14.15";"0.29";"1.10";"8.78";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3329617";"";"None";"525.48";"2";"7.39";"19";"CC[C@@H](c1ncccc1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"183.0";"nM";"6.74";"";"";"UO_0000065";"12.82";"0.26";"-0.65";"9.56";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2398247";"";"None";"654.71";"2";"6.78";"29";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCN(C)[C@@H](C)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"11.91";"0.24";"1.02";"13.11";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2398246";"";"None";"654.71";"2";"6.78";"28";"CC(C)C1=C(C(=O)N2[C@H](C)CC[C@H]2C(=O)N2CCN(C)[C@H](C)C2)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"11.95";"0.24";"1.04";"13.16";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2398248";"";"None";"585.60";"2";"6.70";"9";"CC(C)C1=C(C(=O)N2[C@@H](C)CC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.41";"0.28";"1.15";"13.97";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"10.84";"0.22";"0.41";"7.55";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL3775936";"";"None";"299.40";"0";"4.21";"3c; K-181";"CC(C)C(=O)Sc1ccccc1NC(=O)c1ccccc1";"IC50";"'='";"14600.0";"nM";"4.84";"";"";"UO_0000065";"16.15";"0.31";"0.63";"10.47";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL3775136";"";"None";"251.40";"0";"4.27";"2b";"CCCCCCCC(=O)Nc1ccccc1S";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL362452";"";"None";"433.50";"0";"4.69";"2k";"CCCN1C(=O)c2ccccc2C1(OCc1cc(OC)c(O)c(OC)c1)c1ccccc1";"IC50";"'='";"82000.0";"nM";"4.09";"";"";"UO_0000065";"9.43";"0.17";"-0.60";"5.99";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL583413";"";"None";"564.28";"2";"6.70";"rac-27";"Cc1ccc2c(c1)C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C";"IC50";"'='";"440.0";"nM";"6.36";"";"";"UO_0000065";"11.26";"0.26";"-0.34";"14.72";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL567616";"";"None";"584.70";"2";"7.04";"rac-32";"CN1C2=C(C(c3ccc(Br)cc3)Oc3c(Cl)cccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"9.33";"0.23";"-1.58";"12.64";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3805499";"";"None";"756.77";"2";"6.99";"19";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OC(C)(C)C(=O)O)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"10.52";"0.21";"0.97";"7.07";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3220685";"";"None";"509.39";"2";"5.33";"17";"Cc1cccc([C@H]2N(CC(=O)O)C(=O)C[C@@H](c3cccc(Cl)c3)[C@]23C(=O)Nc2cc(Cl)ccc23)c1";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"12.63";"0.25";"1.10";"7.42";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3220688";"";"None";"554.52";"2";"5.12";"20";"C=C(CC)[C@H]1N2CC(=O)N(CCCN(C)C)N=C2C[C@@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"12.62";"0.25";"1.88";"10.26";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL178578";"";"None";"580.30";"2";"5.27";"2";"O=C(O)[C@H](c1ccccc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(C(F)(F)F)cc1";"IC50";"'='";"2200.0";"nM";"5.66";"";"";"UO_0000065";"9.75";"0.23";"0.39";"6.52";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL369570";"";"None";"553.23";"2";"6.39";"45";"O=C(O)[C@H](c1ccc(Cl)cc1)N1Cc2cc(I)ccc2NC[C@@H]1c1ccc(Cl)cc1";"IC50";"'>'";"125000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL1688280";"";"None";"512.83";"2";"5.75";"4";"O=C1c2ccccc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(Br)cc1";"IC50";"'='";"1200.0";"nM";"5.92";"";"";"UO_0000065";"11.55";"0.25";"0.17";"11.90";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1834286";"";"None";"513.38";"2";"5.55";"(-)-10a";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"14.33";"0.29";"1.81";"7.92";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1771730";"";"None";"608.33";"2";"6.53";"26, Racemic mixture";"CC(C)(O)CN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"10.57";"0.24";"-0.10";"10.14";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1771609";"";"None";"735.40";"2";"6.71";"15, Racemic mixture";"CN(C)CCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21.O=C(O)C(F)(F)F";"IC50";"'='";"7500.0";"nM";"5.12";"";"";"UO_0000065";"8.25";"0.19";"-1.59";"11.04";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3902756";"";"None";"534.52";"2";"7.25";"BDBM215185";"CC[C@@H](CCCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378568";"UO_0000065";"15.71";"0.32";"1.15";"10.79";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125522";"";"None";"526.48";"2";"5.35";"BDBM50448941";"CC[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378705";"UO_0000065";"18.09";"0.38";"4.17";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3958379";"";"None";"584.56";"2";"5.50";"BDBM215342";"CC[C@@H](CS(=O)(=O)CC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378714";"UO_0000065";"16.59";"0.35";"4.20";"8.66";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3974607";"";"None";"601.55";"2";"6.18";"BDBM215352";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccncc2)C2CC2)C1=O";"IC50";"'='";"0.5";"nM";"9.30";"";"378724";"UO_0000065";"15.46";"0.32";"3.12";"8.89";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3897410";"";"None";"558.50";"2";"5.88";"BDBM215408";"CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378797";"UO_0000065";"17.37";"0.37";"3.82";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894034";"";"None";"523.03";"2";"5.94";"BDBM236312";"COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"4.907";"nM";"8.31";"";"411696";"UO_0000065";"15.89";"0.31";"2.37";"9.03";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3911216";"";"None";"567.48";"2";"5.36";"BDBM236320";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.161";"nM";"9.79";"";"411704";"UO_0000065";"17.26";"0.34";"4.43";"11.46";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919729";"";"None";"529.99";"1";"4.09";"BDBM236376";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"5.658";"nM";"8.25";"";"411760";"UO_0000065";"15.56";"0.30";"4.16";"6.25";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955169";"";"None";"553.45";"2";"5.90";"BDBM236452";"COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cnc1OC)C2=O";"IC50";"'='";"0.198";"nM";"9.70";"";"411836";"UO_0000065";"17.53";"0.35";"3.80";"12.35";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115504";"";"None";"462.37";"0";"4.91";"BDBM215057";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CO)C2CC2)C1=O";"IC50";"'='";"40.0";"nM";"7.40";"";"378336";"UO_0000065";"16.00";"0.33";"2.49";"9.50";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3931174";"";"None";"493.05";"1";"6.56";"BDBM236348";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"27.0";"nM";"7.57";"";"411602";"UO_0000065";"15.35";"0.30";"1.01";"13.84";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980916";"";"None";"509.01";"1";"3.94";"BDBM236355";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCC(=O)N(C)C1)C2=O";"IC50";"'='";"3.3";"nM";"8.48";"";"411607";"UO_0000065";"16.66";"0.32";"4.54";"7.96";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919782";"";"None";"580.49";"2";"7.61";"BDBM236254";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"0.119";"nM";"9.92";"";"411639";"UO_0000065";"17.10";"0.34";"2.31";"15.61";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3937629";"";"None";"576.52";"2";"7.78";"BDBM236279";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.094";"nM";"10.03";"";"411664";"UO_0000065";"17.39";"0.34";"2.25";"15.77";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894069";"";"None";"587.44";"2";"5.27";"BDBM238918";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C(=O)N2";"IC50";"'='";"354.0";"nM";"6.45";"";"417050";"UO_0000065";"10.98";"0.22";"1.18";"5.32";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3945756";"";"None";"537.45";"2";"6.91";"BDBM236261";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.068";"nM";"10.17";"";"411646";"UO_0000065";"18.92";"0.38";"3.26";"14.63";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3964289";"";"None";"592.49";"2";"5.23";"BDBM236411";"COc1nc(N(C)C)ncc1-c1c(C#N)c2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.121";"nM";"9.92";"";"411795";"UO_0000065";"16.74";"0.33";"4.69";"9.08";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3911364";"";"None";"572.42";"2";"5.44";"BDBM236443";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.395";"nM";"9.40";"";"411827";"UO_0000065";"16.43";"0.33";"3.96";"10.28";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3913159";"";"None";"545.00";"1";"4.52";"BDBM236462";"COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.527";"nM";"9.28";"";"411846";"UO_0000065";"17.02";"0.32";"4.76";"8.05";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3912687";"";"None";"538.44";"2";"6.30";"BDBM236479";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cn2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"7.156";"nM";"8.14";"";"411865";"UO_0000065";"15.13";"0.30";"1.85";"9.89";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114394";"";"None";"582.55";"1";"4.71";"BDBM215395";"CN(C)S(=O)(=O)NC[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"378787";"UO_0000065";"15.97";"0.33";"4.59";"8.69";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3909721";"";"None";"572.53";"2";"6.27";"BDBM215412";"CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378800";"UO_0000065";"17.47";"0.37";"3.73";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3891247";"";"None";"460.40";"1";"6.33";"BDBM215443";"CC[C@H]1[C@H](C)O[C@]23OC(=O)C[C@@]2(C)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N13";"IC50";"'='";"1.8";"nM";"8.74";"";"378825";"UO_0000065";"18.99";"0.39";"2.41";"22.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3942905";"";"None";"434.36";"1";"5.80";"BDBM215093";"CC(C)CN1C(=O)[C@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"450.0";"nM";"6.35";"";"378372";"UO_0000065";"14.61";"0.30";"0.55";"11.02";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106930";"";"None";"517.45";"2";"5.15";"BDBM215098";"CCOC(=O)CNC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"2380.0";"nM";"5.62";"";"378377";"UO_0000065";"10.87";"0.22";"0.47";"7.43";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3933945";"";"None";"420.34";"1";"5.55";"BDBM215091";"CCCN1C(=O)[C@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"410.0";"nM";"6.39";"";"378370";"UO_0000065";"15.20";"0.31";"0.84";"11.09";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4203529";"";"None";"462.35";"1";"6.18";"(+)-8'";"CC(C)(C)CC1C=C(C(=O)O)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"538.2";"nM";"6.27";"";"";"UO_0000065";"13.56";"0.28";"0.09";"9.44";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"14.54";"0.29";"2.57";"10.13";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL2024320";"";"None";"431.97";"1";"5.67";"2";"COc1ccc(Cn2c(C)nc(Cc3ccc(N)cc3)c2Cc2ccc(Cl)cc2)cc1";"IC50";"'='";"3400.0";"nM";"5.47";"";"";"UO_0000065";"12.66";"0.24";"-0.20";"10.30";"0";"CHEMBL2027062";"Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2021844";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL1834288";"";"None";"493.39";"1";"5.51";"(-)-10c";"N#Cc1ccc(CN2C(=O)c3cccc(Cl)c3C2(OCC2(CO)CC2)c2ccc(Cl)cc2)cc1";"IC50";"'='";"136.0";"nM";"6.87";"";"";"UO_0000065";"13.92";"0.28";"1.36";"9.33";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL4751574";"";"None";"580.49";"2";"6.05";"15";"COC(=O)c1ccc([C@H]2C[C@H]3[C@@H](N2)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc4cc(Cl)ccc42)N3CC2CC2)cc1";"IC50";"'='";"81.0";"nM";"7.09";"";"";"UO_0000065";"12.22";"0.24";"1.04";"10.03";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4739921";"";"None";"486.40";"0";"4.18";"Rac-14";"O=C(O)CN1CC[C@H]2[C@@H]1[C@H](c1cccc(Cl)c1)[C@]1(C(=O)Nc3cc(Cl)ccc31)N2CC1CC1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"14.59";"0.29";"2.92";"9.74";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4754310";"";"None";"432.40";"1";"5.00";"Rac-6c";"CC(C)CCN1[C@@H](C)[C@@H](N)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"1075.0";"nM";"5.97";"";"";"UO_0000065";"13.80";"0.28";"0.97";"10.23";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4778680";"";"None";"416.35";"0";"4.37";"6d";"C[C@H]1[C@@H](N)[C@H](c2cccc(Cl)c2)[C@]2(C(=O)Nc3cc(Cl)ccc32)N1CC1CC1";"IC50";"'='";"563.0";"nM";"6.25";"";"";"UO_0000065";"15.01";"0.30";"1.88";"10.71";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4760968";"";"None";"438.34";"0";"3.90";"Rac-5c";"CSC[C@@H]1N[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@@H](c2cccc(Cl)c2)[C@@H]1[N+](=O)[O-]";"IC50";"'='";"24600.0";"nM";"4.61";"";"";"UO_0000065";"10.51";"0.22";"0.71";"5.47";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4753559";"";"None";"504.39";"1";"4.32";"Rac-12";"O=C(O)CN1CC[C@H]2[C@@H]1[C@H](c1cccc(Cl)c1F)[C@]1(C(=O)Nc3cc(Cl)ccc31)N2CC1CC1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"14.69";"0.30";"3.09";"10.17";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3948736";"";"None";"562.41";"2";"5.94";"BDBM215182";"CC[C@@H](CC(O)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378463";"UO_0000065";"14.22";"0.30";"2.06";"8.16";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3891121";"";"None";"531.98";"2";"5.96";"BDBM236287";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.478";"nM";"9.32";"";"411672";"UO_0000065";"17.52";"0.33";"3.36";"9.99";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329620";"";"None";"434.36";"1";"5.94";"BDBM215122";"CC(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378401";"UO_0000065";"17.32";"0.35";"1.58";"13.06";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329608";"";"None";"511.45";"2";"7.08";"BDBM215273";"CC[C@@H](c1cccnc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"378514";"UO_0000065";"13.88";"0.28";"0.02";"10.07";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108893";"";"None";"523.46";"2";"7.08";"BDBM215301";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](c2ccccn2)C2CC2)C1=O";"IC50";"'='";"20.0";"nM";"7.70";"";"378532";"UO_0000065";"14.71";"0.29";"0.62";"10.92";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929164";"";"None";"460.40";"1";"6.47";"BDBM215124";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CCCC2)C1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"378544";"UO_0000065";"18.03";"0.37";"1.83";"14.41";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125710";"";"None";"541.50";"1";"4.86";"BDBM50448943";"CC[C@@H](CNS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378559";"UO_0000065";"16.62";"0.35";"4.14";"8.67";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329610";"";"None";"525.48";"2";"7.32";"BDBM215285";"CC(C)[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378524";"UO_0000065";"14.32";"0.29";"0.20";"10.67";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109809";"";"None";"519.47";"2";"5.25";"BDBM215070";"CC[C@@H](CN1CCOCC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"378349";"UO_0000065";"13.77";"0.28";"1.90";"10.21";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961139";"";"None";"532.49";"2";"6.49";"BDBM215076";"CC[C@@H](CNc1nccs1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4300.0";"nM";"5.37";"";"378364";"UO_0000065";"10.08";"0.21";"-1.12";"6.50";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918635";"";"None";"570.44";"2";"5.09";"BDBM238916";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C(=O)N3)c(OC)n1";"IC50";"'='";"2914.0";"nM";"5.54";"";"417048";"UO_0000065";"9.70";"0.19";"0.45";"4.76";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112858";"";"None";"483.40";"1";"6.44";"BDBM215163";"Cc1ccnc(N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"378442";"UO_0000065";"15.56";"0.31";"1.08";"10.67";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899355";"";"None";"531.48";"2";"5.93";"BDBM215248";"CC[C@@H](CN1CCCC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378492";"UO_0000065";"14.49";"0.29";"1.77";"9.88";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966228";"";"None";"533.45";"2";"5.76";"BDBM215257";"CC[C@@H](CN1CCOC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378501";"UO_0000065";"14.10";"0.29";"1.76";"8.63";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3936711";"";"None";"524.02";"1";"4.36";"BDBM236356";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(C2CCC(=O)N(C)C2)C3=O)c(OC)n1";"IC50";"'='";"1.6";"nM";"8.80";"";"411740";"UO_0000065";"16.79";"0.32";"4.44";"9.80";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961711";"";"None";"515.96";"1";"4.08";"BDBM236372";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"3.22";"nM";"8.49";"";"411756";"UO_0000065";"16.46";"0.31";"4.41";"5.94";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899074";"";"None";"552.08";"1";"4.17";"BDBM236406";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CN(C)C(=O)N(C)C1)C2=O";"IC50";"'='";"0.161";"nM";"9.79";"";"411790";"UO_0000065";"17.74";"0.34";"5.62";"11.25";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3945499";"";"None";"558.04";"1";"4.57";"BDBM236432";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.225";"nM";"9.65";"";"411816";"UO_0000065";"17.29";"0.33";"5.08";"8.83";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3911189";"";"None";"536.46";"2";"7.60";"BDBM238902";"COc1ccncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2";"IC50";"'='";"3.1";"nM";"8.51";"";"417027";"UO_0000065";"15.86";"0.31";"0.91";"11.77";"0";"CHEMBL3888805";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 μM (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3953377";"";"None";"622.55";"2";"6.93";"BDBM238906";"COc1ccc(C(=O)NCCO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2";"IC50";"'='";"447.0";"nM";"6.35";"";"417038";"UO_0000065";"10.20";"0.20";"-0.58";"5.84";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107457";"";"None";"562.50";"2";"7.47";"BDBM236266";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"180.52";"nM";"6.74";"";"411651";"UO_0000065";"11.99";"0.24";"-0.73";"10.61";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3909112";"";"None";"531.98";"2";"5.96";"BDBM236289";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)n1";"IC50";"'='";"0.246";"nM";"9.61";"";"411674";"UO_0000065";"18.06";"0.35";"3.65";"10.30";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3901889";"";"None";"523.42";"2";"6.35";"BDBM236292";"CCn1c(-c2cnc(OC)nc2OC)cc2c1C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"87.63";"nM";"7.06";"";"411677";"UO_0000065";"13.48";"0.27";"0.71";"10.16";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3952928";"";"None";"492.44";"1";"6.08";"BDBM215190";"CC[C@@H](CC(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378471";"UO_0000065";"16.25";"0.33";"1.92";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107867";"";"None";"547.52";"2";"6.47";"BDBM215221";"CC[C@@H](C(=O)NCC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378485";"UO_0000065";"14.06";"0.28";"1.23";"8.88";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107468";"";"None";"518.48";"2";"6.93";"BDBM215244";"CCC(C(=O)CC(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378627";"UO_0000065";"16.78";"0.34";"1.77";"11.65";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3981229";"";"None";"464.99";"1";"6.12";"BDBM236321";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O";"IC50";"'='";"2.566";"nM";"8.59";"";"411705";"UO_0000065";"18.48";"0.36";"2.47";"19.66";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3983558";"";"None";"580.47";"2";"6.13";"BDBM236365";"COc1ccc(CC(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.311";"nM";"9.51";"";"411749";"UO_0000065";"16.38";"0.32";"3.38";"10.14";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3968623";"";"None";"510.04";"2";"5.27";"BDBM236388";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](OC)CC1)C2=O";"IC50";"'='";"6.845";"nM";"8.16";"";"411772";"UO_0000065";"16.01";"0.31";"2.89";"8.55";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3978654";"";"None";"626.50";"2";"5.48";"BDBM236464";"CCOC(=O)c1c2c(n(C(C)C)c1-c1cnc(OC)nc1OC)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.134";"nM";"9.87";"";"411850";"UO_0000065";"15.76";"0.31";"4.39";"8.38";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3947579";"";"None";"431.36";"0";"4.95";"BDBM215108";"NC(=O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"870.0";"nM";"6.06";"";"378387";"UO_0000065";"14.05";"0.29";"1.11";"9.56";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112059";"";"None";"545.51";"2";"5.64";"BDBM215119";"O=C(O)C[C@@]1(CCN2CCOCC2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"130.0";"nM";"6.89";"";"378398";"UO_0000065";"12.62";"0.25";"1.25";"9.83";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929164";"";"None";"460.40";"1";"6.47";"BDBM215124";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CCCC2)C1=O";"IC50";"'='";"30.0";"nM";"7.52";"";"378403";"UO_0000065";"16.34";"0.33";"1.05";"13.06";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125705";"";"None";"520.50";"2";"6.86";"BDBM50448952";"CC[C@@H](CCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378564";"UO_0000065";"17.29";"0.35";"2.14";"11.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919843";"";"None";"638.01";"2";"6.94";"BDBM215227";"CC[C@@H](CNS(=O)(=O)c1ccc(Cl)cc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378610";"UO_0000065";"13.36";"0.28";"1.58";"8.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919357";"";"None";"633.59";"2";"6.30";"BDBM215231";"CC[C@@H](CNS(=O)(=O)c1ccc(OC)cc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378614";"UO_0000065";"14.20";"0.29";"2.70";"7.96";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975667";"";"None";"615.58";"2";"6.51";"BDBM215234";"CC[C@@H](CN1Cc2ccccc2S1(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"378617";"UO_0000065";"13.48";"0.28";"1.79";"8.74";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3954045";"";"None";"572.04";"2";"5.84";"BDBM236332";"CNC(=O)Cc1cnc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"3.158";"nM";"8.50";"";"411716";"UO_0000065";"14.86";"0.28";"2.66";"8.48";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3978059";"";"None";"572.04";"2";"5.84";"BDBM236333";"CNC(=O)Cc1cc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cccc(Cl)c2F)C3=O)c(OC)cn1";"IC50";"'='";"0.334";"nM";"9.48";"";"411717";"UO_0000065";"16.57";"0.32";"3.64";"9.45";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3969971";"";"None";"545.02";"2";"6.01";"BDBM236341";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.188";"nM";"9.73";"";"411725";"UO_0000065";"17.84";"0.34";"3.72";"11.14";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107542";"";"None";"630.59";"2";"5.82";"BDBM215325";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)Cc2cccnc2)C2CC2)C1=O";"IC50";"'='";"0.3";"nM";"9.52";"";"378694";"UO_0000065";"15.10";"0.31";"3.70";"8.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108486";"";"None";"592.46";"2";"6.24";"BDBM215356";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C(F)(F)F)C2CC2)C1=O";"IC50";"'='";"0.3";"nM";"9.52";"";"378728";"UO_0000065";"16.07";"0.34";"3.28";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892453";"";"None";"649.04";"2";"7.83";"BDBM215358";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2Cl)C2CC2)C1=O";"IC50";"'='";"0.4";"nM";"9.40";"";"378730";"UO_0000065";"14.48";"0.31";"1.57";"10.24";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3986817";"";"None";"632.58";"2";"7.31";"BDBM215359";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2F)C2CC2)C1=O";"IC50";"'='";"0.4";"nM";"9.40";"";"378731";"UO_0000065";"14.86";"0.31";"2.09";"10.24";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3957184";"";"None";"608.51";"2";"6.53";"BDBM215367";"CC(C)[C@@H](CS(=O)(=O)CC(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"378740";"UO_0000065";"14.37";"0.31";"2.21";"9.53";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110667";"";"None";"494.42";"0";"4.66";"BDBM215427";"CC[C@@H]([C@H](O)CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378810";"UO_0000065";"18.20";"0.37";"4.34";"9.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3958512";"";"None";"434.36";"1";"5.72";"BDBM215430";"CC(C)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@]1(C)c1ccc(Cl)cc1";"IC50";"'='";"18.3";"nM";"7.74";"";"378813";"UO_0000065";"17.81";"0.36";"2.02";"13.43";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932076";"";"None";"630.64";"2";"6.52";"BDBM215436";"CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@](C)(Cc2cccc(OC)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"130.0";"nM";"6.89";"";"378819";"UO_0000065";"10.92";"0.22";"0.37";"8.63";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3965576";"";"None";"559.00";"2";"6.18";"BDBM236331";"COc1cnc(CC(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.482";"nM";"9.32";"";"411715";"UO_0000065";"16.67";"0.32";"3.14";"8.59";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3893708";"";"None";"487.56";"0";"4.14";"BDBM236404";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(C2CCOCC2)C3=O)c(OC)n1";"IC50";"'='";"7.896";"nM";"8.10";"";"411788";"UO_0000065";"16.62";"0.31";"3.96";"7.90";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108719";"";"None";"515.48";"2";"7.25";"BDBM215195";"CCC(CC(C)(C)C#N)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378578";"UO_0000065";"16.88";"0.34";"1.45";"10.69";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110761";"";"None";"476.40";"1";"5.90";"BDBM215196";"CC[C@@H](C(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"378579";"UO_0000065";"17.26";"0.35";"2.32";"11.01";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904755";"";"None";"587.47";"2";"6.72";"BDBM215223";"CC[C@@H](CN(CC(F)(F)F)C(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"378603";"UO_0000065";"13.78";"0.28";"1.38";"10.39";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3947547";"";"None";"597.61";"2";"6.37";"BDBM215225";"CC[C@@H](CN(CC)S(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"13.0";"nM";"7.89";"";"378607";"UO_0000065";"13.20";"0.28";"1.52";"8.30";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919318";"";"None";"580.57";"2";"6.53";"BDBM215247";"CC[C@@H](CCS(=O)(=O)CC1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"378630";"UO_0000065";"13.86";"0.29";"1.52";"8.77";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114935";"";"None";"504.45";"2";"6.49";"BDBM215261";"CC[C@@H](C1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378642";"UO_0000065";"16.90";"0.34";"2.03";"12.75";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125517";"";"None";"593.57";"2";"5.73";"BDBM50448969";"CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C1CC1";"IC50";"'<'";"1.0";"nM";"";"";"378664";"UO_0000065";"";"";"";"";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112149";"";"None";"607.60";"2";"6.17";"BDBM215331";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C2CCC2)C2CC2)C1=O";"IC50";"'='";"0.8";"nM";"9.10";"";"378698";"UO_0000065";"14.97";"0.31";"2.93";"8.77";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3968680";"";"None";"578.56";"2";"6.28";"BDBM215374";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CCC2)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378756";"UO_0000065";"16.76";"0.35";"3.42";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3953498";"";"None";"578.56";"2";"6.28";"BDBM215381";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CC2)C2CC2)C1=O";"IC50";"'='";"0.3";"nM";"9.52";"";"378764";"UO_0000065";"16.46";"0.34";"3.24";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962217";"";"None";"592.52";"2";"6.65";"BDBM215401";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](Cn2c(=O)[nH]c3ccccc32)C2CC2)C1=O";"IC50";"'='";"1.4";"nM";"8.85";"";"378791";"UO_0000065";"14.94";"0.29";"2.20";"9.28";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3974082";"";"None";"523.44";"2";"8.25";"BDBM236362";"COc1ccccc1-c1c(F)c2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.485";"nM";"9.31";"";"411746";"UO_0000065";"17.79";"0.35";"1.06";"27.02";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3927561";"";"None";"539.42";"2";"5.58";"BDBM236453";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cnc1OC)C2=O";"IC50";"'='";"0.509";"nM";"9.29";"";"411837";"UO_0000065";"17.23";"0.34";"3.71";"8.57";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941149";"";"None";"538.03";"2";"5.18";"BDBM236456";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c(F)c(C)nn1C)C2=O";"IC50";"'='";"0.158";"nM";"9.80";"";"411840";"UO_0000065";"18.22";"0.35";"4.62";"12.05";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3959690";"";"None";"555.42";"1";"4.69";"BDBM236460";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cn2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"14.24";"nM";"7.85";"";"411844";"UO_0000065";"14.13";"0.28";"3.16";"7.52";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894532";"";"None";"533.50";"2";"5.64";"BDBM215140";"CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378419";"UO_0000065";"15.00";"0.30";"2.36";"11.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3957985";"";"None";"568.56";"2";"6.52";"BDBM215246";"CC[C@@H](CCS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378490";"UO_0000065";"14.07";"0.30";"1.48";"8.72";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329224";"";"None";"525.48";"2";"7.39";"BDBM215276";"CC[C@@H](c1cccc(C)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378517";"UO_0000065";"15.22";"0.30";"0.61";"11.35";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125702";"NAVTEMADLIN";"2.0";"568.56";"2";"6.38";"BDBM50448947";"CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378766";"UO_0000065";"15.83";"0.33";"2.62";"9.81";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125540";"";"None";"582.59";"2";"6.77";"BDBM50448960";"CC(C)S(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C";"IC50";"'='";"0.8";"nM";"9.10";"";"378769";"UO_0000065";"15.61";"0.33";"2.33";"9.91";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3958045";"";"None";"554.54";"2";"6.13";"BDBM215390";"CC[C@@H]([C@H](C)S(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378775";"UO_0000065";"18.03";"0.38";"3.87";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906706";"";"None";"550.10";"2";"5.91";"BDBM236349";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N([C@H]2CC[C@H](O)CC2)C3=O)c1";"IC50";"'='";"13.59";"nM";"7.87";"";"411733";"UO_0000065";"14.30";"0.28";"1.96";"9.39";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3925187";"";"None";"544.02";"1";"4.56";"BDBM236374";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.359";"nM";"9.45";"";"411758";"UO_0000065";"17.36";"0.33";"4.88";"7.86";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3935157";"";"None";"545.00";"1";"4.52";"BDBM236379";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1";"IC50";"'='";"1.15";"nM";"8.94";"";"411763";"UO_0000065";"16.40";"0.31";"4.42";"7.76";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110421";"";"None";"556.43";"2";"5.94";"BDBM236468";"COC[C@@H](C)n1c(-c2cnc(N)nc2OC)cc2c1C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.362";"nM";"9.44";"";"411854";"UO_0000065";"16.97";"0.34";"3.50";"9.89";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112168";"";"None";"558.04";"1";"4.57";"BDBM236477";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"60.2";"nM";"7.22";"";"411863";"UO_0000065";"12.94";"0.25";"2.65";"6.61";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114522";"";"None";"486.44";"1";"6.72";"BDBM215165";"C[C@@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N(C(C2CC2)C2CC2)C1=O";"IC50";"'='";"390.0";"nM";"6.41";"";"378444";"UO_0000065";"13.18";"0.27";"-0.31";"11.12";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177182";"";"None";"446.37";"1";"5.64";"BDBM215096";"COC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"3630.0";"nM";"5.44";"";"378375";"UO_0000065";"12.19";"0.25";"-0.20";"11.67";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106454";"";"None";"489.40";"0";"4.67";"BDBM215099";"O=C(O)CNC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"830.0";"nM";"6.08";"";"378378";"UO_0000065";"12.43";"0.25";"1.41";"7.01";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894955";"";"None";"509.46";"1";"4.54";"BDBM215107";"CS(=O)(=O)NC(=O)C[C@@H]1CC(c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"700.0";"nM";"6.16";"";"378386";"UO_0000065";"12.08";"0.25";"1.61";"7.37";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3979952";"";"None";"456.38";"0";"4.83";"BDBM215109";"O=C1[C@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"160.0";"nM";"6.80";"";"378388";"UO_0000065";"14.89";"0.30";"1.97";"9.09";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111833";"";"None";"462.42";"1";"6.72";"BDBM215120";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378399";"UO_0000065";"16.65";"0.34";"0.98";"13.36";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3908460";"";"None";"456.39";"1";"5.11";"BDBM215167";"CC(C)N1[C@H](c2ccc(Cl)cc2)[C@@H](c2cccc(Cl)c2)C[C@@H](CC(=O)O)S1(=O)=O";"IC50";"'='";"650.0";"nM";"6.19";"";"378446";"UO_0000065";"13.56";"0.29";"1.08";"8.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111356";"";"None";"470.42";"1";"5.50";"BDBM215168";"CC(C)N1[C@H](c2ccc(Cl)cc2)[C@@H](c2cccc(Cl)c2)C[C@](C)(CC(=O)O)S1(=O)=O";"IC50";"'='";"120.0";"nM";"6.92";"";"378447";"UO_0000065";"14.71";"0.32";"1.42";"9.27";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113137";"";"None";"463.40";"1";"6.12";"BDBM215171";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1";"IC50";"'='";"50.0";"nM";"7.30";"";"378450";"UO_0000065";"15.76";"0.32";"1.18";"10.36";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3977905";"";"None";"574.47";"2";"7.40";"BDBM215183";"CC[C@@H](CCC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378464";"UO_0000065";"13.93";"0.29";"0.60";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329612";"";"None";"525.48";"2";"7.47";"BDBM215271";"CCC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"378512";"UO_0000065";"13.51";"0.27";"-0.37";"10.07";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3954030";"";"None";"555.52";"2";"5.20";"BDBM215180";"CC[C@@H](CN(C)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378563";"UO_0000065";"15.66";"0.33";"3.50";"9.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940783";"";"None";"595.59";"2";"6.12";"BDBM215242";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378625";"UO_0000065";"14.61";"0.30";"2.58";"9.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3957985";"";"None";"568.56";"2";"6.52";"BDBM215246";"CC[C@@H](CCS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378629";"UO_0000065";"14.99";"0.31";"2.00";"9.29";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966228";"";"None";"533.45";"2";"5.76";"BDBM215257";"CC[C@@H](CN1CCOC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"378639";"UO_0000065";"15.56";"0.31";"2.54";"9.52";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3924685";"";"None";"518.48";"2";"6.88";"BDBM215264";"CC[C@@H](C1CCCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378646";"UO_0000065";"16.78";"0.34";"1.82";"13.01";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3901116";"";"None";"567.54";"1";"4.65";"BDBM215075";"CC[C@@H](CN1CCS(=O)(=O)CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"130.0";"nM";"6.89";"";"378354";"UO_0000065";"12.13";"0.25";"2.24";"7.25";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108954";"";"None";"476.44";"1";"7.11";"BDBM215136";"CCC(CC)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378415";"UO_0000065";"16.16";"0.33";"0.59";"13.36";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2059435";"";"None";"478.42";"1";"5.69";"BDBM50388626";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378478";"UO_0000065";"16.72";"0.34";"2.31";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177191";"";"None";"464.39";"1";"5.30";"BDBM50397772";"CC[C@@H](CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378488";"UO_0000065";"16.58";"0.34";"2.40";"9.89";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950605";"";"None";"539.45";"2";"6.26";"BDBM215252";"CC[C@@H](CN1CC(F)(F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378496";"UO_0000065";"13.95";"0.29";"1.26";"12.36";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899788";"";"None";"518.44";"2";"6.02";"BDBM215263";"CC[C@@H](C1CCC(=O)O1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378507";"UO_0000065";"14.85";"0.30";"1.68";"9.18";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895235";"";"None";"512.44";"2";"6.47";"BDBM215274";"CC[C@@H](c1cnccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"378515";"UO_0000065";"14.25";"0.28";"0.83";"8.76";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108982";"";"None";"469.41";"1";"6.62";"BDBM215110";"Cc1cc(C[C@@H]2C[C@H](c3cccc(Cl)c3)[C@@H](c3ccc(Cl)cc3)N(CC3CC3)C2=O)no1";"IC50";"'='";"310.0";"nM";"6.51";"";"378389";"UO_0000065";"13.87";"0.28";"-0.11";"14.05";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3930864";"";"None";"518.48";"2";"6.74";"BDBM215117";"CC[C@@H](COCC1CC1)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378396";"UO_0000065";"14.51";"0.29";"0.78";"11.26";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110794";"";"None";"483.40";"1";"6.44";"BDBM215162";"Cc1cccnc1N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378441";"UO_0000065";"15.56";"0.31";"1.08";"10.67";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109586";"";"None";"618.60";"2";"5.24";"BDBM215103";"CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)NCCCN2CCOCC2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2090.0";"nM";"5.68";"";"378382";"UO_0000065";"9.18";"0.18";"0.44";"6.44";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109978";"";"None";"501.46";"2";"5.90";"BDBM215125";"CCC(CC)N1C(=O)[C@@](C)(Cc2n[nH]c(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"220.0";"nM";"6.66";"";"378404";"UO_0000065";"13.28";"0.27";"0.76";"8.13";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107285";"";"None";"502.44";"2";"6.16";"BDBM215131";"CCC(CC)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378410";"UO_0000065";"15.32";"0.31";"1.54";"9.72";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113910";"";"None";"491.42";"1";"5.06";"BDBM215082";"CCNC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"410.0";"nM";"6.39";"";"378361";"UO_0000065";"13.00";"0.26";"1.33";"7.37";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3978594";"";"None";"611.59";"2";"5.27";"BDBM215392";"CC[C@@H](CS(=O)(=O)NCC1(C)COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378777";"UO_0000065";"15.86";"0.33";"4.43";"8.58";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109313";"";"None";"596.58";"2";"5.05";"BDBM215396";"CN(C)S(=O)(=O)N(C)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"378788";"UO_0000065";"15.59";"0.33";"4.25";"9.47";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL360920";"";"None";"426.56";"1";"5.48";"2";"CCCN1C(=O)c2ccccc2C1(NC(=O)c1ccccc1)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"66000.0";"nM";"4.18";"";"";"UO_0000065";"9.80";"0.18";"-1.30";"8.46";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL3329615";"";"None";"525.48";"2";"7.39";"17";"CC[C@@H](c1ccc(C)cn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"15.52";"0.31";"0.76";"11.57";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329612";"";"None";"525.48";"2";"7.47";"13";"CCC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"15.65";"0.31";"0.75";"11.66";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329607";"";"None";"511.45";"2";"7.08";"8";"CC[C@@H](c1ccncc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"15.73";"0.31";"0.97";"11.41";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL1945443";"";"None";"639.62";"2";"7.69";"8m";"CCN(CC)C(=O)CCCNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"4168.69";"nM";"5.38";"";"";"UO_0000065";"8.41";"0.17";"-2.31";"6.45";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL4114852";"";"None";"593.57";"2";"5.73";"BDBM215299";"CN(C[C@@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C1CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"378668";"UO_0000065";"13.74";"0.29";"2.42";"8.59";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112633";"";"None";"661.62";"2";"7.31";"BDBM215310";"CCS(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)c1ccccc1F";"IC50";"'='";"0.1";"nM";"10.00";"";"378679";"UO_0000065";"15.11";"0.31";"2.69";"10.53";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932275";"";"None";"560.44";"2";"7.01";"BDBM215178";"CC[C@@H](CC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378562";"UO_0000065";"15.52";"0.32";"1.69";"11.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109795";"";"None";"486.45";"1";"6.00";"BDBM215286";"CCC(CC)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378654";"UO_0000065";"17.52";"0.35";"2.52";"11.40";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL178215";"";"None";"559.82";"None";"None";"2w";"CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"464000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL361676";"";"None";"597.65";"1";"4.36";"3";"CC(C)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(NN=C3C(=O)N(c4ccccc4)N(c4ccccc4)C3=O)cc2)cc1";"IC50";"'='";"30000.0";"nM";"4.52";"";"";"UO_0000065";"7.57";"0.14";"0.16";"3.29";"0";"CHEMBL828551";"Inhibitory activity against MDM2 (murine double minute-2 gene) binding to p53";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140309";"1";"Scientific Literature";"J Med Chem";"2005";"None";"";""
"CHEMBL367821";"";"None";"581.19";"2";"5.56";"24";"O=C(O)[C@H](c1cccc(Cl)c1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"9.58";"0.24";"0.01";"6.42";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL437916";"";"None";"415.49";"0";"4.37";"S15";"COC(=O)[C@@H](C)COC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"330000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217043";"";"None";"463.54";"0";"4.39";"S13";"O=C(NCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)c1ccncc1";"IC50";"'='";"278000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL182052";"";"None";"445.52";"0";"4.26";"14";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1C(Cc1ccc(O)cc1)C(=O)OC";"IC50";"'='";"90000.0";"nM";"4.05";"";"";"UO_0000065";"9.08";"0.17";"-0.21";"5.32";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL387225";"";"None";"433.50";"0";"3.48";"43";"COc1ccc([C@@H](O)COC2(c3ccccc3)c3ccccc3C(=O)N2CCCO)cc1";"IC50";"'='";"326000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL387279";"";"None";"556.58";"1";"3.96";"50";"COC(=O)C(Cc1ccc(O)cc1)N1C(=O)c2ccccc2C1(OCCn1c([N+](=O)[O-])cnc1C)c1ccccc1";"IC50";"'='";"275000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL216341";"";"None";"455.51";"0";"4.90";"47";"COc1ccc([C@@H](O)COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccco2)cc1";"IC50";"'='";"181000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL362410";"";"None";"627.81";"None";"None";"92";"COc1cc(COC2(c3ccc(OCOCC[Si](C)(C)C)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O";"IC50";"'='";"257000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL180862";"";"None";"496.05";"1";"7.71";"74";"CC(C)(C)c1ccc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1";"IC50";"'='";"99000.0";"nM";"4.00";"";"";"UO_0000065";"8.07";"0.15";"-3.71";"13.56";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL180579";"";"None";"413.56";"1";"6.27";"70";"CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL180866";"";"None";"373.45";"0";"3.94";"68";"O=C1c2ccccc2C(OCCCO)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"245000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217488";"";"None";"372.42";"0";"3.05";"S16";"NC(=O)COC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3902491";"";"None";"638.01";"2";"6.94";"BDBM215229";"CC[C@@H](CNS(=O)(=O)c1ccccc1Cl)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378612";"UO_0000065";"13.36";"0.28";"1.58";"8.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329610";"";"None";"525.48";"2";"7.32";"BDBM215285";"CC(C)[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"378653";"UO_0000065";"15.31";"0.31";"0.73";"11.41";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966670";"";"None";"464.39";"1";"5.57";"BDBM215063";"CC[C@@H](COC)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"290.0";"nM";"6.54";"";"378342";"UO_0000065";"14.08";"0.29";"0.97";"9.78";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109383";"";"None";"629.61";"2";"6.78";"BDBM215318";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(c2ccccc2)S(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"0.6";"nM";"9.22";"";"378687";"UO_0000065";"14.65";"0.30";"2.44";"9.71";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961096";"";"None";"566.55";"2";"6.28";"BDBM215372";"CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378752";"UO_0000065";"16.81";"0.35";"3.24";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177190";"";"None";"462.42";"1";"6.72";"27";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"36.3";"nM";"7.44";"";"";"UO_0000065";"16.09";"0.33";"0.72";"12.91";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177181";"";"None";"446.37";"1";"5.94";"17";"O=C(O)CC[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"6640.0";"nM";"5.18";"";"";"UO_0000065";"11.60";"0.24";"-0.76";"8.99";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177191";"";"None";"464.39";"1";"5.30";"28";"CC[C@@H](CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.8";"nM";"8.17";"";"";"UO_0000065";"17.59";"0.36";"2.87";"10.49";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177184";"";"None";"413.35";"1";"5.99";"20";"N#CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL360141";"";"None";"456.59";"0";"4.99";"65";"CC(=O)NCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccccc1";"IC50";"'='";"14400.0";"nM";"4.84";"";"";"UO_0000065";"10.60";"0.19";"-0.15";"8.26";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL428667";"";"None";"399.49";"0";"3.27";"S21";"CC(=O)NCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL4109614";"";"None";"463.41";"1";"5.79";"BDBM215441";"CCN(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.4";"nM";"8.62";"";"378824";"UO_0000065";"18.60";"0.38";"2.83";"14.17";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941435";"";"None";"446.37";"1";"6.08";"BDBM215123";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CCC2)C1=O";"IC50";"'='";"70.0";"nM";"7.16";"";"378402";"UO_0000065";"16.03";"0.33";"1.07";"12.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904550";"";"None";"610.60";"1";"4.89";"BDBM215145";"CC[C@@H](CN1CCN(S(C)(=O)=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378424";"UO_0000065";"12.61";"0.26";"2.81";"7.84";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3927464";"";"None";"541.48";"2";"6.17";"BDBM215258";"CC[C@@H](Cn1ccccc1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"378502";"UO_0000065";"13.11";"0.26";"0.93";"8.91";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329604";"";"None";"517.48";"2";"7.14";"BDBM215280";"CC[C@@H](c1nccs1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"50.0";"nM";"7.30";"";"378519";"UO_0000065";"14.11";"0.29";"0.16";"10.36";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177191";"";"None";"464.39";"1";"5.30";"BDBM50397772";"CC[C@@H](CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378608";"UO_0000065";"18.73";"0.38";"3.40";"11.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113886";"";"None";"520.45";"2";"6.12";"BDBM215053";"CCOC(=O)[C@H](CC(C)C)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"190.0";"nM";"6.72";"";"378332";"UO_0000065";"12.91";"0.26";"0.60";"8.01";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114861";"";"None";"504.41";"2";"5.48";"BDBM215055";"CCOC(=O)[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378334";"UO_0000065";"14.67";"0.30";"1.92";"8.82";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112950";"";"None";"464.39";"1";"5.57";"BDBM215059";"CC[C@@H](COC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"378338";"UO_0000065";"15.41";"0.32";"1.58";"10.70";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894720";"";"None";"564.53";"2";"5.89";"BDBM215375";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CC2)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"378757";"UO_0000065";"17.71";"0.37";"4.11";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110053";"";"None";"554.54";"2";"5.99";"BDBM215382";"CCS(=O)(=O)C[C@H](C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"378765";"UO_0000065";"16.77";"0.35";"3.31";"10.14";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2398346";"";"None";"654.71";"2";"6.78";"25";"CC[C@@H]1CC[C@@H](C(=O)N2CCN(C)CC2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"11.49";"0.23";"0.74";"12.65";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL2398240";"";"None";"668.73";"2";"7.17";"33";"CC[C@@H]1CC[C@@H](C(=O)N2CCN(C)[C@H](C)C2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"11.27";"0.23";"0.37";"12.68";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL181138";"";"None";"455.30";"0";"4.95";"26";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2ccccc2NC(=O)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"14800.0";"nM";"4.83";"";"";"UO_0000065";"10.61";"0.21";"-0.12";"5.57";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL182149";"";"None";"497.38";"1";"6.08";"28";"CC(C)c1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2";"IC50";"'='";"1020.0";"nM";"5.99";"";"";"UO_0000065";"12.05";"0.24";"-0.09";"6.91";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL1771729";"";"None";"575.26";"2";"6.28";"25, Racemic mixture";"N#CCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"10.67";"0.25";"-0.14";"9.16";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1771727";"";"None";"636.34";"2";"7.01";"23";"O=C(O)CCCCN1C2=C([C@H](c3ccc(Br)cc3)n3ncnc31)[C@@H](c1ccc(Br)cc1)Oc1ccccc12";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"10.15";"0.23";"-0.55";"8.02";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1771726";"";"None";"636.34";"2";"7.01";"22, Racemic mixture";"O=C(O)CCCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"760.0";"nM";"6.12";"";"";"UO_0000065";"9.62";"0.22";"-0.89";"7.60";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL4108893";"";"None";"523.46";"2";"7.08";"BDBM215301";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](c2ccccn2)C2CC2)C1=O";"IC50";"'='";"3.0";"nM";"8.52";"";"378670";"UO_0000065";"16.28";"0.32";"1.44";"12.09";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106856";"";"None";"567.54";"2";"5.25";"BDBM215314";"CCS(=O)(=O)NC[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"378683";"UO_0000065";"16.39";"0.34";"4.05";"8.96";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114646";"";"None";"502.44";"2";"6.16";"BDBM215126";"CCC(CC)N1C(=O)[C@@](C)(Cc2n[nH]c(=O)o2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"260.0";"nM";"6.58";"";"378405";"UO_0000065";"13.11";"0.26";"0.43";"8.31";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3893802";"";"None";"581.56";"2";"5.73";"BDBM215187";"CC[C@@H](CN(C1CC1)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378468";"UO_0000065";"13.76";"0.29";"2.27";"8.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125703";"";"None";"492.44";"1";"6.08";"BDBM50448954";"CC[C@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)O";"IC50";"'='";"10.0";"nM";"8.00";"";"378480";"UO_0000065";"16.25";"0.33";"1.92";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3967015";"";"None";"668.68";"1";"4.51";"BDBM215214";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NCCC(O)CO)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"28.0";"nM";"7.55";"";"378595";"UO_0000065";"11.30";"0.23";"3.04";"5.94";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955779";"";"None";"569.55";"2";"5.64";"BDBM215224";"CC[C@@H](CNS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378606";"UO_0000065";"14.96";"0.31";"2.88";"8.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941170";"";"None";"494.46";"0";"4.96";"BDBM215444";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(C[C@H](O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"371.0";"nM";"6.43";"";"378656";"UO_0000065";"13.01";"0.27";"1.47";"7.94";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107995";"";"None";"518.44";"2";"5.87";"BDBM215290";"CCOC(=O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378659";"UO_0000065";"17.36";"0.35";"3.13";"10.73";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112786";"";"None";"595.59";"2";"6.03";"BDBM215330";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C(C)C)C2CC2)C1=O";"IC50";"'='";"0.9";"nM";"9.05";"";"378697";"UO_0000065";"15.19";"0.32";"3.02";"8.72";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125531";"";"None";"568.52";"2";"5.12";"BDBM50448932";"CC[C@@H](CS(=O)(=O)C1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378711";"UO_0000065";"16.75";"0.35";"4.40";"9.43";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3897481";"";"None";"653.00";"2";"7.58";"BDBM215353";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(F)cc2Cl)C2CC2)C1=O";"IC50";"'='";"1.3";"nM";"8.89";"";"378725";"UO_0000065";"13.61";"0.29";"1.31";"9.69";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3318767";"";"None";"609.57";"1";"4.97";"BDBM50053052";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCOCC2)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"378783";"UO_0000065";"16.41";"0.34";"5.03";"9.60";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125520";"";"None";"579.55";"2";"5.35";"BDBM50448942";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCC2)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378786";"UO_0000065";"16.74";"0.35";"4.35";"10.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3965712";"";"None";"587.54";"2";"5.73";"BDBM215406";"CC[C@@H](CN(C)S(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"378795";"UO_0000065";"16.00";"0.34";"3.67";"9.89";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918643";"";"None";"568.52";"1";"4.79";"BDBM215414";"CC[C@@H](CNS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cncc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.6";"nM";"8.34";"";"378803";"UO_0000065";"14.66";"0.31";"3.55";"7.15";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3946498";"";"None";"582.55";"2";"5.13";"BDBM215415";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cncc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378804";"UO_0000065";"14.42";"0.30";"3.27";"7.78";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL1944935";"";"None";"584.50";"2";"6.61";"6a";"CCOC(=O)CNC(=O)N1C(c2ccc(OC)cc2OC(C)C)=N[C@H](c2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"4290.0";"nM";"5.37";"";"";"UO_0000065";"9.18";"0.18";"-1.24";"6.00";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945440";"";"None";"652.62";"2";"6.21";"8j";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@@H](C)C(=O)N2CCN(C)CC2)c(OC(C)C)c1";"IC50";"'='";"5960.0";"nM";"5.22";"";"";"UO_0000065";"8.01";"0.16";"-0.99";"6.03";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945442";"";"None";"652.62";"2";"6.21";"8l";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@H](C)C(=O)N2CCN(C)CC2)c(OC(C)C)c1";"IC50";"'='";"5960.0";"nM";"5.22";"";"";"UO_0000065";"8.01";"0.16";"-0.99";"6.03";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL217621";"";"None";"373.45";"0";"4.21";"44";"COCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"490000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3967652";"";"None";"494.46";"0";"4.96";"BDBM215287";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(C[C@@H](O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"378655";"UO_0000065";"14.16";"0.29";"2.04";"8.64";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107929";"";"None";"654.62";"2";"7.33";"BDBM215316";"[C-]#[N+]c1ccccc1N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(C)(=O)=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378685";"UO_0000065";"14.82";"0.30";"2.37";"9.76";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3935760";"";"None";"488.46";"1";"6.97";"BDBM215088";"CC1(C)CCCC1CN1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"300.0";"nM";"6.52";"";"378367";"UO_0000065";"13.35";"0.27";"-0.45";"11.32";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3920713";"";"None";"632.58";"2";"7.31";"BDBM215360";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2cccc(F)c2)C2CC2)C1=O";"IC50";"'='";"1.4";"nM";"8.85";"";"378732";"UO_0000065";"14.00";"0.29";"1.54";"9.65";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177201";"";"None";"420.34";"1";"5.39";"12";"CCOC(=O)[C@H](C)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2059300";"";"None";"534.48";"2";"6.65";"25";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"16.20";"0.33";"2.01";"10.32";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177181";"";"None";"446.37";"1";"5.94";"17";"O=C(O)CC[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"340.0";"nM";"6.47";"";"";"UO_0000065";"14.49";"0.29";"0.53";"11.23";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177193";"";"None";"374.31";"1";"5.85";"(5S,6R)-4";"O=C1CC[C@@H](c2cccc(Cl)c2)[C@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177192";"";"None";"374.31";"1";"5.85";"(5R,6S)-4";"O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2059435";"";"None";"478.42";"1";"5.69";"29, AM-8553";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"18.73";"0.38";"3.27";"11.51";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2315843";"";"None";"571.57";"2";"6.32";"1";"CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"8.3";"nM";"8.08";"";"";"UO_0000065";"14.14";"0.29";"1.76";"14.37";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL426784";"";"None";"518.73";"None";"None";"2z";"CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"312000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL180862";"";"None";"496.05";"1";"7.71";"2n";"CC(C)(C)c1ccc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1";"IC50";"'='";"99000.0";"nM";"4.00";"";"";"UO_0000065";"8.07";"0.15";"-3.71";"13.56";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL361345";"";"None";"448.01";"1";"6.92";"2p";"CCCN1C(=O)c2ccccc2C1(OCc1ccc(C(C)(C)C)cc1)c1ccc(Cl)cc1";"IC50";"'='";"187000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL3895110";"";"None";"496.01";"0";"4.62";"BDBM236315";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"14.17";"nM";"7.85";"";"411699";"UO_0000065";"15.82";"0.31";"3.23";"7.37";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3902919";"";"None";"540.00";"2";"6.62";"BDBM236335";"COc1ncc(CC#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"1.64";"nM";"8.79";"";"411719";"UO_0000065";"16.27";"0.31";"2.17";"9.25";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110714";"";"None";"563.48";"2";"7.74";"BDBM236339";"COc1ccc(CC(=O)O)cc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"41.92";"nM";"7.38";"";"411723";"UO_0000065";"13.09";"0.26";"-0.36";"10.28";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3937960";"";"None";"525.05";"2";"5.35";"BDBM236350";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N([C@H]2CC[C@H](O)CC2)C3=O)c(OC)n1";"IC50";"'='";"30.15";"nM";"7.52";"";"411734";"UO_0000065";"14.32";"0.28";"2.17";"8.38";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943855";"";"None";"519.47";"2";"8.28";"BDBM236363";"COc1ccccc1-c1cc2c(n1C(C)C)C(C)(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.496";"nM";"9.30";"";"411747";"UO_0000065";"17.91";"0.35";"1.02";"26.99";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975933";"";"None";"553.45";"2";"5.35";"BDBM236370";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.106";"nM";"9.97";"";"411754";"UO_0000065";"18.02";"0.36";"4.62";"10.35";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3936752";"";"None";"553.45";"2";"5.35";"BDBM236387";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"0.231";"nM";"9.64";"";"411771";"UO_0000065";"17.41";"0.35";"4.29";"10.00";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940794";"";"None";"536.46";"2";"6.81";"BDBM236396";"COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.11";"nM";"9.96";"";"411780";"UO_0000065";"18.56";"0.37";"3.15";"17.64";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3909949";"";"None";"500.60";"1";"4.20";"BDBM236437";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(C1CCOCC1)C2=O";"IC50";"'='";"0.631";"nM";"9.20";"";"411821";"UO_0000065";"18.38";"0.34";"5.00";"9.53";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940087";"";"None";"540.41";"2";"5.29";"BDBM236451";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.195";"nM";"9.71";"";"411835";"UO_0000065";"17.97";"0.36";"4.42";"9.49";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3947634";"";"None";"538.03";"2";"5.18";"BDBM236459";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1F)N(c1cc(C)nn1C)C2=O";"IC50";"'='";"0.769";"nM";"9.11";"";"411843";"UO_0000065";"16.94";"0.33";"3.93";"11.21";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL385595";"";"None";"519.71";"None";"None";"86";"C[Si](C)(C)CCOCOc1ccc(C2(OCCCO)c3ccccc3C(=O)N2Cc2ccccc2)cc1";"IC50";"'='";"476000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL181083";"";"None";"515.99";"2";"6.14";"75";"COc1cc(COC2(c3ccc(Cl)cc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O";"IC50";"'='";"42000.0";"nM";"4.38";"";"";"UO_0000065";"8.48";"0.16";"-1.76";"6.41";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL441538";"";"None";"431.49";"0";"4.39";"S7";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1[C@H](C(=O)OC)c1ccc(O)cc1";"IC50";"'='";"90000.0";"nM";"4.05";"";"";"UO_0000065";"9.38";"0.17";"-0.34";"5.32";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL216416";"";"None";"457.60";"0";"4.21";"S14";"C=CCNC(=S)NCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"408000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL1834381";"";"None";"547.82";"2";"6.20";"10m";"O=C1c2cc(Cl)c(Cl)cc2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"3670.0";"nM";"5.43";"";"";"UO_0000065";"9.92";"0.21";"-0.76";"5.85";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2177200";"";"None";"448.39";"1";"6.17";"11";"CCC[C@@H](C(=O)OCC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177194";"";"None";"362.30";"1";"5.85";"5";"CCCN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL4111092";"";"None";"569.53";"2";"7.31";"BDBM215281";"CC[C@H](c1cccc(C(C)(C)O)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378520";"UO_0000065";"13.52";"0.27";"0.39";"8.49";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109795";"";"None";"486.45";"1";"6.00";"BDBM215286";"CCC(CC)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378525";"UO_0000065";"15.83";"0.32";"1.70";"10.30";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113757";"";"None";"492.40";"1";"5.48";"BDBM215052";"CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378536";"UO_0000065";"16.25";"0.33";"2.52";"9.53";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3976926";"";"None";"574.47";"2";"7.40";"BDBM215184";"CC[C@@H](CCC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378567";"UO_0000065";"15.67";"0.32";"1.60";"11.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3969208";"";"None";"520.50";"2";"6.72";"BDBM215194";"CCC([C@H](C)C(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"378577";"UO_0000065";"15.80";"0.32";"1.50";"10.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3973418";"";"None";"654.66";"1";"4.12";"BDBM215210";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NC[C@@H](O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"64.0";"nM";"7.19";"";"378591";"UO_0000065";"10.99";"0.23";"3.07";"5.65";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899019";"";"None";"628.58";"2";"6.16";"BDBM215238";"CC[C@@H](CNS(=O)(=O)c1cccc(C#N)c1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'<'";"1.0";"nM";"";"";"378621";"UO_0000065";"";"";"";"";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107352";"";"None";"508.44";"2";"5.58";"BDBM215060";"CC[C@@H](COCCOC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"90.0";"nM";"7.05";"";"378339";"UO_0000065";"13.86";"0.28";"1.47";"9.26";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL179446";"";"None";"588.83";"2";"6.03";"16";"CC(C)c1ccc([C@@H](C(=O)O)N2C(=O)c3cc(I)ccc3NC(=O)[C@@H]2c2ccc(Cl)cc2)cc1";"IC50";"'='";"1550.0";"nM";"5.81";"";"";"UO_0000065";"9.87";"0.23";"-0.22";"6.70";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL369560";"";"None";"630.74";"2";"5.80";"23";"O=C(O)[C@H](c1ccc(Cl)cc1)N1C(=O)c2cc(I)ccc2NC(=O)[C@@H]1c1ccc(OC(F)(F)F)cc1";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"11.23";"0.27";"1.28";"7.38";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL359740";"";"None";"483.35";"1";"5.52";"27";"CCc1ccc2c(c1)C(=O)N([C@H](C(=O)O)c1ccc(Cl)cc1)[C@@H](c1ccc(Cl)cc1)C(=O)N2";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"12.05";"0.24";"0.30";"6.72";"0";"CHEMBL833471";"Inhibition of p53-binding to HDM2 (human MDM2) by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1140282";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"None";"";""
"CHEMBL1834372";"";"None";"600.44";"2";"5.93";"10d";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc(S(=O)(=O)C(F)(F)F)cc1";"IC50";"'='";"9000.0";"nM";"5.05";"";"";"UO_0000065";"8.40";"0.18";"-0.88";"6.01";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3601400";"";"None";"646.23";"2";"5.94";"14";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CC(=O)N(C)C4)CC3)nc1)C(=O)C2";"IC50";"'='";"11.4";"nM";"7.94";"";"";"UO_0000065";"12.29";"0.24";"2.00";"10.13";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3955184";"";"None";"512.01";"2";"7.11";"BDBM238911";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C(=O)N2";"IC50";"'='";"724.0";"nM";"6.14";"";"417043";"UO_0000065";"11.99";"0.23";"-0.97";"7.38";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3938597";"";"None";"574.40";"2";"5.21";"BDBM238923";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c[nH]c2=O)C(=O)N3)c(OC)n1";"IC50";"'='";"356.0";"nM";"6.45";"";"417055";"UO_0000065";"11.23";"0.23";"1.24";"5.07";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3112825";"";"None";"645.53";"1";"4.70";"14k";"Cl.O=C(N1CCN(c2ccccn2)CC1)C1(Oc2ccc(C(F)(F)F)cc2)CCCN(S(=O)(=O)c2ccccc2Cl)C1";"IC50";"'='";"31000.0";"nM";"4.51";"";"";"UO_0000065";"7.40";"0.15";"-0.19";"5.43";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112807";"";"None";"700.08";"2";"5.48";"12d";"CC(=O)Nc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1.Cl";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"9.67";"0.19";"0.94";"6.75";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112791";"";"None";"645.00";"1";"4.31";"11b";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(C(F)(F)F)cc2)(C(=O)N2CCN(c3ccncn3)CC2)C1";"IC50";"'='";"18000.0";"nM";"4.75";"";"";"UO_0000065";"7.80";"0.15";"0.43";"5.17";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112781";"";"None";"594.01";"1";"4.04";"9d";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(F)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"6000.0";"nM";"5.22";"";"";"UO_0000065";"9.37";"0.18";"1.18";"6.62";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL3112780";"";"None";"610.46";"1";"4.55";"9c";"Cl.O=C(c1cnccc1C(F)(F)F)N1CCCC(Oc2ccc(Cl)cc2)(C(=O)N2CCN(c3ccccn3)CC2)C1";"IC50";"'='";"6700.0";"nM";"5.17";"";"";"UO_0000065";"9.01";"0.18";"0.62";"6.56";"0";"CHEMBL3119571";"Inhibition of human MDM2/p53 interaction by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3112574";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";""
"CHEMBL181688";"";"None";"461.61";"1";"7.06";"13";"CC(C)(C)c1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1";"IC50";"'='";"92000.0";"nM";"4.04";"";"";"UO_0000065";"8.74";"0.16";"-3.02";"13.66";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217792";"";"None";"464.57";"0";"4.23";"15";"O=C1c2ccccc2C(N[C@@H](CO)[C@@H](O)c2ccccc2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"85000.0";"nM";"4.07";"";"";"UO_0000065";"8.76";"0.16";"-0.16";"5.59";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL178106";"";"None";"481.55";"1";"5.48";"40";"COc1cc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc(OC)c1O";"IC50";"'='";"17900.0";"nM";"4.75";"";"";"UO_0000065";"9.86";"0.18";"-0.73";"6.96";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL384379";"";"None";"494.55";"0";"4.40";"35";"O=C(NCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)c1ccc(O)cc1O";"IC50";"'='";"96000.0";"nM";"4.02";"";"";"UO_0000065";"8.12";"0.15";"-0.38";"4.05";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL386085";"";"None";"423.47";"1";"5.17";"34";"O=Cc1ccc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)o1";"IC50";"'='";"97000.0";"nM";"4.01";"";"";"UO_0000065";"9.48";"0.17";"-1.16";"6.72";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL216487";"";"None";"400.48";"0";"3.70";"26";"CC(=O)NCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"281000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL424731";"";"None";"451.57";"1";"5.83";"22";"CCCCc1nc(COC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)c[nH]1";"IC50";"'='";"78000.0";"nM";"4.11";"";"";"UO_0000065";"9.10";"0.17";"-1.72";"7.06";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL216364";"";"None";"486.61";"1";"5.20";"59";"CCCN1C(=O)c2ccccc2C1(OCCNC(=O)c1ccccc1O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"70100.0";"nM";"4.15";"";"";"UO_0000065";"8.54";"0.16";"-1.05";"5.27";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL386519";"";"None";"575.67";"2";"5.27";"49";"COC(=O)C(Cc1ccc(O)cc1)N1C(=O)c2ccccc2C1(OCCN(CCC#N)c1ccccc1)c1ccccc1";"IC50";"'='";"88000.0";"nM";"4.06";"";"";"UO_0000065";"7.04";"0.13";"-1.21";"3.93";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL215683";"";"None";"387.48";"0";"4.98";"48";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccc(OC)cc1";"IC50";"'='";"413000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL214460";"";"None";"488.54";"0";"4.86";"S9";"O=C1c2ccccc2C(=O)N1CCOC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"152000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL216211";"";"None";"500.60";"1";"4.41";"S26";"CCOC(=O)CCC(NC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)C(=O)OCC";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL216358";"";"None";"426.52";"0";"4.25";"S25";"C=C(C)C(=O)OCCNC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1";"IC50";"'='";"353000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL387183";"";"None";"450.54";"0";"4.57";"S19";"O=C1c2ccccc2C(NCC(O)c2cccc(O)c2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"84000.0";"nM";"4.08";"";"";"UO_0000065";"9.05";"0.16";"-0.49";"5.60";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217248";"";"None";"464.57";"0";"4.96";"S18";"CC(NC1(c2ccccc2)c2ccccc2C(=O)N1Cc1ccccc1)C(O)c1ccc(O)cc1";"IC50";"'='";"185000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL2398242";"";"None";"696.74";"2";"7.08";"35";"CC[C@@H]1CC[C@@H](C(=O)N2CCN(C(C)=O)[C@H](C)C2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"10.39";"0.21";"0.16";"9.46";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3982187";"";"None";"606.55";"2";"7.91";"BDBM238908";"COc1ccc(C(=O)N(C)C)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2";"IC50";"'='";"432.0";"nM";"6.37";"";"417040";"UO_0000065";"10.49";"0.21";"-1.55";"7.99";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3601316";"";"None";"556.11";"2";"7.24";"2";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"14.56";"0.28";"0.86";"14.75";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL1771608";"";"None";"707.34";"2";"6.11";"14, Racemic mixture";"NCCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21.O=C(O)C(F)(F)F";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"9.15";"0.21";"-0.68";"7.85";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1771706";"";"None";"550.25";"2";"6.39";"1";"CN1C2=C([C@H](c3ccc(Br)cc3)n3ncnc31)[C@@H](c1ccc(Br)cc1)Oc1ccccc12";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"10.64";"0.25";"-0.54";"13.56";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1771611";"";"None";"594.26";"2";"5.84";"20";"O=C(O)CN1C2=C([C@H](c3ccc(Br)cc3)n3ncnc31)[C@@H](c1ccc(Br)cc1)Oc1ccccc12";"IC50";"'='";"480.0";"nM";"6.32";"";"";"UO_0000065";"10.63";"0.25";"0.48";"7.85";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3134178";"";"None";"486.57";"1";"5.70";"45";"CCOc1ccc(CCC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"352700.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134218";"";"None";"458.51";"1";"5.18";"34";"COc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1";"IC50";"'='";"185600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134209";"";"None";"444.51";"1";"5.82";"25";"CCOc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(F)cc2)n(Cc2ccccc2)n1";"IC50";"'='";"100800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL4573478";"";"None";"358.23";"0";"4.77";"3";"Cc1n[nH]c2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C2=O";"IC50";"'='";"350.0";"nM";"6.46";"";"";"UO_0000065";"18.02";"0.37";"1.69";"13.18";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL4534782";"";"None";"400.31";"1";"5.76";"5";"CC(C)(C)c1n[nH]c2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C2=O";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"19.35";"0.39";"1.98";"15.81";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL1933126";"";"None";"1512.78";"None";"None";"1";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(N)=O)[C@@H](C)O";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"4.79";"None";"None";"None";"0";"CHEMBL1936335";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1933030";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL1834286";"";"None";"513.38";"2";"5.55";"10a, rac-10a";"O=C1c2cccc(Cl)c2C(OCC2(CO)CC2)(c2ccc(Cl)cc2)N1Cc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"13.69";"0.27";"1.48";"7.56";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL2402737";"IDASANUTLIN";"3.0";"616.49";"2";"6.94";"2, RG7388";"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"13.05";"0.26";"1.11";"7.22";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL218294";"";"None";"502.57";"2";"5.90";"60";"CCCN1C(=O)c2ccccc2C1(OCc1cc2c(cc1[N+](=O)[O-])OCO2)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"70200.0";"nM";"4.15";"";"";"UO_0000065";"8.26";"0.15";"-1.75";"4.56";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL384995";"";"None";"428.53";"0";"3.89";"S4";"O=C1c2ccccc2C(OCCN2CCOCC2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3926073";"";"None";"588.45";"2";"6.72";"BDBM238921";"COc1nc(N(C)C)ncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1ccc(F)c(Cl)c1)C(=O)N2";"IC50";"'='";"385.0";"nM";"6.42";"";"417053";"UO_0000065";"10.90";"0.22";"-0.31";"7.26";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329605";"";"None";"511.45";"2";"7.08";"6";"CC[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"14.77";"0.29";"0.47";"10.71";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329602";"";"None";"504.45";"2";"6.49";"3";"CC[C@@H]([C@@H]1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"15.26";"0.31";"1.21";"11.52";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL1944942";"";"None";"570.47";"2";"6.52";"7c";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)N[C@H](C)C(=O)O)c(OC(C)C)c1";"IC50";"'='";"3235.94";"nM";"5.49";"";"";"UO_0000065";"9.62";"0.19";"-1.03";"5.46";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL1945234";"";"None";"652.62";"2";"6.21";"8h";"COc1ccc(C2=N[C@H](c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N2C(=O)NCCC(=O)N2CCN(C)CC2)c(OC(C)C)c1";"IC50";"'='";"5888.44";"nM";"5.23";"";"";"UO_0000065";"8.01";"0.16";"-0.98";"6.03";"0";"CHEMBL1949022";"Competitive inhibition of MDM2/P53 interaction after 1 hr by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1944528";"1";"Scientific Literature";"Bioorg Med Chem";"2012";"None";"";""
"CHEMBL3134189";"";"None";"472.54";"1";"5.57";"4";"CCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1";"IC50";"'='";"13980.0";"nM";"4.85";"";"";"UO_0000065";"10.27";"0.19";"-0.72";"5.86";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL1933129";"";"None";"1864.28";"None";"None";"4";"CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CSCc2ccc(cn2)-c2ccc(nc2)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)NCCCNCCCCNCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC1=O)[C@@H](C)O";"IC50";"'='";"46.0";"nM";"7.34";"";"";"UO_0000065";"3.94";"None";"None";"None";"0";"CHEMBL1936335";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1933030";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3134185";"";"None";"444.49";"0";"4.99";"52";"COc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"1018000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL5176284";"";"None";"685.57";"2";"8.00";"3b";"O=C(Nc1cccc(-n2ccc(-c3ccccc3)n2)c1)C1=NN(c2ccc(Cl)cc2)C2(C(=O)Nc3cc(Cl)ccc32)C1c1cccc(O)c1";"IC50";"'='";"26.1";"nM";"7.58";"";"";"UO_0000065";"11.06";"0.21";"-0.42";"6.78";"0";"CHEMBL5110382";"Inhibition of MDM2/p53 interaction in human U-87 MG cells preincubated for 10 mins under shaking condition and measured after 1.5 hrs by immuno-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5108018";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.667 hr";"INHIBITOR"
"CHEMBL4783006";"";"None";"499.45";"0";"4.27";"Rac-6f";"CC(C)CCN1[C@@H](Cn2cncn2)[C@@H](N)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"2064.0";"nM";"5.68";"";"";"UO_0000065";"11.38";"0.23";"1.42";"6.38";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL2177199";"";"None";"434.36";"1";"5.78";"10";"CCOC(=O)[C@@H](CC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177187";"";"None";"520.45";"2";"6.26";"23";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"16.10";"0.33";"2.12";"9.98";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177185";"";"None";"456.38";"0";"4.83";"21";"O=C1[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"17.21";"0.35";"3.02";"10.50";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177182";"";"None";"446.37";"1";"5.64";"18";"COC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"790.0";"nM";"6.10";"";"";"UO_0000065";"13.67";"0.28";"0.46";"13.09";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177812";"";"None";"446.37";"1";"5.94";"16";"O=C(O)CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"570.0";"nM";"6.24";"";"";"UO_0000065";"13.99";"0.28";"0.30";"10.84";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177196";"";"None";"376.33";"1";"6.24";"7";"CCCCN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2700.0";"nM";"5.57";"";"";"UO_0000065";"14.80";"0.30";"-0.67";"27.42";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3604660";"";"None";"534.02";"2";"5.22";"5";"CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(C)cc1OCc1nn[nH]n1)C(=O)C2";"IC50";"'='";"380.0";"nM";"6.42";"";"";"UO_0000065";"12.02";"0.23";"1.20";"6.27";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3604659";"";"None";"456.37";"1";"6.47";"2";"CCOc1cc2c(cc1OCC)C(c1ccc(Cl)cc1)N(c1ccc(Cl)cc1)C(=O)C2";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"13.15";"0.26";"-0.47";"15.48";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL2059435";"";"None";"478.42";"1";"5.69";"1, AM-8553";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"17.19";"0.35";"2.53";"10.56";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329224";"";"None";"525.48";"2";"7.39";"14";"CC[C@@H](c1cccc(C)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.55";"0.33";"1.31";"12.34";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329603";"";"None";"501.41";"2";"6.67";"4";"CC[C@@H](c1cnco1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"16.15";"0.33";"1.43";"9.68";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2315841";"";"None";"515.47";"2";"5.15";"13a";"CC(C)C1=C(C(=O)N2CNC(=O)C2)SC2=NC(C)(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)N21";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"11.69";"0.24";"0.88";"9.27";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL2315835";"";"None";"529.49";"2";"5.19";"8c";"CC(C)C1=C(C(=O)N2CCNC(=O)C2)SC2=N[C@](C)(c3ccc(Cl)cc3)[C@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"11.00";"0.23";"0.63";"8.96";"0";"CHEMBL2321370";"Inhibition of human His-tagged p53/GST-tagged MDM2 interaction after 60 mins by chemiluminescence assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2311336";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";""
"CHEMBL3930604";"";"None";"576.03";"1";"4.71";"BDBM236446";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.257";"nM";"9.59";"";"411830";"UO_0000065";"16.65";"0.32";"4.88";"8.78";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3973720";"";"None";"515.55";"1";"4.35";"BDBM236458";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2c(F)c(C)nn2C)C3=O)c(OC)n1";"IC50";"'='";"1.675";"nM";"8.78";"";"411842";"UO_0000065";"17.02";"0.32";"4.43";"7.90";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895404";"";"None";"554.43";"2";"5.30";"BDBM236368";"COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.106";"nM";"9.97";"";"411848";"UO_0000065";"17.99";"0.36";"4.67";"10.90";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3805372";"";"None";"756.77";"2";"7.00";"21";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCCC(=O)O)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"10.78";"0.21";"1.15";"7.25";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3950029";"";"None";"565.50";"2";"7.70";"BDBM238909";"COc1ccc(CO)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2";"IC50";"'='";"371.0";"nM";"6.43";"";"417041";"UO_0000065";"11.37";"0.23";"-1.27";"8.08";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4299636";"";"None";"715.72";"2";"5.52";"8";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1nc(C(F)(F)F)cs1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"8.33";"0.17";"0.44";"5.50";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL4299645";"";"None";"782.80";"2";"7.39";"23";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC2(CC(=O)O)CC2)CC1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"9.56";"0.19";"0.09";"6.65";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3892226";"";"None";"567.54";"2";"5.39";"BDBM215215";"CC[C@@H](CNS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378596";"UO_0000065";"15.86";"0.33";"3.61";"8.67";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125515";"";"None";"597.61";"2";"6.37";"BDBM50448972";"CC[C@@H](CN(C)S(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378605";"UO_0000065";"14.05";"0.29";"2.03";"8.84";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3960885";"";"None";"617.60";"2";"6.60";"BDBM215228";"CC[C@@H](CNS(=O)(=O)c1ccc(C)cc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378611";"UO_0000065";"14.57";"0.30";"2.40";"8.67";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3945887";"";"None";"595.59";"2";"6.12";"BDBM215240";"CC[C@@H](CN(C)S(=O)(=O)C1(C)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378623";"UO_0000065";"15.11";"0.32";"2.88";"9.47";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926559";"";"None";"545.51";"2";"5.78";"BDBM215249";"CC[C@@H](CN1C[C@H]2C[C@@H]1CO2)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"378632";"UO_0000065";"14.75";"0.30";"2.27";"11.48";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3963661";"";"None";"539.44";"2";"8.04";"BDBM238900";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C(=O)N2";"IC50";"'='";"779.0";"nM";"6.11";"";"417036";"UO_0000065";"11.32";"0.23";"-1.93";"10.29";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329224";"";"None";"525.48";"2";"7.39";"14";"CC[C@@H](c1cccc(C)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"14.26";"0.28";"0.10";"10.63";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329601";"";"None";"492.44";"1";"6.35";"2";"CC[C@@H]([C@H](C)OC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"15.83";"0.32";"1.45";"11.66";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2177202";"";"None";"392.28";"0";"4.61";"13";"COC(=O)CN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177196";"";"None";"376.33";"1";"6.24";"7";"CCCCN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177813";"";"None";"432.35";"1";"5.55";"2";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"14.88";"0.30";"0.88";"11.16";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177197";"";"None";"410.34";"1";"6.64";"8";"O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"5400.0";"nM";"5.27";"";"";"UO_0000065";"12.84";"0.26";"-1.37";"25.94";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177192";"";"None";"374.31";"1";"5.85";"(5R,6S)-4";"O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'='";"820.0";"nM";"6.09";"";"";"UO_0000065";"16.26";"0.33";"0.24";"29.97";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177814";"";"None";"320.22";"0";"4.73";"3";"O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"15.61";"0.33";"0.27";"17.18";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2059299";"";"None";"432.35";"1";"5.55";"1";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"2420.0";"nM";"5.62";"";"";"UO_0000065";"12.99";"0.26";"0.07";"9.75";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"12.13";"0.24";"1.17";"8.45";"0";"CHEMBL4726227";"Inhibition of human MDM2-p53 interaction";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4725256";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"None";"";"INHIBITOR"
"CHEMBL2347393";"";"None";"452.33";"0";"4.25";"2";"CC[C@@H](CO)N1C(=O)[C@H](CC(=O)O)O[C@@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"610000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3372383";"Inhibition of MDM2/P53 (unknown origin) protein interaction under serum free conditions by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351271";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3329617";"";"None";"525.48";"2";"7.39";"19";"CC[C@@H](c1ncccc1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"15.80";"0.31";"0.91";"11.77";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3329608";"";"None";"511.45";"2";"7.08";"9";"CC[C@@H](c1cccnc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"17.25";"0.34";"1.74";"12.52";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3911759";"";"None";"592.53";"2";"7.56";"BDBM238907";"CNC(=O)c1ccc(OC)c(-c2nc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C(=O)N3)c1";"IC50";"'='";"210.0";"nM";"6.68";"";"417039";"UO_0000065";"11.27";"0.22";"-0.88";"7.55";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL568293";"";"None";"578.31";"2";"6.95";"rac-28, (1:3 anti/syn)";"CCc1ccc2c(c1)C1=C(C(c3ccc(Br)cc3)O2)C(c2ccc(Br)cc2)n2ncnc2N1C";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"9.50";"0.22";"-1.46";"12.73";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL584497";"";"None";"584.70";"2";"7.04";"rac-31";"CN1C2=C(C(c3ccc(Br)cc3)Oc3cc(Cl)ccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"15100.0";"nM";"4.82";"";"";"UO_0000065";"8.25";"0.20";"-2.22";"11.16";"0";"CHEMBL1052159";"Inhibition of human MDM2/P53 interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1154659";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";""
"CHEMBL3220686";"";"None";"640.10";"2";"6.44";"18";"Cc1ccc(F)cc1[C@@H]1NC(=O)C[C@H](c2ccccc2OC(C)(C)C(=O)N2CCC(F)(F)CC2)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"54.0";"nM";"7.27";"";"";"UO_0000065";"11.35";"0.22";"0.83";"8.28";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3938216";"";"None";"553.47";"2";"8.34";"BDBM238905";"COc1ccc(F)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2";"IC50";"'='";"531.0";"nM";"6.28";"";"417037";"UO_0000065";"11.34";"0.23";"-2.07";"10.57";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4740480";"";"None";"492.38";"0";"4.22";"9";"C[C@H]1[C@@H](NCC(=O)O)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)N1CC1CC1";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"14.64";"0.30";"2.99";"8.83";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4756922";"";"None";"514.43";"2";"5.69";"Rac-6g";"CCOc1cccc(CN2[C@@H](C)[C@@H](N)[C@H](c3cccc(Cl)c3F)[C@]23C(=O)Nc2cc(Cl)ccc23)c1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"14.08";"0.28";"1.55";"10.72";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4792225";"";"None";"449.29";"0";"2.81";"Rac-5k";"NC(=O)CC[C@@H]1N[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@@H](c2cccc(Cl)c2)[C@@H]1[N+](=O)[O-]";"IC50";"'='";"13500.0";"nM";"4.87";"";"";"UO_0000065";"10.84";"0.22";"2.06";"3.82";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4743311";"";"None";"408.24";"0";"2.53";"Rac-5h";"O=C1Nc2cc(Cl)ccc2[C@]12N[C@@H](CO)[C@@H]([N+](=O)[O-])[C@@H]2c1cccc(Cl)c1";"IC50";"'='";"30700.0";"nM";"4.51";"";"";"UO_0000065";"11.05";"0.23";"1.98";"4.32";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4776839";"";"None";"566.46";"2";"5.96";"3; BI-0252";"O=C(O)c1ccc([C@H]2C[C@H]3[C@@H](N2)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc4cc(Cl)ccc42)N3CC2CC2)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"14.83";"0.29";"2.44";"10.28";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3220699";"";"None";"642.18";"2";"6.00";"35";"CCOC(=O)N1CCN(C(=O)[C@@]2(Sc3ccccc3)CC(=O)N(Cc3ccc(C#N)cc3)[C@@H]2c2c[nH]c3cc(Cl)ccc23)CC1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"9.34";"0.18";"0.00";"5.47";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL180866";"";"None";"373.45";"0";"3.94";"2h";"O=C1c2ccccc2C(OCCCO)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"245000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL3217786";"";"None";"572.56";"2";"5.71";"33";"CC(C)C1=C(C(=O)N2CCC[C@H]2C(=O)N(C)C)SC2=N[C@@](C)(c3ccc(Cl)nc3)[C@@H](c3ccc(Cl)cc3)N21";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"13.72";"0.28";"2.14";"11.36";"0";"CHEMBL3223366";"Inhibition of His-tagged p53 interaction to GST-tagged MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL2177112";"";"None";"414.38";"1";"6.65";"15";"C=CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"6500.0";"nM";"5.19";"";"";"UO_0000065";"12.52";"0.25";"-1.46";"25.54";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL4214609";"";"None";"574.52";"2";"5.55";"Rac-4a''";"CC(C)(C)C[C@H]1C=C(C(=O)NCCN2CCOCC2)[C@@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"3680.0";"nM";"5.43";"";"";"UO_0000065";"9.46";"0.19";"-0.12";"7.69";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3220437";"";"None";"681.60";"1";"4.87";"15";"COC(=O)c1cccc(S(=O)(=O)N2c3ccc(C(=O)N4CCN(C)CC4)c(=O)n3[C@@H](c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)c1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"9.30";"0.19";"1.47";"5.80";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL179549";"";"None";"572.82";"None";"None";"16";"CCCN1C(=O)c2ccccc2C1(NC(=O)c1ccc(C(C)(C)C)cc1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"27000.0";"nM";"4.57";"";"";"UO_0000065";"7.98";"None";"None";"None";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217884";"";"None";"445.47";"0";"3.45";"41";"O=C1c2ccccc2C(OCCS(=O)(=O)[O-])(c2ccccc2)N1Cc1ccccc1.[Na+]";"IC50";"'='";"345000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3647052";"";"None";"550.06";"2";"5.07";"56; MK-4688";"C[C@H]1CC[C@H](Cn2c(N3CCO[C@@H]4CCC[C@H]43)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"0.65";"nM";"9.19";"";"";"UO_0000065";"16.70";"0.32";"4.12";"7.99";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5070769";"";"None";"555.73";"2";"5.62";"35";"C[C@@H](Nc1nc(-c2nnc[nH]2)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"724.0";"nM";"6.14";"";"";"UO_0000065";"11.05";"0.20";"0.52";"5.60";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL4203887";"";"None";"581.47";"2";"7.44";"(+)-4d'";"CC(C)(C)CC1C=C(C(=O)Nc2ccc(C(=O)O)cc2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"654.8";"nM";"6.18";"";"";"UO_0000065";"10.63";"0.21";"-1.26";"6.48";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4218748";"";"None";"462.35";"1";"6.18";"rac-8'";"CC(C)(C)C[C@@H]1C=C(C(=O)O)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"10.1";"nM";"8.00";"";"";"UO_0000065";"17.29";"0.35";"1.82";"12.04";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3805963";"";"None";"714.73";"2";"6.12";"2";"CCCC1N(C(=O)c2cnccc2C(F)(F)F)CCCC1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"10.95";"0.22";"1.70";"8.20";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5203689";"";"None";"714.73";"2";"6.12";"12";"CCC[C@H]1N(C(=O)c2ncccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"11.41";"0.23";"2.03";"8.54";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5203684";"";"None";"730.73";"2";"5.83";"18";"CCC[C@H]1N(C(=O)c2c(C(F)(F)F)ccnc2O)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"10.07";"0.20";"1.53";"6.36";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL379173";"";"None";"577.53";"1";"4.33";"MI-63";"CC(C)(C)C[C@H]1N[C@@H](C(=O)NCCN2CCOCC2)[C@H](c2cccc(Cl)c2F)[C@@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"13.29";"0.27";"3.35";"9.28";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3895665";"";"None";"608.52";"2";"6.76";"BDBM236284";"COc1ccc(C(=O)NOCCO)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"1.1";"nM";"8.96";"";"411598";"UO_0000065";"14.72";"0.29";"2.20";"9.63";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895294";"";"None";"532.00";"1";"4.71";"BDBM236484";"COc1ncc(-c2cc3c(n2C2CC2)C(c2ccc(Cl)cc2)N(c2cc(C)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"33.3";"nM";"7.48";"";"411610";"UO_0000065";"14.06";"0.27";"2.77";"8.17";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3900710";"";"None";"500.99";"1";"4.60";"BDBM236486";"Cc1cc(N2C(=O)c3cc(-c4ccn(C)c(=O)c4)n(C4CC4)c3C2c2ccc(Cl)cc2)cn(C)c1=O";"IC50";"'='";"2044.3";"nM";"5.69";"";"411612";"UO_0000065";"11.36";"0.22";"1.09";"8.22";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110748";"";"None";"576.52";"2";"7.78";"BDBM236280";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"44.56";"nM";"7.35";"";"411665";"UO_0000065";"12.75";"0.25";"-0.43";"11.56";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5198115";"";"None";"494.39";"1";"6.30";"1";"O=C1Nc2ccc(Br)cc2C12C(c1ccccc1)C(c1ccccc1)=NN2c1ccccc1";"IC50";"'='";"144.0";"nM";"6.84";"";"";"UO_0000065";"13.84";"0.28";"0.54";"15.31";"0";"CHEMBL5110382";"Inhibition of MDM2/p53 interaction in human U-87 MG cells preincubated for 10 mins under shaking condition and measured after 1.5 hrs by immuno-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5108018";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.667 hr";"INHIBITOR"
"CHEMBL5085709";"";"None";"585.76";"1";"4.92";"36";"C[C@@H](Nc1nc(-c2n[nH]c(=O)n2C)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"13.36";"0.25";"2.90";"6.59";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5083548";"";"None";"585.76";"1";"4.92";"37";"C[C@@H](Nc1nc(-c2nc(=O)n(C)[nH]2)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"15.06";"0.28";"3.90";"7.43";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3901716";"";"None";"537.45";"2";"6.91";"BDBM236270";"COc1ncc(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.065";"nM";"10.19";"";"411655";"UO_0000065";"18.95";"0.38";"3.28";"14.66";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3969509";"";"None";"522.43";"2";"6.50";"BDBM236293";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.203";"nM";"9.69";"";"411678";"UO_0000065";"18.55";"0.37";"3.19";"17.16";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177189";"";"None";"558.51";"2";"5.93";"BDBM50397774";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378454";"UO_0000065";"14.32";"0.29";"2.07";"7.92";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110761";"";"None";"476.40";"1";"5.90";"BDBM215196";"CC[C@@H](C(C)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378477";"UO_0000065";"16.16";"0.33";"1.80";"10.31";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892703";"";"None";"546.41";"2";"6.62";"BDBM215188";"CC[C@@H](CC(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"378571";"UO_0000065";"14.13";"0.29";"1.10";"9.92";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5084302";"";"None";"562.00";"2";"5.85";"58";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3C(F)(F)F)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"0.76";"nM";"9.12";"";"";"UO_0000065";"16.23";"0.32";"3.27";"8.62";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3963661";"";"None";"539.44";"2";"8.04";"BDBM238900";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C(=O)N2";"IC50";"'='";"2.1";"nM";"8.68";"";"417025";"UO_0000065";"16.09";"0.32";"0.64";"14.61";"0";"CHEMBL3888805";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 μM (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3982177";"";"None";"535.48";"2";"8.20";"BDBM238901";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2";"IC50";"'='";"1.8";"nM";"8.74";"";"417026";"UO_0000065";"16.33";"0.32";"0.54";"14.72";"0";"CHEMBL3888805";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 μM (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4203887";"";"None";"581.47";"2";"7.44";"(-)-4d'";"CC(C)(C)CC1C=C(C(=O)Nc2ccc(C(=O)O)cc2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"1039.0";"nM";"5.98";"";"";"UO_0000065";"10.29";"0.20";"-1.46";"6.27";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3918131";"";"None";"585.47";"2";"5.50";"BDBM236444";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.356";"nM";"9.45";"";"411828";"UO_0000065";"16.14";"0.32";"3.95";"11.05";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3920430";"";"None";"571.44";"2";"5.48";"BDBM236471";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.071";"nM";"10.15";"";"411857";"UO_0000065";"17.76";"0.36";"4.67";"10.53";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107344";"";"None";"556.43";"2";"5.94";"BDBM236474";"COC[C@@H](C)n1c(-c2cnc(N)nc2OC)cc2c1[C@@H](c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"281.0";"nM";"6.55";"";"411860";"UO_0000065";"11.77";"0.24";"0.61";"6.86";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3959598";"";"None";"549.45";"2";"7.81";"BDBM236282";"COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.169";"nM";"9.77";"";"411667";"UO_0000065";"17.79";"0.35";"1.96";"13.62";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL360719";"";"None";"407.90";"0";"4.60";"2c";"O=C1c2ccccc2C(OCCCO)(c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'='";"15900.0";"nM";"4.80";"";"";"UO_0000065";"11.76";"0.23";"0.20";"9.64";"0";"CHEMBL828042";"Inhibitory concentration against MDM2-p53 interaction in SJSA human sarcoma cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"SJSA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1142026";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2005";"CHEMBL3308885";"";""
"CHEMBL2385523";"";"None";"417.36";"1";"6.21";"MCL0527-1";"Nc1sc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)c1C(=O)N1CCCC1";"IC50";"'='";"2840.0";"nM";"5.55";"";"";"UO_0000065";"13.29";"0.28";"-0.66";"11.97";"0";"CHEMBL3136590";"Inhibition of p53-MDM2 (1 to 118 residues) interaction (unknown origin) expressed in Escherichia coli BL-21 (DE3) assessed as inhibition of MDM2 binding by fluorescence polarization competitive binding assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132800";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL5092438";"";"None";"511.03";"2";"5.63";"62";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1[C@H](C)[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"17.21";"0.33";"3.17";"7.87";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5084690";"";"None";"518.71";"2";"5.32";"34";"C[C@@H](Nc1nc(CO)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"4100.0";"nM";"5.39";"";"";"UO_0000065";"10.39";"0.19";"0.07";"6.10";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL5094473";"";"None";"566.67";"1";"4.94";"40";"Cc1cncc(-c2nc(-c3noc(=O)[nH]3)nc3nc(N4CCOC[C@H]4c4ccccc4)n(C[C@H]4CC[C@H](C)CC4)c23)c1";"IC50";"'='";"3673.0";"nM";"5.43";"";"";"UO_0000065";"9.59";"0.18";"0.49";"4.25";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL5092465";"";"None";"587.08";"2";"5.29";"41";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3nc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"401.0";"nM";"6.40";"";"";"UO_0000065";"10.90";"0.21";"1.11";"5.00";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL3805484";"";"None";"742.78";"2";"6.90";"16";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC(C)(C)O)CC1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"10.28";"0.20";"0.74";"8.00";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL1834378";"";"None";"535.04";"2";"6.19";"10j";"CC(C)(C)c1ccc2c(c1)C(=O)N(Cc1ccc([N+](=O)[O-])cc1)C2(OCC1(CO)CC1)c1ccc(Cl)cc1";"IC50";"'='";"152.0";"nM";"6.82";"";"";"UO_0000065";"12.74";"0.25";"0.63";"7.34";"0";"CHEMBL1838865";"Inhibition of human MDM2-p53 interaction after 20 mins by ELSA method";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1833901";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL4466891";"";"None";"386.28";"1";"5.59";"4";"CC(C)c1n[nH]c2c1C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1)C2=O";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"19.40";"0.39";"1.90";"15.30";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3134176";"";"None";"398.46";"1";"5.36";"43";"CCOc1ccccc1-c1cc(-c2ccc(C(=O)O)cc2)nn1Cc1ccccc1";"IC50";"'='";"346400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134206";"";"None";"472.54";"1";"5.77";"22";"CCCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"79270.0";"nM";"4.10";"";"";"UO_0000065";"8.68";"0.16";"-1.67";"4.95";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL5076263";"";"None";"572.71";"2";"5.17";"16";"C[C@@H](Nc1nc(-c2noc(=O)[nH]2)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"64.0";"nM";"7.19";"";"";"UO_0000065";"12.56";"0.23";"2.02";"5.66";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL3601398";"CGM-097";"1.0";"659.27";"2";"6.58";"1, NVP-CGM097";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"13.30";"0.25";"2.19";"13.38";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601396";"";"None";"631.22";"2";"6.20";"11";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CNC(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"1.7";"nM";"8.77";"";"";"UO_0000065";"13.89";"0.27";"2.57";"11.79";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601320";"";"None";"576.18";"2";"7.16";"6";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N)CC3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.79";"0.28";"1.36";"12.53";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL5070769";"";"None";"555.73";"2";"5.62";"35";"C[C@@H](Nc1nc(-c2nnc[nH]2)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"14.32";"0.27";"2.34";"7.26";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3775883";"";"None";"249.31";"0";"2.84";"1e";"CC(C)C(=O)Nc1ccccc1OC(=O)C(C)C";"IC50";"'>'";"25000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL4789769";"";"None";"458.31";"0";"3.51";"Rac-5g";"O=C1Nc2cc(Cl)ccc2[C@]12N[C@@H](Cc1c[nH]cn1)[C@@H]([N+](=O)[O-])[C@@H]2c1cccc(Cl)c1";"IC50";"'='";"15200.0";"nM";"4.82";"";"";"UO_0000065";"10.51";"0.21";"1.31";"4.27";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4796160";"";"None";"459.29";"0";"2.83";"Rac-5f";"O=C1Nc2cc(Cl)ccc2[C@]12N[C@@H](Cn1cncn1)[C@@H]([N+](=O)[O-])[C@@H]2c1cccc(Cl)c1";"IC50";"'='";"5500.0";"nM";"5.26";"";"";"UO_0000065";"11.45";"0.23";"2.43";"4.57";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4207959";"";"None";"574.52";"2";"5.55";"(+)-4a'";"CC(C)(C)CC1C=C(C(=O)NCCN2CCOCC2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"23.7";"nM";"7.62";"";"";"UO_0000065";"13.27";"0.27";"2.08";"10.79";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL5091392";"";"None";"572.56";"2";"6.40";"30";"CC(C)c1ccnc(-c2nc3nc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(OC(F)(F)F)c(F)c2)c1";"IC50";"'='";"9.5";"nM";"8.02";"";"";"UO_0000065";"14.01";"0.27";"1.62";"6.97";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5089893";"";"None";"537.06";"2";"6.36";"63";"CCO[C@@H](c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1[C@H](C)[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"0.35";"nM";"9.46";"";"";"UO_0000065";"17.61";"0.34";"3.10";"8.46";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5085142";"";"None";"419.53";"0";"4.90";"1";"Cc1cccc(-c2nc3nc(C(=O)O)nc(NCC4CC4)c3n2CC2CCCCC2)c1";"IC50";"'='";"8400.0";"nM";"5.08";"";"";"UO_0000065";"12.10";"0.22";"0.18";"5.46";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL2024322";"";"None";"418.33";"1";"7.05";"4";"Clc1ccc(Cn2cnc(-c3ccccc3)c2-c2c[nH]c3cc(Cl)ccc23)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"";"UO_0000065";"16.01";"0.32";"-0.35";"19.93";"0";"CHEMBL2027062";"Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2021844";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL2024323";"";"None";"574.51";"2";"6.12";"5";"O=C(NCCN1CCOCC1)c1[nH]c2cc(Cl)ccc2c1-c1c(-c2ccccc2)ncn1Cc1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"13.09";"0.26";"1.40";"10.01";"0";"CHEMBL2027062";"Inhibition of p53 (18 to 26)-MDM2 (2 to 188) interaction using fluorescent dye Cy5 by TR-FRET assay";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2021844";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"None";"";""
"CHEMBL4779524";"";"None";"333.22";"0";"3.57";"Rac-4";"O=C1Nc2cc(Cl)ccc2[C@]12CNC[C@@H]2c1cccc(Cl)c1";"IC50";"'='";"36000.0";"nM";"4.44";"";"";"UO_0000065";"13.34";"0.28";"0.87";"10.80";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL5080197";"";"None";"554.57";"2";"6.26";"29";"CC(C)c1ccnc(-c2nc3nc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(OC(F)(F)F)cc2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"14.28";"0.27";"1.66";"6.88";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5084690";"";"None";"518.71";"2";"5.32";"34";"C[C@@H](Nc1nc(CO)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"13.69";"0.26";"1.78";"8.04";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3906706";"";"None";"550.10";"2";"5.91";"BDBM236349";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N([C@H]2CC[C@H](O)CC2)C3=O)c1";"IC50";"'='";"12.7";"nM";"7.90";"";"411603";"UO_0000065";"14.35";"0.28";"1.99";"9.42";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3924973";"";"None";"544.02";"1";"4.56";"BDBM236414";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.8";"nM";"9.10";"";"411609";"UO_0000065";"16.72";"0.32";"4.54";"7.57";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932259";"";"None";"530.46";"2";"7.98";"BDBM236264";"COc1ccc(C#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.281";"nM";"9.55";"";"411649";"UO_0000065";"18.01";"0.35";"1.57";"16.39";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3916525";"";"None";"576.52";"2";"7.81";"BDBM236267";"COc1ccc(C(=O)N(C)C)cc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.075";"nM";"10.12";"";"411652";"UO_0000065";"17.56";"0.35";"2.31";"18.48";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL179114";"";"None";"464.57";"0";"4.88";"18";"COc1ccc(C(O)CNC2(c3ccccc3)c3ccccc3C(=O)N2Cc2ccccc2)cc1";"IC50";"'='";"70000.0";"nM";"4.16";"";"";"UO_0000065";"8.94";"0.16";"-0.73";"6.72";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL387459";"";"None";"450.49";"1";"5.67";"19";"O=C1c2ccccc2C(OCc2cccc([N+](=O)[O-])c2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"284000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL426784";"";"None";"518.73";"None";"None";"87";"CCCN1C(=O)c2ccccc2C1(OCCc1ccccn1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"312000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL217719";"";"None";"454.45";"0";"4.24";"S12";"O=C1c2ccccc2C(OCCNC(=O)C(F)(F)F)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"409000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL3134186";"";"None";"486.57";"1";"5.96";"1";"CCCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1";"IC50";"'='";"6560.0";"nM";"5.18";"";"";"UO_0000065";"10.65";"0.20";"-0.78";"6.26";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134187";"";"None";"500.60";"2";"6.21";"2";"COc1cccc(-c2cc(-c3cc(C(=O)O)ccc3OCC(C)C)nn2CCc2ccccc2)c1OC";"IC50";"'='";"8220.0";"nM";"5.08";"";"";"UO_0000065";"10.16";"0.19";"-1.12";"6.14";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2398244";"";"None";"682.72";"2";"6.70";"26";"CC[C@@H]1CC[C@@H](C(=O)N2CCN(C(C)=O)CC2)N1C(=O)C1=C(C(C)C)N2C(=N[C@@](C)(c3ccc(Cl)cc3)[C@H]2c2ccc(Cl)cc2)S1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"10.79";"0.22";"0.67";"9.63";"0";"CHEMBL2401351";"Inhibition of GST-tagged MDM2 (25 to 108, L33E)/His-tagged p53 (1 to 132) interaction (unknown origin) after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"Q00987";"L33E";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2396597";"1";"Scientific Literature";"Bioorg Med Chem";"2013";"None";"";""
"CHEMBL3896443";"";"None";"580.49";"2";"7.61";"BDBM236249";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"0.757";"nM";"9.12";"";"411635";"UO_0000065";"15.71";"0.31";"1.51";"14.35";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961756";"";"None";"553.46";"2";"7.74";"BDBM236251";"COc1ccc(CO)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.286";"nM";"9.54";"";"411636";"UO_0000065";"17.24";"0.34";"1.80";"17.45";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3901714";"";"None";"524.42";"2";"7.64";"BDBM236252";"COc1ncccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"1.696";"nM";"8.77";"";"411637";"UO_0000065";"16.72";"0.33";"1.13";"18.52";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3971119";"";"None";"523.44";"2";"8.25";"BDBM236248";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"9.5";"nM";"8.02";"";"411591";"UO_0000065";"15.33";"0.30";"-0.23";"23.27";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3930918";"";"None";"491.42";"1";"7.81";"BDBM236276";"Cc1ccc(Cl)cc1N1C(=O)c2cc(-c3ccccc3O)n(C(C)C)c2C1c1ccc(Cl)cc1";"IC50";"'='";"0.306";"nM";"9.51";"";"411661";"UO_0000065";"19.36";"0.38";"1.70";"20.92";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3902934";"";"None";"519.47";"2";"8.42";"BDBM236277";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.376";"nM";"9.43";"";"411662";"UO_0000065";"18.14";"0.36";"1.00";"27.34";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3963943";"";"None";"573.52";"2";"5.09";"BDBM215148";"CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378551";"UO_0000065";"15.17";"0.30";"3.61";"9.49";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3896807";"";"None";"581.56";"2";"5.78";"BDBM215233";"CC[C@@H](CNS(=O)(=O)C1(C)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378616";"UO_0000065";"15.48";"0.32";"3.22";"8.67";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3134202";"";"None";"500.60";"2";"5.89";"18";"CCCOc1ccc(CC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(CCc2ccccc2)n1";"IC50";"'='";"60600.0";"nM";"4.22";"";"";"UO_0000065";"8.42";"0.16";"-1.67";"5.09";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134199";"";"None";"541.02";"2";"7.65";"15";"O=C(O)CCc1ccc(OCc2cccc(Cl)c2)c(-c2cc(-c3ccc(F)cc3)n(Cc3ccccc3)n2)c1";"IC50";"'='";"51880.0";"nM";"4.29";"";"";"UO_0000065";"7.92";"0.15";"-3.36";"6.66";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"12.12";"0.24";"1.16";"8.45";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177188";"";"None";"544.48";"2";"5.54";"24";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.3";"nM";"7.69";"";"";"UO_0000065";"14.13";"0.28";"2.15";"7.61";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177182";"";"None";"446.37";"1";"5.64";"18";"COC(=O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL4787941";"";"None";"646.55";"2";"7.15";"17";"CCOc1cccc(CN2[C@H]3C[C@H](c4ccc(C(=O)O)cc4)N[C@H]3[C@H](c3cccc(Cl)c3F)[C@]23C(=O)Nc2cc(Cl)ccc23)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"13.45";"0.26";"1.55";"9.57";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4749001";"";"None";"565.48";"2";"5.36";"16";"NC(=O)c1ccc([C@H]2C[C@H]3[C@@H](N2)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc4cc(Cl)ccc42)N3CC2CC2)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"13.79";"0.27";"2.44";"8.91";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL1333839";"";"None";"337.81";"0";"4.43";"2";"Cc1ccc(N2C(=O)c3[nH]nc(C)c3C2c2ccc(Cl)cc2)cc1";"IC50";"'='";"1500.0";"nM";"5.82";"";"";"UO_0000065";"17.24";"0.33";"1.39";"11.89";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3894532";"";"None";"533.50";"2";"5.64";"BDBM215140";"CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378545";"UO_0000065";"15.74";"0.32";"2.76";"11.98";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980222";"";"None";"561.55";"2";"6.42";"BDBM215142";"CC[C@@H](CN1CCOC(C)(C)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378546";"UO_0000065";"15.18";"0.31";"2.10";"12.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110607";"";"None";"616.61";"2";"6.13";"BDBM215432";"CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@H](Cc2cccc(OC)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"123.0";"nM";"6.91";"";"378815";"UO_0000065";"11.21";"0.23";"0.78";"8.66";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111829";"";"None";"520.45";"2";"6.26";"BDBM215050";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378329";"UO_0000065";"14.21";"0.29";"1.14";"8.82";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113757";"";"None";"492.40";"1";"5.48";"BDBM215052";"CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"378331";"UO_0000065";"14.67";"0.30";"1.74";"8.61";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109794";"";"None";"504.45";"2";"6.35";"BDBM215058";"CC[C@@H](COCC1CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378337";"UO_0000065";"14.91";"0.30";"1.17";"11.26";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961139";"";"None";"532.49";"2";"6.49";"BDBM215076";"CC[C@@H](CNc1nccs1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"378355";"UO_0000065";"13.15";"0.27";"0.51";"8.48";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2059299";"";"None";"432.35";"1";"5.55";"1";"O=C(O)C[C@@H]1C[C@@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"18900.0";"nM";"4.72";"";"";"UO_0000065";"10.93";"0.22";"-0.83";"8.20";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3805987";"";"None";"749.17";"2";"6.78";"13";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1Cl)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"9.19";"0.19";"0.11";"7.22";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL2177814";"";"None";"320.22";"0";"4.73";"3";"O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177188";"";"None";"544.48";"2";"5.54";"24";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@H](Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"16.06";"0.32";"3.20";"8.65";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177200";"";"None";"448.39";"1";"6.17";"11";"CCC[C@@H](C(=O)OCC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"13.06";"0.27";"-0.32";"12.56";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL4465041";"";"None";"414.34";"1";"6.21";"6";"Cc1cc(Cl)ccc1C1c2c(C(C)C)n[nH]c2C(=O)N1c1cc(Cl)ccc1C";"IC50";"'='";"4.2";"nM";"8.38";"";"";"UO_0000065";"20.22";"0.41";"2.17";"17.10";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL4797302";"";"None";"584.48";"2";"5.51";"13";"CCOc1cccc(CN2[C@H]3CCN(CC(=O)O)[C@H]3[C@H](c3cccc(Cl)c3F)[C@]23C(=O)Nc2cc(Cl)ccc23)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"14.88";"0.30";"3.19";"10.59";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4794841";"";"None";"446.35";"0";"4.52";"10";"O=C1Nc2cc(Cl)ccc2[C@@]12[C@@H](c1cccc(Cl)c1F)[C@@H]1NCC[C@@H]1N2CC1CC1";"IC50";"'='";"137.0";"nM";"6.86";"";"";"UO_0000065";"15.38";"0.31";"2.34";"15.47";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4785458";"";"None";"418.37";"0";"4.61";"6b";"CC(C)(C)CN1C[C@@H](N)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"819.0";"nM";"6.09";"";"";"UO_0000065";"14.55";"0.30";"1.48";"10.43";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4743217";"";"None";"450.28";"0";"3.41";"Rac-5i";"O=C(O)CC[C@@H]1N[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@@H](c2cccc(Cl)c2)[C@@H]1[N+](=O)[O-]";"IC50";"'='";"16000.0";"nM";"4.80";"";"";"UO_0000065";"10.65";"0.22";"1.39";"3.94";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4761462";"";"None";"511.37";"1";"3.88";"Rac-5e";"NC(=O)c1cccc(C[C@@H]2N[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@@H](c3cccc(Cl)c3)[C@@H]2[N+](=O)[O-])c1";"IC50";"'='";"18300.0";"nM";"4.74";"";"";"UO_0000065";"9.26";"0.18";"0.86";"3.72";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4755387";"";"None";"404.34";"0";"4.22";"6a";"CC(C)CN1C[C@@H](N)[C@H](c2cccc(Cl)c2)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"944.0";"nM";"6.03";"";"";"UO_0000065";"14.90";"0.30";"1.81";"10.32";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3134171";"";"None";"470.57";"1";"5.88";"38";"CCOc1ccccc1-c1cc(-c2cc(CCC(=O)O)ccc2OC)nn1CCc1ccccc1";"IC50";"'='";"258400.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134192";"";"None";"484.60";"1";"6.74";"7";"CCCCOc1ccc(C(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1";"IC50";"'='";"16750.0";"nM";"4.78";"";"";"UO_0000065";"9.86";"0.18";"-1.96";"6.49";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL360920";"";"None";"426.56";"1";"5.48";"17";"CCCN1C(=O)c2ccccc2C1(NC(=O)c1ccccc1)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"66000.0";"nM";"4.18";"";"";"UO_0000065";"9.80";"0.18";"-1.30";"8.46";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL438472";"";"None";"607.74";"None";"None";"64";"CCCN1C(=O)c2ccccc2C1(OCc1cc([N+](=O)[O-])c(C)c([N+](=O)[O-])c1)c1ccc(OCOCC[Si](C)(C)C)cc1";"IC50";"'='";"103000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL384464";"";"None";"383.49";"0";"4.17";"57";"CCCOC1(c2ccccc2)c2ccccc2C(=O)N1CCCC(OC)OC";"IC50";"'='";"70000.0";"nM";"4.16";"";"";"UO_0000065";"10.83";"0.20";"-0.02";"8.66";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL438289";"";"None";"395.46";"1";"5.35";"S5";"O=C1c2ccccc2C(OCc2ccco2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'>'";"500000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL385219";"";"None";"450.54";"0";"4.57";"S17";"O=C1c2ccccc2C(NCC(O)c2ccc(O)cc2)(c2ccccc2)N1Cc1ccccc1";"IC50";"'='";"227000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL908897";"Inhibition of p53-MDM2 interaction by ELISA";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1137314";"1";"Scientific Literature";"J Med Chem";"2006";"None";"";""
"CHEMBL4205549";"";"None";"574.52";"2";"5.55";"Rac-4a'''";"CC(C)(C)C[C@@H]1C=C(C(=O)NCCN2CCOCC2)[C@@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"3384.5";"nM";"5.47";"";"";"UO_0000065";"9.52";"0.19";"-0.08";"7.74";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4207959";"";"None";"574.52";"2";"5.55";"(+)-4a'";"CC(C)(C)CC1C=C(C(=O)NCCN2CCOCC2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"1144.0";"nM";"5.94";"";"";"UO_0000065";"10.34";"0.21";"0.39";"8.41";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL3953300";"";"None";"536.46";"2";"7.51";"BDBM236269";"COc1ccc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.323";"nM";"9.49";"";"411654";"UO_0000065";"17.69";"0.35";"1.98";"16.77";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3916320";"";"None";"579.48";"2";"5.86";"BDBM236296";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c1";"IC50";"'='";"0.137";"nM";"9.86";"";"411681";"UO_0000065";"17.02";"0.34";"4.00";"11.53";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3775808";"";"None";"263.75";"0";"3.88";"4b";"O=C(Nc1ccccc1S)c1ccc(Cl)cc1";"IC50";"'='";"18400.0";"nM";"4.74";"";"";"UO_0000065";"17.95";"0.38";"0.86";"16.27";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL3775281";"";"None";"264.74";"0";"3.28";"5b";"O=C(Nc1ccccc1S)c1ccc(Cl)nc1";"IC50";"'='";"15300.0";"nM";"4.82";"";"";"UO_0000065";"18.19";"0.39";"1.54";"11.47";"0";"CHEMBL3778678";"Inhibition of Flag-tagged p53/GST-tagged Mdm2 (unknown origin) expressed in Escherichia coli BL21 after 1 hr by ELISA microplate reader method";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3774315";"1";"Scientific Literature";"Bioorg Med Chem";"2016";"None";"";""
"CHEMBL4108935";"";"None";"500.47";"2";"6.92";"BDBM215128";"CCC(CC)N1C(=O)[C@@](C)(Cc2cc(O)n[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"580.0";"nM";"6.24";"";"378407";"UO_0000065";"12.46";"0.25";"-0.68";"9.01";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114346";"";"None";"474.39";"1";"5.38";"BDBM215132";"CC(C)N1C(=O)[C@@](C)(Cc2noc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378411";"UO_0000065";"15.86";"0.32";"2.14";"9.50";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108877";"";"None";"437.39";"1";"6.40";"BDBM215112";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)s2)C(CC2CC2)C1=O";"IC50";"'='";"430.0";"nM";"6.37";"";"378391";"UO_0000065";"14.56";"0.31";"-0.03";"11.71";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109543";"";"None";"593.50";"2";"6.60";"BDBM215127";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)NS(=O)(=O)C(F)(F)F)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"530.0";"nM";"6.28";"";"378406";"UO_0000065";"10.57";"0.23";"-0.32";"7.51";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113210";"";"None";"542.46";"2";"6.94";"BDBM215138";"CC[C@@H](c1nc(C2CC2)no1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"378417";"UO_0000065";"13.08";"0.26";"0.16";"7.35";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3977225";"";"None";"533.50";"2";"5.64";"BDBM215256";"CC[C@@H](CN(C)C1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378638";"UO_0000065";"15.98";"0.32";"2.88";"12.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3984400";"";"None";"580.57";"2";"6.53";"BDBM215339";"CC[C@@H](CS(=O)(=O)CC1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"378709";"UO_0000065";"16.02";"0.33";"2.77";"10.14";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3983607";"";"None";"568.56";"2";"6.52";"BDBM215343";"CC[C@@H](CS(=O)(=O)[C@H](C)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"11.2";"nM";"7.95";"";"378716";"UO_0000065";"13.98";"0.29";"1.43";"8.67";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3959436";"";"None";"592.59";"2";"6.67";"BDBM215345";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C2CCCC2)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378717";"UO_0000065";"16.37";"0.34";"3.03";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3968189";"";"None";"635.01";"2";"7.44";"BDBM215349";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccccc2Cl)C2CC2)C1=O";"IC50";"'='";"1.2";"nM";"8.92";"";"378721";"UO_0000065";"14.05";"0.30";"1.48";"9.72";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3951924";"";"None";"632.58";"2";"7.31";"BDBM215361";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(F)cc2)C2CC2)C1=O";"IC50";"'='";"1.6";"nM";"8.80";"";"378733";"UO_0000065";"13.90";"0.29";"1.49";"9.59";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125529";"";"None";"566.55";"2";"6.28";"BDBM50448934";"CC[C@@H](CS(=O)(=O)C1CCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378747";"UO_0000065";"17.12";"0.36";"3.42";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125537";"";"None";"580.57";"2";"6.52";"BDBM50448963";"CC(C)(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378755";"UO_0000065";"17.22";"0.36";"3.48";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111158";"";"None";"566.55";"2";"6.14";"BDBM215377";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)CC)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378761";"UO_0000065";"17.12";"0.36";"3.56";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107265";"";"None";"602.58";"2";"5.82";"BDBM215434";"CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@H](Cc2cccc(O)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"104.0";"nM";"6.98";"";"378817";"UO_0000065";"11.59";"0.24";"1.16";"7.69";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4789374";"";"None";"551.41";"2";"5.61";"Ia-30";"CCN1[C@H]2Cc3c4ccc(C(=O)O)cc4nn3[C@H]2[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.78";"0.31";"3.09";"9.95";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3985044";"";"None";"505.45";"2";"8.11";"BDBM236256";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.6";"nM";"9.22";"";"411595";"UO_0000065";"18.24";"0.36";"1.11";"26.75";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3906442";"";"None";"553.06";"1";"4.55";"BDBM236354";"CNC(=O)N1CCC(N2C(=O)c3cc(-c4cnc(OC)nc4OC)n(C(C)C)c3C2c2ccc(Cl)cc2)CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"411606";"UO_0000065";"15.41";"0.30";"3.97";"8.37";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107315";"";"None";"576.52";"2";"7.81";"BDBM236268";"COc1ccc(C(=O)N(C)C)cc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"620.83";"nM";"6.21";"";"411653";"UO_0000065";"10.77";"0.21";"-1.60";"11.33";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125526";"";"None";"554.54";"2";"6.13";"BDBM50448937";"CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378745";"UO_0000065";"17.49";"0.37";"3.57";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112399";"";"None";"434.38";"1";"7.18";"BDBM215403";"C=CC[C@@]1(C)C[C@H](c2ccc(F)c(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C(C)C)C1=O";"IC50";"'='";"5.0";"nM";"8.30";"";"378792";"UO_0000065";"19.11";"0.39";"1.12";"40.87";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3931077";"";"None";"541.50";"2";"5.14";"BDBM215416";"CC[C@@H](CS(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1";"IC50";"'='";"0.9";"nM";"9.05";"";"378805";"UO_0000065";"16.70";"0.35";"3.91";"8.64";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3925236";"";"None";"562.50";"2";"7.47";"BDBM236257";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.116";"nM";"9.94";"";"411642";"UO_0000065";"17.66";"0.35";"2.47";"15.63";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926268";"";"None";"554.43";"2";"5.30";"BDBM236295";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.188";"nM";"9.73";"";"411680";"UO_0000065";"17.54";"0.35";"4.43";"10.63";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3902175";"";"None";"566.46";"2";"7.30";"BDBM236300";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2ccc(F)c(Cl)c2)C3=O)c1";"IC50";"'='";"0.323";"nM";"9.49";"";"411685";"UO_0000065";"16.75";"0.33";"2.19";"14.93";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115157";"";"None";"568.56";"2";"6.38";"BDBM215384";"CCS(=O)(=O)C[C@@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)C";"IC50";"'='";"0.3";"nM";"9.52";"";"378768";"UO_0000065";"16.75";"0.35";"3.14";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113936";"";"None";"581.56";"2";"5.64";"BDBM215333";"CC(C)[C@@H](CNS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.4";"nM";"8.36";"";"378701";"UO_0000065";"14.37";"0.30";"2.72";"8.05";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125530";"";"None";"580.57";"2";"6.67";"BDBM50448933";"CC[C@@H](CS(=O)(=O)C1CCCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378710";"UO_0000065";"16.40";"0.34";"2.85";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3915847";"";"None";"596.57";"2";"5.76";"BDBM215340";"CC[C@@H](CS(=O)(=O)CC1(C)COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378712";"UO_0000065";"16.76";"0.35";"4.24";"9.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899040";"";"None";"578.56";"2";"6.14";"BDBM215354";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)CC2CC2)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"378726";"UO_0000065";"17.28";"0.36";"3.86";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3805162";"";"None";"772.63";"2";"5.71";"5";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1cc(I)cs1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"9.12";"0.21";"1.34";"7.38";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL4299638";"";"None";"714.73";"2";"6.12";"10";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"10.95";"0.22";"1.70";"8.20";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3805382";"";"None";"728.76";"2";"6.43";"14";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1cc(C(F)(F)F)sc1C)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"470.0";"nM";"6.33";"";"";"UO_0000065";"8.68";"0.17";"-0.10";"6.63";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL4299668";"";"None";"741.76";"2";"5.88";"18";"CCC[C@@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCC(=O)NC)CC1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"11.32";"0.22";"2.52";"8.05";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL4746141";"";"None";"362.26";"0";"3.24";"Rac-1";"C[C@@H]1N[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@@H](c2cccc(Cl)c2)[C@@H]1N";"IC50";"'='";"74000.0";"nM";"4.13";"";"";"UO_0000065";"11.40";"0.24";"0.89";"6.15";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4113211";"";"None";"580.49";"2";"7.61";"BDBM236255";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"49.03";"nM";"7.31";"";"411640";"UO_0000065";"12.59";"0.25";"-0.30";"11.50";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3985044";"";"None";"505.45";"2";"8.11";"BDBM236256";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.298";"nM";"9.53";"";"411641";"UO_0000065";"18.85";"0.37";"1.42";"27.63";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3923310";"";"None";"576.52";"2";"7.81";"BDBM236262";"COc1ccc(C(=O)N(C)C)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.133";"nM";"9.88";"";"411647";"UO_0000065";"17.13";"0.34";"2.07";"18.03";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3903599";"";"None";"566.44";"2";"6.20";"BDBM236297";"COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.234";"nM";"9.63";"";"411682";"UO_0000065";"17.00";"0.34";"3.43";"10.27";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3983005";"";"None";"539.42";"1";"4.87";"BDBM236298";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.461";"nM";"9.34";"";"411683";"UO_0000065";"17.31";"0.34";"4.47";"8.62";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107240";"";"None";"496.50";"1";"6.29";"BDBM215137";"CCC(CC)N1C(=O)[C@@](C)(CS(C)(=O)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"840.0";"nM";"6.08";"";"378416";"UO_0000065";"12.24";"0.26";"-0.21";"11.16";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3976926";"";"None";"574.47";"2";"7.40";"BDBM215184";"CC[C@@H](CCC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'<'";"10.0";"nM";"";"";"378465";"UO_0000065";"";"";"";"";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108719";"";"None";"515.48";"2";"7.25";"BDBM215195";"CCC(CC(C)(C)C#N)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378476";"UO_0000065";"15.52";"0.31";"0.75";"9.83";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932275";"";"None";"560.44";"2";"7.01";"BDBM215178";"CC[C@@H](CC(C)(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"378561";"UO_0000065";"12.77";"0.26";"0.14";"9.19";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3952928";"";"None";"492.44";"1";"6.08";"BDBM215190";"CC[C@@H](CC(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378573";"UO_0000065";"17.05";"0.35";"2.32";"10.79";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980413";"";"None";"478.42";"1";"5.69";"BDBM215202";"CC[C@@H](CCO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378585";"UO_0000065";"18.18";"0.37";"3.01";"11.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3979336";"";"None";"596.58";"2";"5.16";"BDBM215208";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"26.0";"nM";"7.58";"";"378589";"UO_0000065";"12.71";"0.27";"2.43";"7.09";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125697";"";"None";"566.55";"2";"6.13";"BDBM50448959";"CC(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378754";"UO_0000065";"17.65";"0.37";"3.87";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113035";"";"None";"554.54";"2";"6.13";"BDBM215389";"CC[C@@H]([C@@H](C)S(=O)(=O)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"378774";"UO_0000065";"16.95";"0.36";"3.27";"10.24";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125519";"";"None";"567.54";"2";"5.20";"BDBM50448948";"CN(C)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378781";"UO_0000065";"17.09";"0.36";"4.50";"10.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4781151";"";"None";"591.47";"2";"6.39";"Ib-108";"O=C(O)c1ccc2c(c1)nc1n2CC[C@@H]2[C@H]1[C@H](c1cccc(Cl)c1F)[C@]1(C(=O)Nc3cc(Cl)ccc31)N2CC1CC1";"IC50";"'='";"79.0";"nM";"7.10";"";"";"UO_0000065";"12.01";"0.24";"0.71";"8.12";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3901604";"";"None";"635.55";"2";"5.97";"BDBM236294";"COc1ccc(C(=O)N2CCOCC2)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.15";"nM";"9.82";"";"411679";"UO_0000065";"15.46";"0.30";"3.85";"11.42";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110667";"";"None";"494.42";"0";"4.66";"BDBM215427";"CC[C@@H]([C@H](O)CO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.7";"nM";"8.57";"";"378811";"UO_0000065";"17.33";"0.35";"3.91";"8.74";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4760223";"";"None";"577.44";"2";"6.00";"Ia-25";"O=C(O)c1ccc2c3n(nc2c1)[C@@H]1[C@H](C3)N(CC2CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.06";"0.30";"2.70";"9.95";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3329618";"";"None";"469.37";"1";"6.13";"20";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccccn2)C1=O";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"16.80";"0.34";"1.76";"11.19";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3956221";"";"None";"580.57";"2";"6.52";"BDBM215379";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)C(C)C)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"378762";"UO_0000065";"17.22";"0.36";"3.48";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3934002";"";"None";"583.53";"1";"4.63";"BDBM215391";"CC[C@@H](CS(=O)(=O)NC1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378776";"UO_0000065";"16.62";"0.35";"5.07";"8.58";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3949903";"";"None";"588.43";"2";"5.22";"BDBM238917";"COc1ncc(-c2nc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c(=O)n(C)c2)C(=O)N3)c(OC)n1";"IC50";"'='";"930.0";"nM";"6.03";"";"417049";"UO_0000065";"10.25";"0.21";"0.81";"5.18";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975725";"";"None";"616.61";"2";"6.13";"BDBM215433";"CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@@H](Cc2cccc(OC)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"194.0";"nM";"6.71";"";"378816";"UO_0000065";"10.89";"0.22";"0.58";"8.41";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3909154";"";"None";"541.43";"2";"8.39";"BDBM236250";"COc1ccc(F)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"6.0";"nM";"8.22";"";"411593";"UO_0000065";"15.19";"0.30";"-0.17";"23.85";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3937629";"";"None";"576.52";"2";"7.78";"BDBM236279";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.5";"nM";"9.30";"";"411597";"UO_0000065";"16.13";"0.32";"1.52";"14.63";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3916949";"";"None";"481.98";"0";"4.49";"BDBM236325";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(C1CCOCC1)C2=O";"IC50";"'='";"8.5";"nM";"8.07";"";"411601";"UO_0000065";"16.74";"0.32";"3.58";"8.45";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3898237";"";"None";"506.43";"2";"7.50";"BDBM236259";"COc1ncccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.49";"nM";"9.31";"";"411644";"UO_0000065";"18.38";"0.36";"1.81";"19.66";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4749651";"";"None";"607.47";"2";"6.01";"Ia-36";"COc1c(C(=O)O)ccc2c3n(nc12)[C@@H]1[C@H](C3)N(CC2CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.66";"0.27";"2.29";"8.59";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3904865";"";"None";"643.63";"2";"7.25";"BDBM215235";"CC[C@@H](CN1C(C)(C)c2ccccc2S1(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378618";"UO_0000065";"13.52";"0.28";"1.45";"9.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107558";"";"None";"581.56";"2";"5.64";"BDBM215317";"CCCS(=O)(=O)NC[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"378686";"UO_0000065";"15.99";"0.33";"3.66";"8.96";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3943183";"";"None";"594.60";"2";"6.92";"BDBM215363";"CCCCS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378735";"UO_0000065";"16.31";"0.34";"2.78";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3916712";"";"None";"552.52";"2";"5.74";"BDBM215445";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"0.3";"nM";"9.52";"";"378739";"UO_0000065";"17.24";"0.36";"3.78";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125700";"";"None";"540.51";"2";"5.60";"BDBM50448956";"CC(C)[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378742";"UO_0000065";"17.62";"0.37";"3.92";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114145";"";"None";"595.59";"2";"6.03";"BDBM215394";"CC(C)(C)NS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378779";"UO_0000065";"16.79";"0.35";"3.97";"9.64";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3318755";"";"None";"553.51";"1";"4.86";"BDBM50053045";"CNS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378780";"UO_0000065";"16.26";"0.34";"4.14";"8.67";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962130";"";"None";"526.40";"2";"7.12";"BDBM238904";"COc1ccncc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cccc(Cl)c1F)C(=O)N2";"IC50";"'='";"8.5";"nM";"8.07";"";"417029";"UO_0000065";"15.33";"0.31";"0.95";"11.17";"0";"CHEMBL3888805";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: This assay was used to evaluate compounds displaying inhibition of p53-MDM2 interaction and p53-MDM4 interaction at IC50s of 0.005 to 50 μM (p53-MDM2 Assay 1 and p53-MDM4 Assay 1, respectively). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2059435";"";"None";"478.42";"1";"5.69";"BDBM50388626";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378580";"UO_0000065";"18.81";"0.38";"3.31";"11.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3905833";"";"None";"654.66";"1";"4.12";"BDBM215211";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NC[C@H](O)CO)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"58.0";"nM";"7.24";"";"378592";"UO_0000065";"11.05";"0.23";"3.12";"5.69";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113137";"";"None";"463.40";"1";"6.12";"BDBM215171";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1";"IC50";"'='";"11.0";"nM";"7.96";"";"378554";"UO_0000065";"17.17";"0.35";"1.84";"11.29";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113117";"";"None";"581.56";"2";"5.78";"BDBM215217";"CC[C@@H](C(C)NS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378599";"UO_0000065";"15.48";"0.32";"3.22";"8.67";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3891284";"";"None";"617.60";"2";"6.60";"BDBM215230";"CC[C@@H](CNS(=O)(=O)c1ccccc1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"378613";"UO_0000065";"13.44";"0.28";"1.70";"8.00";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3974584";"";"None";"603.57";"2";"6.29";"BDBM215232";"CC[C@@H](CNS(=O)(=O)c1ccccc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378615";"UO_0000065";"14.91";"0.31";"2.71";"8.67";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962786";"";"None";"547.52";"2";"6.03";"BDBM215250";"CC[C@@H](CN1CCOCC1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378633";"UO_0000065";"15.89";"0.32";"2.67";"12.41";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941874";"";"None";"561.55";"2";"6.42";"BDBM215254";"CC[C@@H](CN1CCOCC1(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378636";"UO_0000065";"15.18";"0.31";"2.10";"12.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3927464";"";"None";"541.48";"2";"6.17";"BDBM215258";"CC[C@@H](Cn1ccccc1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"378640";"UO_0000065";"14.26";"0.29";"1.55";"9.70";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114226";"";"None";"532.46";"2";"6.26";"BDBM215289";"CC(C)(C)OC(=O)[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"378658";"UO_0000065";"15.44";"0.31";"1.96";"9.80";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108086";"";"None";"476.40";"1";"5.30";"BDBM215291";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CO)C2CC2)C1=O";"IC50";"'='";"1.0";"nM";"9.00";"";"378660";"UO_0000065";"18.89";"0.38";"3.70";"11.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111967";"";"None";"593.57";"2";"5.78";"BDBM215294";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)C2CC2)C2CC2)C1=O";"IC50";"'<'";"1.0";"nM";"";"";"378662";"UO_0000065";"";"";"";"";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112490";"";"None";"581.56";"2";"5.64";"BDBM215295";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)CC)C2CC2)C1=O";"IC50";"'<'";"1.0";"nM";"";"";"378663";"UO_0000065";"";"";"";"";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108117";"";"None";"581.56";"2";"5.64";"BDBM215298";"CC(C)S(=O)(=O)NC[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378667";"UO_0000065";"14.96";"0.31";"3.06";"8.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3983226";"";"None";"492.44";"1";"5.94";"BDBM215300";"CC(C)[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378669";"UO_0000065";"18.28";"0.37";"3.06";"11.56";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110001";"";"None";"670.08";"2";"7.35";"BDBM215305";"CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)c1ccc(Cl)s1";"IC50";"'='";"0.5";"nM";"9.30";"";"378674";"UO_0000065";"13.88";"0.30";"1.95";"9.79";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111346";"";"None";"661.62";"2";"7.31";"BDBM215315";"CCS(=O)(=O)N(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)c1cccc(F)c1";"IC50";"'='";"0.2";"nM";"9.70";"";"378684";"UO_0000065";"14.66";"0.30";"2.39";"10.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125710";"";"None";"541.50";"1";"4.86";"BDBM50448943";"CC[C@@H](CNS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378455";"UO_0000065";"14.77";"0.31";"3.14";"7.71";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125705";"";"None";"520.50";"2";"6.86";"BDBM50448952";"CC[C@@H](CCC(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378462";"UO_0000065";"15.37";"0.31";"1.14";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962770";"";"None";"581.56";"2";"5.73";"BDBM215186";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'<'";"10.0";"nM";"";"";"378467";"UO_0000065";"";"";"";"";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961625";"";"None";"623.52";"2";"6.13";"BDBM215192";"CC[C@@H](CN(CC(F)(F)F)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378473";"UO_0000065";"12.83";"0.27";"1.87";"8.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115408";"";"None";"567.54";"2";"5.35";"BDBM215193";"CCC(CN1CCCS1(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'<'";"10.0";"nM";"";"";"378474";"UO_0000065";"";"";"";"";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3959723";"";"None";"515.44";"2";"6.98";"BDBM215268";"CC[C@@H](c1cc(C)no1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378510";"UO_0000065";"14.35";"0.29";"0.42";"8.84";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110711";"";"None";"547.43";"2";"7.32";"BDBM215284";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](CC(F)F)c2ccccn2)C1=O";"IC50";"'='";"40.0";"nM";"7.40";"";"378523";"UO_0000065";"13.51";"0.27";"0.08";"10.49";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114226";"";"None";"532.46";"2";"6.26";"BDBM215289";"CC(C)(C)OC(=O)[C@H](C1CC1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378526";"UO_0000065";"14.13";"0.29";"1.26";"8.97";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895600";"";"None";"600.59";"2";"5.86";"BDBM215147";"CC[C@@H](CN1CCN(C(=O)C2CC2)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378550";"UO_0000065";"13.98";"0.28";"2.54";"10.35";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3896895";"";"None";"651.70";"2";"5.33";"BDBM215213";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)NCCN(C)C)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"106.0";"nM";"6.97";"";"378594";"UO_0000065";"10.70";"0.22";"1.64";"7.75";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3893802";"";"None";"581.56";"2";"5.73";"BDBM215187";"CC[C@@H](CN(C1CC1)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378570";"UO_0000065";"15.48";"0.32";"3.27";"9.47";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5189775";"";"None";"801.85";"2";"6.06";"21";"CCC[C@H]1N(C(=O)c2c(C(F)(F)F)ccnc2OCCN(C)C)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"9.98";"0.20";"1.94";"7.41";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL3805372";"";"None";"756.77";"2";"7.00";"26";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCCC(=O)O)CC1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"10.78";"0.21";"1.15";"7.25";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL3139619";"";"None";"636.59";"2";"5.53";"1";"COc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.77";"0.19";"0.69";"8.27";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"INHIBITOR"
"CHEMBL3329611";"";"None";"523.46";"2";"7.08";"12";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](c2ccccn2)C2CC2)C1=O";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"16.62";"0.33";"1.62";"12.34";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL2059435";"";"None";"478.42";"1";"5.69";"1, AM-8553";"CC[C@@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"18.81";"0.38";"3.31";"11.56";"0";"CHEMBL3363505";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL4110424";"";"None";"554.54";"1";"4.60";"BDBM215204";"CCC(CN(C)S(C)(=O)=O)N1C(=O)[C@@](C)(CC(N)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"378484";"UO_0000065";"12.62";"0.27";"2.40";"6.95";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3948246";"";"None";"597.56";"2";"5.11";"BDBM215243";"CC[C@@H](CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@](CC(=O)O)(OC)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378626";"UO_0000065";"15.06";"0.32";"3.89";"8.64";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111092";"";"None";"569.53";"2";"7.31";"BDBM215281";"CC[C@H](c1cccc(C(C)(C)O)n1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378652";"UO_0000065";"14.96";"0.30";"1.21";"9.39";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111149";"";"None";"630.59";"2";"6.17";"BDBM215320";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(c2cccnc2)S(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378689";"UO_0000065";"15.38";"0.32";"3.53";"8.99";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106749";"";"None";"552.52";"2";"5.74";"BDBM215373";"CCS(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378753";"UO_0000065";"18.10";"0.38";"4.26";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125521";"";"None";"593.57";"2";"5.74";"BDBM50448945";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCCC2)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"378785";"UO_0000065";"16.85";"0.35";"4.26";"10.53";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941159";"";"None";"569.55";"2";"5.92";"BDBM215413";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cncc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.5";"nM";"8.82";"";"378802";"UO_0000065";"15.49";"0.33";"2.90";"8.43";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107290";"";"None";"458.39";"1";"5.22";"BDBM215135";"CC(C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378414";"UO_0000065";"17.45";"0.35";"2.78";"10.70";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113463";"";"None";"476.40";"1";"5.71";"BDBM215156";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C2CCCOC2)C1=O";"IC50";"'='";"210.0";"nM";"6.68";"";"378435";"UO_0000065";"14.02";"0.29";"0.97";"9.99";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110280";"";"None";"486.44";"1";"6.72";"BDBM215164";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(C(C2CC2)C2CC2)C1=O";"IC50";"'<'";"10.0";"nM";"";"";"378443";"UO_0000065";"";"";"";"";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940102";"";"None";"534.48";"2";"5.04";"BDBM215170";"CC[C@@H](CN1CCOCC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1";"IC50";"'='";"50.0";"nM";"7.30";"";"378449";"UO_0000065";"13.66";"0.28";"2.26";"8.80";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3969208";"";"None";"520.50";"2";"6.72";"BDBM215194";"CCC([C@H](C)C(C)(C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378475";"UO_0000065";"14.21";"0.29";"0.68";"9.50";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109136";"";"None";"504.45";"2";"6.08";"BDBM215292";"CC[C@@H](O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"378529";"UO_0000065";"14.32";"0.29";"1.14";"9.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125517";"";"None";"593.57";"2";"5.73";"BDBM50448969";"CN(C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)S(=O)(=O)C1CC1";"IC50";"'<'";"10.0";"nM";"";"";"378530";"UO_0000065";"";"";"";"";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926383";"";"None";"506.43";"2";"5.87";"BDBM215114";"CCOC(=O)[C@H](CC)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378539";"UO_0000065";"16.83";"0.34";"2.65";"10.16";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329620";"";"None";"434.36";"1";"5.94";"BDBM215122";"CC(C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"378543";"UO_0000065";"18.93";"0.39";"2.28";"14.27";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3960530";"";"None";"478.42";"1";"5.69";"BDBM215199";"CC[C@H]([C@H](C)O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"378583";"UO_0000065";"16.64";"0.34";"2.27";"10.22";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125703";"";"None";"492.44";"1";"6.08";"BDBM50448954";"CC[C@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(C)O";"IC50";"'='";"2.0";"nM";"8.70";"";"378584";"UO_0000065";"17.67";"0.36";"2.62";"11.18";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3899788";"";"None";"518.44";"2";"6.02";"BDBM215263";"CC[C@@H](C1CCC(=O)O1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"4.0";"nM";"8.40";"";"378644";"UO_0000065";"16.20";"0.33";"2.38";"10.01";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108590";"";"None";"554.54";"2";"5.99";"BDBM215383";"CC(C)(C)[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378767";"UO_0000065";"17.49";"0.37";"3.71";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112965";"";"None";"594.60";"2";"6.91";"BDBM215385";"CCC(CC)S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378770";"UO_0000065";"16.82";"0.35";"3.09";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3955553";"";"None";"573.48";"2";"7.29";"BDBM236281";"COc1ccc(-c2nnn[nH]2)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.188";"nM";"9.73";"";"411666";"UO_0000065";"16.96";"0.33";"2.44";"10.94";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895665";"";"None";"608.52";"2";"6.76";"BDBM236284";"COc1ccc(C(=O)NOCCO)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.125";"nM";"9.90";"";"411669";"UO_0000065";"16.27";"0.32";"3.14";"10.65";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3894270";"";"None";"516.96";"2";"5.53";"BDBM236286";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.556";"nM";"9.26";"";"411671";"UO_0000065";"17.90";"0.34";"3.72";"8.41";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3954342";"";"None";"567.48";"2";"5.36";"BDBM236299";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.137";"nM";"9.86";"";"411684";"UO_0000065";"17.38";"0.35";"4.50";"11.54";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3954470";"";"None";"507.42";"2";"6.90";"BDBM236263";"COc1ncncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.308";"nM";"9.51";"";"411648";"UO_0000065";"18.74";"0.37";"2.61";"15.79";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3945261";"";"None";"522.44";"2";"6.48";"BDBM236272";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.263";"nM";"9.58";"";"411657";"UO_0000065";"18.34";"0.36";"3.10";"11.10";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL2177812";"";"None";"446.37";"1";"5.94";"16";"O=C(O)CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"6630.0";"nM";"5.18";"";"";"UO_0000065";"11.60";"0.24";"-0.76";"8.99";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177112";"";"None";"414.38";"1";"6.65";"15";"C=CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177197";"";"None";"410.34";"1";"6.64";"8";"O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1Cc1ccccc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177195";"";"None";"376.33";"1";"6.10";"6";"CC(C)CN1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177192";"";"None";"374.31";"1";"5.85";"4";"O=C1CC[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N1CC1CC1";"IC50";"'>'";"30000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2182643";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutlin-3a";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"17.8";"nM";"7.75";"";"";"UO_0000065";"13.33";"0.26";"1.86";"9.28";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177189";"";"None";"558.51";"2";"5.93";"26";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(Cc2nnn[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.9";"nM";"9.05";"";"";"UO_0000065";"16.20";"0.33";"3.12";"8.95";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177184";"";"None";"413.35";"1";"5.99";"20";"N#CC[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"2340.0";"nM";"5.63";"";"";"UO_0000065";"13.62";"0.27";"-0.36";"12.77";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177203";"";"None";"432.35";"1";"5.55";"14";"O=C(O)C[C@@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"76.0";"nM";"7.12";"";"";"UO_0000065";"16.47";"0.34";"1.57";"12.36";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177199";"";"None";"434.36";"1";"5.78";"10";"CCOC(=O)[C@@H](CC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3500.0";"nM";"5.46";"";"";"UO_0000065";"12.56";"0.26";"-0.32";"11.71";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177198";"";"None";"434.36";"1";"5.78";"9";"CCOC(=O)[C@H](CC)N1C(=O)CC[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"940.0";"nM";"6.03";"";"";"UO_0000065";"13.88";"0.28";"0.25";"12.93";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL2177813";"";"None";"432.35";"1";"5.55";"2";"O=C(O)C[C@H]1C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(CC2CC2)C1=O";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"17.27";"0.35";"1.92";"12.96";"0";"CHEMBL2182642";"Inhibition of human MDM2-p53 interaction after 18 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL2176930";"1";"Scientific Literature";"J Med Chem";"2012";"None";"";""
"CHEMBL3894269";"";"None";"520.45";"2";"6.26";"BDBM215051";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"200.0";"nM";"6.70";"";"378330";"UO_0000065";"12.87";"0.26";"0.44";"7.98";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106846";"";"None";"506.43";"2";"5.87";"BDBM215054";"CCC[C@@H](C(=O)OCC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"270.0";"nM";"6.57";"";"378333";"UO_0000065";"12.97";"0.26";"0.70";"7.83";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895079";"";"None";"522.47";"2";"5.71";"BDBM215067";"CC[C@@H](COCC(C)(C)O)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"378346";"UO_0000065";"13.32";"0.27";"1.25";"7.99";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926383";"";"None";"506.43";"2";"5.87";"BDBM215114";"CCOC(=O)[C@H](CC)N1C(=O)[C@@](C)(CC(=O)O)CC(c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378393";"UO_0000065";"15.20";"0.31";"1.83";"9.18";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108531";"";"None";"517.45";"2";"6.27";"BDBM215130";"CCC(CC)N1C(=O)[C@@](C)(CC2OC(=O)NC2=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"490.0";"nM";"6.31";"";"378409";"UO_0000065";"12.19";"0.25";"0.04";"8.33";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112284";"";"None";"518.51";"2";"6.63";"BDBM215133";"CCC(CC)N1C(=O)[C@@](C)(Cc2nsc(=O)[nH]2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"378412";"UO_0000065";"11.10";"0.23";"-0.88";"8.71";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926751";"";"None";"561.51";"2";"6.54";"BDBM215149";"CC[C@@H](CN1CC(C)(C)OC1=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378428";"UO_0000065";"13.71";"0.28";"1.16";"8.83";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107660";"";"None";"533.50";"2";"6.22";"BDBM215150";"CC[C@@H](C(=O)NC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378429";"UO_0000065";"14.43";"0.29";"1.48";"8.88";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3926199";"";"None";"557.44";"2";"6.56";"BDBM215153";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H]2CCCN(CC(F)(F)F)C2)C1=O";"IC50";"'='";"40.0";"nM";"7.40";"";"378432";"UO_0000065";"13.27";"0.27";"0.84";"12.16";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107967";"";"None";"470.36";"1";"5.53";"BDBM215159";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccncn2)C1=O";"IC50";"'='";"340.0";"nM";"6.47";"";"378438";"UO_0000065";"13.75";"0.28";"0.94";"7.76";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111242";"";"None";"456.39";"1";"5.11";"BDBM215166";"CC(C)N1[C@H](c2ccc(Cl)cc2)[C@@H](c2cccc(Cl)c2)C[C@H](CC(=O)O)S1(=O)=O";"IC50";"'='";"710.0";"nM";"6.15";"";"378445";"UO_0000065";"13.47";"0.29";"1.04";"8.23";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL1771725";"";"None";"622.32";"2";"6.62";"21, Racemic mixture";"O=C(O)CCCN1C2=C(C(c3ccc(Br)cc3)Oc3ccccc32)C(c2ccc(Br)cc2)n2ncnc21";"IC50";"'='";"650.0";"nM";"6.19";"";"";"UO_0000065";"9.94";"0.23";"-0.43";"7.69";"0";"CHEMBL1772463";"Inhibition of human GST-fused HDM2-p53 protein-protein interaction by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL1770142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"None";"";""
"CHEMBL3134181";"";"None";"472.54";"1";"5.31";"48";"COc1ccc(CCC(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"449200.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3219399";"";"None";"426.30";"1";"5.56";"95a";"O=C(O)[C@H]1c2ccccc2C(=O)N(Cc2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'>'";"60000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3222408";"Inhibition of Mdm2-p53 interaction in human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL3134179";"";"None";"456.54";"1";"5.69";"46";"CCOc1ccccc1-c1cc(-c2cc(CCC(=O)O)ccc2OC)nn1Cc1ccccc1";"IC50";"'='";"388100.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134169";"";"None";"428.49";"1";"5.37";"36";"CCOc1ccccc1-c1cc(-c2cc(C(=O)O)ccc2OC)nn1Cc1ccccc1";"IC50";"'='";"238000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134197";"";"None";"460.96";"1";"6.14";"12";"COc1ccc(CCC(=O)O)cc1-c1cc(-c2ccc(Cl)cc2)n(CCc2ccccc2)n1";"IC50";"'='";"38870.0";"nM";"4.41";"";"";"UO_0000065";"9.57";"0.18";"-1.73";"6.85";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3604663";"";"None";"573.11";"2";"7.98";"7";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccc(F)cc3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"12.08";"0.23";"-1.06";"16.47";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3220690";"";"None";"398.29";"1";"5.48";"22";"COc1cccc(C2(Cc3cccc(Cl)c3)C(=O)Nc3cc(Cl)ccc32)c1";"IC50";"'='";"460.0";"nM";"6.34";"";"";"UO_0000065";"15.91";"0.32";"0.86";"16.53";"0";"CHEMBL3223361";"Inhibition of p53 interaction to MDM2 (unknown origin)";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217437";"1";"Scientific Literature";"Medchemcomm";"2011";"None";"";""
"CHEMBL3139619";"";"None";"636.59";"2";"5.53";"1";"COc1ccccc1N1CCN(C(=O)C2(Oc3ccc(C(F)(F)F)cc3)CCCN(C(=O)c3cnccc3C(F)(F)F)C2)CC1";"IC50";"'='";"600.0";"nM";"6.22";"";"";"UO_0000065";"9.77";"0.19";"0.69";"8.27";"0";"CHEMBL3807696";"Inhibition of human recombinant His-tagged MDM2 (1 to 118 residues) interaction with FAM-tagged p53-based peptide (unknown origin) incubated for 15 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3804796";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";""
"CHEMBL3329610";"";"None";"525.48";"2";"7.32";"11";"CC(C)[C@@H](c1ccccn1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"14.47";"0.29";"0.28";"10.78";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL3134173";"";"None";"458.51";"1";"5.38";"40";"CCOc1ccc(C(=O)O)cc1-c1cc(-c2cccc(OC)c2OC)n(Cc2ccccc2)n1";"IC50";"'='";"294500.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134170";"";"None";"567.09";"2";"7.72";"37";"CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OCc2cccc(Cl)c2)nn1CCc1ccccc1";"IC50";"'='";"248800.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3134198";"";"None";"555.05";"2";"7.85";"13";"O=C(O)CCc1ccc(OCc2cccc(Cl)c2)c(-c2cc(-c3ccc(F)cc3)n(CCc3ccccc3)n2)c1";"IC50";"'='";"47830.0";"nM";"4.32";"";"";"UO_0000065";"7.78";"0.15";"-3.53";"6.71";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL3601322";"";"None";"604.24";"2";"7.76";"8";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)[C@H]2c1ccc(Cl)cc1";"IC50";"'='";"1.9";"nM";"8.72";"";"";"UO_0000065";"14.43";"0.28";"0.96";"19.27";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601316";"";"None";"556.11";"2";"7.24";"9";"CC[C@@H](C)Oc1cc2c(cc1OC)CC(=O)N(c1ccc(N(C)Cc3ccncc3)cc1)C2c1ccc(Cl)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"14.56";"0.28";"0.86";"14.75";"0";"CHEMBL3607773";"Inhibition of p53-MDM2 interaction (unknown origin) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3603835";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";""
"CHEMBL3927572";"";"None";"560.49";"2";"8.08";"BDBM238910";"COc1ccc(C#N)cc1-c1nc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C(=O)N2";"IC50";"'='";"414.0";"nM";"6.38";"";"417042";"UO_0000065";"11.39";"0.22";"-1.70";"7.67";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940097";"";"None";"515.98";"2";"6.95";"BDBM238912";"COc1ccccc1-c1nc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C(=O)N2";"IC50";"'='";"473.0";"nM";"6.33";"";"417044";"UO_0000065";"12.26";"0.23";"-0.62";"7.60";"0";"CHEMBL3888807";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2). The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations, both MDM2 and MDM4 are biotinylated at the C-terminal of the peptide construct), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation, the Cy5 dye is directly bound to the N-terminal part of p53 peptide construct) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886839";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3969153";"";"None";"558.40";"2";"5.43";"BDBM236449";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)c(F)c2)N(c2cc(Cl)c[nH]c2=O)C3=O)c(OC)n1";"IC50";"'='";"0.201";"nM";"9.70";"";"411833";"UO_0000065";"17.37";"0.35";"4.27";"9.48";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106953";"";"None";"545.02";"2";"6.01";"BDBM236417";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"31.31";"nM";"7.50";"";"411801";"UO_0000065";"13.77";"0.26";"1.49";"8.60";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3918620";"";"None";"524.00";"2";"5.03";"BDBM236455";"COc1cn(C)c(=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1c(F)c(C)nn1C)C2=O";"IC50";"'='";"0.861";"nM";"9.06";"";"411839";"UO_0000065";"17.30";"0.33";"4.03";"12.20";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3310187";"";"None";"583.47";"2";"6.53";"22";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C#N)cc2F)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.98";"0.28";"1.62";"8.67";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL4108586";"";"None";"518.36";"2";"5.84";"BDBM215068";"CC[C@@H](C(O)C(F)(F)F)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"378348";"UO_0000065";"13.80";"0.29";"1.31";"9.19";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107158";"";"None";"654.62";"2";"7.33";"BDBM215319";"[C-]#[N+]c1cccc(N(C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)S(C)(=O)=O)c1";"IC50";"'='";"0.3";"nM";"9.52";"";"378688";"UO_0000065";"14.55";"0.30";"2.19";"9.59";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115516";"";"None";"629.61";"2";"6.43";"BDBM215323";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)Cc2ccccc2)C2CC2)C1=O";"IC50";"'='";"0.8";"nM";"9.10";"";"378692";"UO_0000065";"14.45";"0.30";"2.67";"8.77";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110271";"";"None";"630.59";"2";"6.17";"BDBM215326";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CN(c2ccccn2)S(C)(=O)=O)C2CC2)C1=O";"IC50";"'='";"13.5";"nM";"7.87";"";"378695";"UO_0000065";"12.48";"0.26";"1.70";"7.29";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3982594";"";"None";"635.01";"2";"7.44";"BDBM215350";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(Cl)cc2)C2CC2)C1=O";"IC50";"'='";"2.9";"nM";"8.54";"";"378722";"UO_0000065";"13.44";"0.28";"1.10";"9.31";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3950450";"";"None";"618.55";"2";"6.92";"BDBM215351";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(F)cc2)C2CC2)C1=O";"IC50";"'='";"2.4";"nM";"8.62";"";"378723";"UO_0000065";"13.94";"0.29";"1.70";"9.39";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5188441";"";"None";"714.73";"2";"6.12";"10";"CCC[C@H]1N(C(=O)c2cccnc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"117.0";"nM";"6.93";"";"";"UO_0000065";"9.70";"0.19";"0.81";"7.26";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5204077";"";"None";"700.70";"2";"6.47";"25";"CCC[C@H]1N(C(=O)c2c(C(F)(F)F)ccnc2O)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OC)CC1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"10.70";"0.21";"1.02";"7.85";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL3220312";"";"None";"518.90";"1";"2.51";"RO-5963";"Cc1c(Cl)ccc2c(/C=C3\NC(=O)N(C(C(=O)NC(CO)CO)c4ccc(F)c(F)c4)C3=O)c[nH]c12";"IC50";"'='";"17.3";"nM";"7.76";"";"";"UO_0000065";"14.96";"0.29";"5.25";"5.76";"0";"CHEMBL5164646";"Inhibition of GST-tagged MDM2/Biotin-tagged p53 interaction (unknown origin) incubated for 40 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL2177190";"";"None";"462.42";"1";"6.72";"22";"CCC(CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"55.0";"nM";"7.26";"";"";"UO_0000065";"15.70";"0.32";"0.54";"12.60";"0";"CHEMBL3363506";"Inhibition of human MDM2 (1-188 aa) -p53 (1-83 aa) interaction expressed in Escherichia coli after 18 hrs by HTRF assay in presence of 15% human serum";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3351557";"1";"Scientific Literature";"ACS Med Chem Lett";"2014";"None";"";""
"CHEMBL4206333";"";"None";"545.48";"2";"6.13";"(-)-4b'";"CC(C)(C)CC1C=C(C(=O)NC2CC(C)(O)C2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"3032.5";"nM";"5.52";"";"";"UO_0000065";"10.12";"0.20";"-0.61";"7.04";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4779757";"";"None";"672.54";"2";"6.98";"Ib-173";"CCOc1cccc(CN2[C@H]3CCn4c(nc5cc(C(=O)O)ccc54)[C@H]3[C@H](c3cccc(Cl)c3F)[C@]23C(=O)Nc2nc(Cl)ccc23)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"12.13";"0.24";"1.17";"7.44";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL5181526";"";"None";"731.73";"2";"6.87";"13";"CCC[C@H]1N(C(=O)c2cc(F)ccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"10.21";"0.20";"0.60";"9.05";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5184149";"";"None";"728.76";"2";"6.31";"16";"CCC[C@H]1N(C(=O)c2c(N)cccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"6800.0";"nM";"5.17";"";"";"UO_0000065";"7.09";"0.14";"-1.14";"4.76";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL4742864";"";"None";"578.43";"2";"5.40";"Ia-43";"O=C(O)c1ccc2c3n(nc2c1)[C@@H]1[C@H](C3)N(CC2CC2)[C@@]2(C(=O)Nc3nc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.04";"0.30";"3.30";"8.67";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL5177933";"";"None";"770.79";"2";"6.69";"7";"C=CCOc1nccc(C(F)(F)F)c1C(=O)N1CCC[C@@](Oc2csc(C(F)(F)F)c2)(C(=O)N2CCN(c3ccccc3OCCO)CC2)[C@H]1CCC";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"9.80";"0.19";"0.86";"7.22";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL3125535";"";"None";"582.59";"2";"6.77";"33";"CC(C)[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"378741";"UO_0000065";"15.83";"0.33";"2.45";"10.05";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3905634";"";"None";"580.57";"2";"6.67";"BDBM215371";"CC[C@@H](CS(=O)(=O)C1CCC1)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.3";"nM";"9.52";"";"378751";"UO_0000065";"16.40";"0.34";"2.85";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3929489";"";"None";"636.54";"2";"7.06";"BDBM215378";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)c2ccc(F)cc2F)C2CC2)C1=O";"IC50";"'='";"0.9";"nM";"9.05";"";"378760";"UO_0000065";"14.21";"0.29";"1.99";"9.86";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3896849";"";"None";"600.54";"2";"5.98";"BDBM215398";"CN1C(=O)N(C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)C(=O)C1(C)C";"IC50";"'='";"1.8";"nM";"8.74";"";"378789";"UO_0000065";"14.56";"0.29";"2.76";"8.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3971528";"";"None";"586.52";"2";"5.64";"BDBM215399";"CC1(C)NC(=O)N(C[C@H](C2CC2)N2C(=O)[C@@](C)(CC(=O)O)C[C@H](c3cccc(Cl)c3)[C@H]2c2ccc(Cl)cc2)C1=O";"IC50";"'='";"7.0";"nM";"8.15";"";"378790";"UO_0000065";"13.90";"0.28";"2.51";"7.62";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4759500";"";"None";"436.25";"0";"3.02";"Rac-5j";"O=C(O)C[C@@H]1N[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@@H](c2cccc(Cl)c2)[C@@H]1[N+](=O)[O-]";"IC50";"'='";"18600.0";"nM";"4.73";"";"";"UO_0000065";"10.84";"0.22";"1.71";"3.89";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4791190";"";"None";"673.62";"2";"6.87";"Ic-35";"Cc1c(C(=O)N2CCCCC2)ccn2c3c(nc12)[C@@H]1[C@H](CC3)N(CC2CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1ccnc(Cl)c1F";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"11.88";"0.23";"1.13";"9.66";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4746561";"";"None";"692.62";"2";"6.09";"Ib-219";"COCCOCCNC(=O)c1ccc2c(c1)nc1n2CC[C@H]2[C@@H]1[C@H](c1cccc(Cl)c1F)[C@]1(C(=O)Nc3cc(Cl)ccc31)N2CC1CC1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"11.98";"0.24";"2.21";"8.49";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3134205";"";"None";"484.60";"1";"6.27";"21";"CCCOc1ccc(CC(=O)O)cc1-c1cc(-c2ccccc2OCC)n(CCc2ccccc2)n1";"IC50";"'='";"71980.0";"nM";"4.14";"";"";"UO_0000065";"8.55";"0.16";"-2.13";"5.63";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL2313487";"";"None";"502.59";"2";"5.49";"RS-3594";"COc1cc(Cc2c(-c3ccn(S(=O)(=O)c4ccccc4)c3)[nH]c3ccccc23)cc(OC)c1OC";"IC50";"'='";"10.6";"nM";"7.97";"";"";"UO_0000065";"15.87";"0.30";"2.48";"9.66";"0";"CHEMBL5164645";"Inhibition of MDM2/p53 interaction in human U-87 MG cells using TMB as substrate incubated for 10 mins by quantitative immuno-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.1667 hr";"INHIBITOR"
"CHEMBL5070566";"";"None";"537.59";"2";"6.98";"23";"CC(C)c1cccc(-c2nc3nc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(C(F)(F)F)cc2)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"14.55";"0.27";"0.84";"8.42";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5093756";"";"None";"544.60";"2";"6.44";"31";"CC(C)c1ccnc(-c2nc3nc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(C(F)(F)F)s2)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"13.90";"0.27";"1.13";"7.15";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5090236";"";"None";"490.65";"1";"6.14";"32";"CC(C)c1ccnc(-c2nc3nc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2C[C@H]2CC[C@@H](C)CC2)c1";"IC50";"'='";"348.0";"nM";"6.46";"";"";"UO_0000065";"13.16";"0.25";"0.32";"6.10";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5076169";"";"None";"532.69";"2";"5.53";"15";"C[C@@H](Nc1nc(C(=O)O)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"0.2";"nM";"9.70";"";"";"UO_0000065";"18.21";"0.34";"4.17";"9.20";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3649993";"";"None";"497.00";"1";"5.07";"60";"COCC(C)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"16.19";"0.31";"2.98";"7.20";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5076169";"";"None";"532.69";"2";"5.53";"15";"C[C@@H](Nc1nc(C(=O)O)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"1100.0";"nM";"5.96";"";"";"UO_0000065";"11.19";"0.21";"0.43";"5.65";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL3647046";"";"None";"586.10";"2";"5.89";"42";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"0.61";"nM";"9.21";"";"";"UO_0000065";"15.72";"0.30";"3.32";"8.02";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3649967";"";"None";"523.04";"2";"5.80";"61";"CCOC(c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1)C1CC1";"IC50";"'='";"1.2";"nM";"8.92";"";"";"UO_0000065";"17.06";"0.33";"3.12";"7.98";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5084175";"";"None";"504.02";"2";"6.32";"2";"C[C@@H](Nc1nc(C(=O)O)nc2nc(-c3ccc4sccc4c3)n(Cc3ccc(Cl)cc3)c12)C1CC1";"IC50";"'='";"260.0";"nM";"6.58";"";"";"UO_0000065";"13.07";"0.26";"0.27";"7.09";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5083548";"";"None";"585.76";"1";"4.92";"37";"C[C@@H](Nc1nc(-c2nc(=O)n(C)[nH]2)nc2nc(N3CCOC[C@H]3c3ccccc3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1";"IC50";"'='";"203.0";"nM";"6.69";"";"";"UO_0000065";"11.43";"0.21";"1.77";"5.63";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL3754362";"";"None";"1810.80";"None";"None";"8";"CC(C)CCN(CC(=O)N(CCS(N)(=O)=O)CC(=O)N(CC(N)=O)Cc1ccc([N+](=O)[O-])cc1)C(=O)CN(CCCP(=O)(O)O)C(=O)CN(Cc1ccc([N+](=O)[O-])cc1)C(=O)CN(CCc1c[nH]c2ccccc12)C(=O)CN(CCCCP(=O)(O)O)C(=O)CN(Cc1ccc([N+](=O)[O-])cc1)C(=O)CN(CCc1ccccc1)C(=O)CNCc1ccc([N+](=O)[O-])cc1";"IC50";"'='";"6600.0";"nM";"5.18";"";"";"UO_0000065";"2.86";"None";"None";"None";"0";"CHEMBL3754930";"Inhibition of p53-HDM2 (unknown origin) interaction";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3751840";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3601399";"";"None";"591.20";"2";"6.77";"13";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)nc1)C(=O)C2";"IC50";"'='";"1.6";"nM";"8.80";"";"";"UO_0000065";"14.88";"0.29";"2.03";"15.13";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601323";"";"None";"590.21";"2";"7.37";"9";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N(C)C)CC3)cc1)C(=O)C2";"IC50";"'='";"1.1";"nM";"8.96";"";"";"UO_0000065";"15.18";"0.29";"1.59";"19.80";"0";"CHEMBL3602283";"Inhibition of MDM2/p53 interaction (unknown origin) using biotinylated MDM2 and Cy5-p53 (18 to 26 amino acids) by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3601398";"CGM-097";"1.0";"659.27";"2";"6.58";"1, NVP-CGM097";"COc1cc2c(cc1OC(C)C)[C@H](c1ccc(Cl)cc1)N(c1ccc(N(C)C[C@H]3CC[C@H](N4CCN(C)C(=O)C4)CC3)cc1)C(=O)C2";"IC50";"'='";"224.0";"nM";"6.65";"";"";"UO_0000065";"10.09";"0.19";"0.07";"10.14";"0";"CHEMBL3603534";"Inhibition of MDM2/p53 interaction (unknown origin) assessed as p53 nuclear translocation by GRIP p53 translocation assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3600357";"1";"Scientific Literature";"J Med Chem";"2015";"None";"";""
"CHEMBL3917376";"";"None";"536.46";"2";"6.94";"BDBM236273";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c(OC)n1";"IC50";"'='";"0.195";"nM";"9.71";"";"411658";"UO_0000065";"18.10";"0.36";"2.77";"13.43";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3310322";"";"None";"601.48";"2";"5.76";"26";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(N)=O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.67";"0.27";"2.46";"7.26";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310187";"";"None";"583.47";"2";"6.53";"22";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C#N)cc2F)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"13.98";"0.28";"1.62";"8.67";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310322";"";"None";"601.48";"2";"5.76";"26";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(N)=O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)c(F)cc12";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.67";"0.27";"2.46";"7.26";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310186";"";"None";"613.52";"2";"5.63";"21";"COc1cc(NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2cccc(Cl)c2F)ccc1C(N)=O";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.53";"0.27";"2.67";"6.77";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL5169352";"";"None";"646.73";"2";"5.10";"9";"CCC[C@H]1N(C(=O)c2cccnc2)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"1771.0";"nM";"5.75";"";"";"UO_0000065";"8.89";"0.17";"0.65";"6.03";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL3310185";"";"None";"583.49";"2";"5.62";"20";"CC(C)(C)C[C@@H]1N[C@@H](C(=O)Nc2ccc(C(N)=O)cc2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"14.23";"0.28";"2.68";"7.33";"0";"CHEMBL3364003";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.02% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310321";"";"None";"631.51";"2";"5.77";"25";"COc1cc(C(N)=O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)cc(F)c32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"13.02";"0.26";"2.45";"6.71";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3310320";"";"None";"630.54";"2";"5.90";"24";"COc1cc(OCCO)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"13.16";"0.26";"2.40";"7.62";"0";"CHEMBL3364002";"Inhibition of p53-MDM2 (unknown origin) interaction using 0.2% BSA buffer after 1 hr by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3352737";"1";"Scientific Literature";"Bioorg Med Chem";"2014";"None";"";""
"CHEMBL3134172";"";"None";"442.52";"1";"5.30";"39";"CCOc1ccccc1-c1cc(-c2cc(CC(=O)O)ccc2OC)nn1Cc1ccccc1";"IC50";"'='";"287600.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3136838";"Inhibition of 6His-tagged MDM2 (1 to 118) interaction to FITC-tagged p53 (17 to 26) (unknown origin) after 30 mins by fluorescence polarization assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3132806";"1";"Scientific Literature";"Medchemcomm";"2013";"None";"";""
"CHEMBL5090666";"";"None";"551.65";"2";"5.24";"38";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3nc(-c4noc(=O)[nH]4)nc(-c4ccccc4)c32)CC1";"IC50";"'='";"632.0";"nM";"6.20";"";"";"UO_0000065";"11.24";"0.21";"0.96";"5.39";"0";"CHEMBL5030010";"Inhibition of HDM2/p53 interaction in human HCT-116 cells expressing p53RE/Bla incubated for 16 hrs by beta-lactamase reporter gene assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HCT-116";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 16.0 hr";"INHIBITOR"
"CHEMBL3219400";"";"None";"483.40";"1";"5.24";"96a";"COCCNC(=O)[C@H]1c2ccccc2C(=O)N(Cc2ccc(Cl)cc2)[C@@H]1c1ccc(Cl)cc1";"IC50";"'='";"27100.0";"nM";"4.57";"";"";"UO_0000065";"9.45";"0.19";"-0.67";"7.79";"0";"CHEMBL3222408";"Inhibition of Mdm2-p53 interaction in human PA-1 cells";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"PA-1";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3217577";"1";"Scientific Literature";"Medchemcomm";"2012";"CHEMBL3308812";"";""
"CHEMBL5190920";"";"None";"593.56";"2";"7.31";"18";"COc1ccccc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)cc(OCCN(C)C)c1)C2=O";"IC50";"'='";"0.13";"nM";"9.89";"";"";"UO_0000065";"16.66";"0.33";"2.58";"16.52";"0";"CHEMBL5128505";"Inhibition of recombinant human MDM2/p53 interaction";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5126548";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL4750228";"";"None";"488.39";"0";"4.78";"Rac-11";"CC(=O)N1CC[C@H]2[C@@H]1[C@H](c1cccc(Cl)c1F)[C@]1(C(=O)Nc3cc(Cl)ccc31)N2CC1CC1";"IC50";"'='";"212.0";"nM";"6.67";"";"";"UO_0000065";"13.66";"0.28";"1.89";"12.68";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4750195";"";"None";"392.24";"0";"3.56";"Rac-5b";"C[C@@H]1N[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@@H](c2cccc(Cl)c2)[C@@H]1[N+](=O)[O-]";"IC50";"'='";"40000.0";"nM";"4.40";"";"";"UO_0000065";"11.21";"0.23";"0.84";"5.22";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL5174764";"";"None";"714.73";"2";"6.12";"11";"CCC[C@H]1N(C(=O)c2ccncc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"10.05";"0.20";"1.06";"7.52";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5183518";"";"None";"774.78";"2";"5.49";"20";"CCC[C@H]1N(C(=O)c2c(C(F)(F)F)ccnc2OCCO)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"103.0";"nM";"6.99";"";"";"UO_0000065";"9.02";"0.18";"1.50";"5.59";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5079727";"";"None";"586.10";"2";"5.89";"39";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3nc(-c4noc(=O)[nH]4)nc(-c4cccc(Cl)c4)c32)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"15.16";"0.29";"3.00";"7.73";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3691737";"";"None";"520.46";"2";"7.68";"7";"COc1ccccc1-n1nc2c(c1C(C)C)[C@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"13.23";"0.26";"-0.79";"14.54";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL4095983";"";"None";"523.63";"2";"5.30";"12";"O=C(CC(c1ccccc1)c1ccccc1)N[C@@H](Cc1ccc(OCCCNc2ccccn2)cc1)C(=O)O";"IC50";"'='";"7.85";"nM";"8.11";"";"";"UO_0000065";"15.48";"0.28";"2.81";"8.06";"0";"CHEMBL5164645";"Inhibition of MDM2/p53 interaction in human U-87 MG cells using TMB as substrate incubated for 10 mins by quantitative immuno-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.1667 hr";"INHIBITOR"
"CHEMBL3920354";"";"None";"511.02";"2";"5.23";"BDBM236352";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(C2CCOCC2)C3=O)c(OC)n1";"IC50";"'='";"10.2";"nM";"7.99";"";"411605";"UO_0000065";"15.64";"0.30";"2.76";"10.15";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3912203";"";"None";"536.07";"2";"5.61";"BDBM236311";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N([C@H]2CC[C@H](O)CC2)C3=O)c1";"IC50";"'='";"1.001";"nM";"9.00";"";"411695";"UO_0000065";"16.79";"0.32";"3.39";"10.74";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3967624";"";"None";"511.02";"2";"5.05";"BDBM236313";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N([C@H]2CC[C@H](O)CC2)C3=O)c(OC)n1";"IC50";"'='";"1.385";"nM";"8.86";"";"411697";"UO_0000065";"17.34";"0.34";"3.81";"9.87";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3942945";"";"None";"539.42";"1";"4.87";"BDBM236318";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)cn(C)c1=O)C2=O";"IC50";"'='";"0.635";"nM";"9.20";"";"411702";"UO_0000065";"17.05";"0.34";"4.33";"8.49";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3889539";"";"None";"562.50";"2";"7.14";"BDBM236327";"COc1ccc(CC(N)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.115";"nM";"9.94";"";"411711";"UO_0000065";"17.67";"0.35";"2.80";"12.81";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919093";"";"None";"590.55";"2";"7.74";"BDBM236329";"COc1ccc(CC(=O)N(C)C)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.152";"nM";"9.82";"";"411713";"UO_0000065";"16.63";"0.33";"2.08";"17.92";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3976189";"";"None";"548.43";"2";"6.47";"BDBM236345";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C#N)C3=O)c(OC)n1";"IC50";"'='";"0.316";"nM";"9.50";"";"411729";"UO_0000065";"17.32";"0.34";"3.03";"10.19";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3958779";"";"None";"544.02";"1";"4.55";"BDBM236380";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.327";"nM";"9.48";"";"411764";"UO_0000065";"17.44";"0.33";"4.94";"8.03";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3927773";"";"None";"515.96";"1";"4.08";"BDBM236381";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"1.252";"nM";"8.90";"";"411765";"UO_0000065";"17.25";"0.33";"4.82";"6.23";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961386";"";"None";"530.97";"1";"4.51";"BDBM236382";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(C#N)cc2)N(c2c[nH]c(=O)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"0.427";"nM";"9.37";"";"411766";"UO_0000065";"17.65";"0.34";"4.86";"7.43";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3978626";"";"None";"536.46";"2";"6.81";"BDBM236391";"COc1ccccc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1C)N(c1cc(Cl)c(=O)n(C)c1)C2=O";"IC50";"'='";"0.554";"nM";"9.26";"";"411775";"UO_0000065";"17.25";"0.34";"2.45";"16.39";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3961681";"";"None";"593.51";"2";"6.17";"BDBM236392";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c1";"IC50";"'='";"0.187";"nM";"9.73";"";"411776";"UO_0000065";"16.39";"0.32";"3.56";"11.37";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3941966";"";"None";"567.48";"2";"5.64";"BDBM236398";"CNc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"0.243";"nM";"9.61";"";"411782";"UO_0000065";"16.94";"0.34";"3.97";"10.20";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109562";"";"None";"568.46";"2";"5.61";"BDBM236408";"COc1ncc(-c2cc3c(n2C(C)C)[C@@H](c2ccc(Cl)cc2C)N(c2cc(Cl)c(=O)n(C)c2)C3=O)c(OC)n1";"IC50";"'='";"307.54";"nM";"6.51";"";"411792";"UO_0000065";"11.46";"0.23";"0.90";"7.12";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106757";"";"None";"544.02";"1";"4.56";"BDBM236415";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(C#N)cc1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"107.25";"nM";"6.97";"";"411799";"UO_0000065";"12.81";"0.24";"2.41";"5.80";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921044";"";"None";"516.96";"2";"5.53";"BDBM236418";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(C#N)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.699";"nM";"9.16";"";"411802";"UO_0000065";"17.71";"0.34";"3.63";"8.32";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975723";"";"None";"491.98";"0";"4.56";"BDBM236422";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(C)nn1C)C2=O";"IC50";"'='";"3.717";"nM";"8.43";"";"411806";"UO_0000065";"17.13";"0.33";"3.87";"8.10";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3921731";"";"None";"520.04";"2";"5.05";"BDBM236429";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)nc1C)C2=O";"IC50";"'='";"0.659";"nM";"9.18";"";"411813";"UO_0000065";"17.65";"0.34";"4.13";"11.29";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3896773";"";"None";"553.08";"2";"5.59";"BDBM236430";"COc1ccc(S(C)(=O)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cn(C)nc1C)C2=O";"IC50";"'='";"2.573";"nM";"8.59";"";"411814";"UO_0000065";"15.53";"0.31";"3.00";"9.94";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3928320";"";"None";"553.45";"2";"5.35";"BDBM236435";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@H](c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"0.079";"nM";"10.10";"";"411819";"UO_0000065";"18.25";"0.36";"4.75";"10.49";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108538";"";"None";"553.45";"2";"5.35";"BDBM236436";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)[C@@H](c1ccc(Cl)cc1)N(c1c[nH]c(=O)c(Cl)c1)C2=O";"IC50";"'='";"10.59";"nM";"7.97";"";"411820";"UO_0000065";"14.41";"0.29";"2.63";"8.28";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3939598";"";"None";"562.01";"1";"4.70";"BDBM236448";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.25";"nM";"9.60";"";"411832";"UO_0000065";"17.09";"0.33";"4.90";"7.99";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3966324";"";"None";"571.44";"2";"5.48";"BDBM236450";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)c(F)c1)N(c1cc(Cl)c[nH]c1=O)C2=O";"IC50";"'='";"0.119";"nM";"9.92";"";"411834";"UO_0000065";"17.37";"0.35";"4.44";"10.30";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3949888";"";"None";"558.04";"2";"5.28";"BDBM236454";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)cnc1OC)C2=O";"IC50";"'='";"0.185";"nM";"9.73";"";"411838";"UO_0000065";"17.44";"0.33";"4.45";"8.90";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3912023";"";"None";"542.40";"2";"6.13";"BDBM236461";"COc1ncc(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cn2)N(c2ccc(F)c(Cl)c2)C3=O)c(OC)n1";"IC50";"'='";"1.887";"nM";"8.72";"";"411845";"UO_0000065";"16.08";"0.32";"2.59";"10.59";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3905941";"";"None";"528.59";"1";"4.40";"BDBM236475";"COc1nc(N(C)C)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1c(F)c(C)nn1C)C2=O";"IC50";"'='";"0.224";"nM";"9.65";"";"411861";"UO_0000065";"18.26";"0.34";"5.25";"9.18";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919031";"";"None";"545.43";"2";"6.46";"BDBM215141";"CC[C@@H](CNCC(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"40.0";"nM";"7.40";"";"378420";"UO_0000065";"13.56";"0.28";"0.94";"10.62";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3972181";"";"None";"636.64";"2";"5.42";"BDBM215144";"CC[C@@H](CN1CCN(S(=O)(=O)C2CC2)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378423";"UO_0000065";"11.82";"0.24";"2.10";"7.66";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112305";"";"None";"535.47";"2";"6.05";"BDBM215173";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cn1";"IC50";"'='";"20.0";"nM";"7.70";"";"378452";"UO_0000065";"14.38";"0.29";"1.65";"7.95";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3968648";"";"None";"554.54";"2";"6.14";"BDBM215337";"CCCS(=O)(=O)C[C@H](CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.4";"nM";"9.40";"";"378706";"UO_0000065";"16.95";"0.36";"3.26";"10.24";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125702";"NAVTEMADLIN";"2.0";"568.56";"2";"6.38";"5; AMG-232";"CC(C)[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.6";"nM";"9.22";"";"";"UO_0000065";"16.22";"0.34";"2.84";"10.05";"0";"CHEMBL5164640";"Inhibition of human MDM2/p53 interaction by HTRF based biochemical assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL3647051";"";"None";"526.02";"2";"5.25";"57";"C[C@H]1CC[C@H](Cn2c(N3CCC[C@H]3CF)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"1.3";"nM";"8.89";"";"";"UO_0000065";"16.89";"0.33";"3.64";"8.40";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5191489";"";"None";"731.73";"2";"6.87";"14";"CCC[C@H]1N(C(=O)c2c(F)cccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"9.82";"0.20";"0.32";"8.71";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL3894034";"";"None";"523.03";"2";"5.94";"BDBM236312";"COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N([C@H]1CC[C@H](O)CC1)C2=O";"IC50";"'='";"12.3";"nM";"7.91";"";"411599";"UO_0000065";"15.12";"0.29";"1.97";"8.60";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3902132";"";"None";"654.62";"2";"6.88";"BDBM236283";"COc1ccc(C(=O)NCCS(C)(=O)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.115";"nM";"9.94";"";"411668";"UO_0000065";"15.18";"0.31";"3.06";"10.17";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980413";"";"None";"478.42";"1";"5.69";"BDBM215202";"CC[C@@H](CCO)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378482";"UO_0000065";"16.72";"0.34";"2.31";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3913666";"";"None";"523.50";"2";"7.89";"BDBM215260";"C=CC[C@@]1(C)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](CC)COc2cccnc2)C1=O";"IC50";"'='";"30.0";"nM";"7.52";"";"378504";"UO_0000065";"14.37";"0.29";"-0.37";"17.73";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109848";"";"None";"565.42";"2";"7.62";"BDBM215283";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H](CC(F)(F)F)c2ccccn2)C1=O";"IC50";"'='";"30.0";"nM";"7.52";"";"378522";"UO_0000065";"13.30";"0.27";"-0.10";"10.67";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3972181";"";"None";"636.64";"2";"5.42";"BDBM215144";"CC[C@@H](CN1CCN(S(=O)(=O)C2CC2)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"378547";"UO_0000065";"12.64";"0.26";"2.63";"8.19";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3942141";"";"None";"608.63";"2";"7.16";"BDBM215364";"CC[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)CCC(C)C)C2CC2)C1=O";"IC50";"'='";"0.3";"nM";"9.52";"";"378736";"UO_0000065";"15.65";"0.33";"2.36";"10.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3318766";"";"None";"607.60";"2";"6.13";"BDBM50053051";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CS(=O)(=O)N2CCCCC2)C2CC2)C1=O";"IC50";"'='";"0.6";"nM";"9.22";"";"378784";"UO_0000065";"15.18";"0.31";"3.09";"9.71";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3935799";"";"None";"544.47";"2";"5.49";"BDBM215407";"CC[C@@H](CS(C)(=O)=O)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.5";"nM";"9.30";"";"378796";"UO_0000065";"17.08";"0.36";"3.81";"10.14";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3932147";"";"None";"553.51";"2";"5.28";"BDBM215411";"CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cncc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"3.8";"nM";"8.42";"";"378801";"UO_0000065";"15.21";"0.32";"3.14";"8.05";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5186444";"";"None";"504.39";"2";"5.63";"2a";"CCOC(=O)C1=NN(C2CCCCC2)C2(C(=O)Nc3cc(Cl)ccc32)C1c1cccc(Cl)c1F";"IC50";"'='";"18.5";"nM";"7.73";"";"";"UO_0000065";"15.33";"0.31";"2.10";"10.89";"0";"CHEMBL5110382";"Inhibition of MDM2/p53 interaction in human U-87 MG cells preincubated for 10 mins under shaking condition and measured after 1.5 hrs by immuno-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5108018";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.667 hr";"INHIBITOR"
"CHEMBL4209483";"";"None";"559.51";"2";"6.52";"(-)-4c'";"CC(C)(C)CC1C=C(C(=O)NC2CCC(O)CC2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"3724.7";"nM";"5.43";"";"";"UO_0000065";"9.70";"0.20";"-1.09";"6.92";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL4206333";"";"None";"545.48";"2";"6.13";"(+)-4b'";"CC(C)(C)CC1C=C(C(=O)NC2CC(C)(O)C2)C(c2cccc(Cl)c2F)C12C(=O)Nc1cc(Cl)ccc12";"IC50";"'='";"712.2";"nM";"6.15";"";"";"UO_0000065";"11.27";"0.23";"0.02";"7.84";"0";"CHEMBL4201979";"Inhibition of human MDM2 (1 to 125 residues) and p53 (unknown origin) interaction pre-incubated for 20 mins before peptide-2-biot addition and measured after 3 hrs by HTRF assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4196214";"1";"Scientific Literature";"J Med Chem";"2018";"None";"";""
"CHEMBL5208707";"";"None";"609.47";"2";"6.33";"3f";"O=C(Nc1cccc(-n2cccn2)c1)C1=NN(c2ccc(Cl)cc2)C2(C(=O)Nc3cc(Cl)ccc32)C1c1cccc(O)c1";"IC50";"'='";"35.9";"nM";"7.45";"";"";"UO_0000065";"12.22";"0.24";"1.11";"6.66";"0";"CHEMBL5110382";"Inhibition of MDM2/p53 interaction in human U-87 MG cells preincubated for 10 mins under shaking condition and measured after 1.5 hrs by immuno-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5108018";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.667 hr";"INHIBITOR"
"CHEMBL4107560";"";"None";"595.54";"2";"5.26";"BDBM215220";"CC[C@@H](C(=O)N(C)S(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"53.0";"nM";"7.28";"";"378601";"UO_0000065";"12.22";"0.25";"2.02";"6.49";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3964874";"";"None";"587.47";"2";"5.92";"BDBM215255";"CC[C@@H](CN1CC(O)(C(F)(F)F)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"378637";"UO_0000065";"14.00";"0.29";"2.30";"10.14";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114935";"";"None";"504.45";"2";"6.49";"BDBM215261";"CC[C@@H](C1CCCO1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"378643";"UO_0000065";"17.84";"0.36";"2.51";"13.46";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3329607";"";"None";"511.45";"2";"7.08";"BDBM215277";"CC[C@@H](c1ccncc1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"378650";"UO_0000065";"15.73";"0.31";"0.97";"11.41";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3891817";"";"None";"504.45";"2";"6.35";"BDBM215062";"CC[C@@H](COCC1CC1)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"110.0";"nM";"6.96";"";"378341";"UO_0000065";"13.79";"0.28";"0.61";"10.41";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108586";"";"None";"518.36";"2";"5.84";"BDBM215068";"CC[C@@H](C(O)C(F)(F)F)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378347";"UO_0000065";"15.43";"0.32";"2.16";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5088712";"";"None";"580.61";"2";"5.77";"28";"C[C@@H](Nc1nc(C(=O)O)nc2nc(N3CCOC[C@@H]3c3ccccc3)n(Cc3ccc(C(F)(F)F)cc3)c12)C1CCC1";"IC50";"'='";"121.0";"nM";"6.92";"";"";"UO_0000065";"11.91";"0.22";"1.15";"6.56";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL4110925";"";"None";"501.45";"2";"7.18";"BDBM215129";"CCC(CC)N1C(=O)[C@@](C)(Cc2cc(O)no2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"378408";"UO_0000065";"14.15";"0.29";"-0.08";"10.66";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3980222";"";"None";"561.55";"2";"6.42";"BDBM215142";"CC[C@@H](CN1CCOC(C)(C)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378421";"UO_0000065";"14.25";"0.29";"1.58";"11.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3910104";"";"None";"561.55";"2";"6.42";"BDBM215143";"CC[C@@H](CN1CC(C)OC(C)C1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378422";"UO_0000065";"14.25";"0.29";"1.58";"11.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892703";"";"None";"546.41";"2";"6.62";"BDBM215188";"CC[C@@H](CC(O)C(F)(F)F)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378469";"UO_0000065";"13.77";"0.29";"0.90";"9.66";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3919602";"";"None";"448.39";"1";"6.33";"BDBM215095";"CCC(CC)N1C(=O)[C@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"270.0";"nM";"6.57";"";"378374";"UO_0000065";"14.65";"0.30";"0.24";"11.40";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4109575";"";"None";"569.51";"1";"4.47";"BDBM215102";"CCOC(=O)[C@H](CC)N1C(=O)[C@@H](CC(=O)NS(C)(=O)=O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"130.0";"nM";"6.89";"";"378381";"UO_0000065";"12.09";"0.25";"2.42";"6.27";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3962786";"";"None";"547.52";"2";"6.03";"BDBM215250";"CC[C@@H](CN1CCOCC1C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378494";"UO_0000065";"14.61";"0.30";"1.97";"11.42";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3977225";"";"None";"533.50";"2";"5.64";"BDBM215256";"CC[C@@H](CN(C)C1COC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378500";"UO_0000065";"14.10";"0.29";"1.88";"10.73";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3983607";"";"None";"568.56";"2";"6.52";"BDBM215343";"CC[C@@H](CS(=O)(=O)[C@H](C)CC)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378715";"UO_0000065";"17.59";"0.37";"3.48";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3972089";"";"None";"570.51";"2";"6.03";"BDBM215409";"CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378798";"UO_0000065";"17.00";"0.36";"3.67";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4776003";"";"None";"468.34";"0";"4.78";"Rac-5d";"O=C1Nc2cc(Cl)ccc2[C@]12N[C@@H](Cc1ccccc1)[C@@H]([N+](=O)[O-])[C@@H]2c1cccc(Cl)c1";"IC50";"'='";"15600.0";"nM";"4.81";"";"";"UO_0000065";"10.26";"0.21";"0.03";"5.70";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4783915";"";"None";"434.34";"0";"4.51";"6e";"C[C@H]1[C@@H](N)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)N1CC1CC1";"IC50";"'='";"157.0";"nM";"6.80";"";"";"UO_0000065";"15.67";"0.32";"2.29";"11.66";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4782226";"";"None";"568.48";"2";"6.03";"2";"C[C@H]1[C@@H](NCc2ccc(C(=O)O)cc2)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)N1CC1CC1";"IC50";"'='";"107.0";"nM";"6.97";"";"";"UO_0000065";"12.26";"0.24";"0.94";"8.54";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4756922";"";"None";"514.43";"2";"5.69";"6g";"CCOc1cccc(CN2[C@@H](C)[C@@H](N)[C@H](c3cccc(Cl)c3F)[C@]23C(=O)Nc2cc(Cl)ccc23)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"14.52";"0.29";"1.78";"11.05";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3919782";"";"None";"580.49";"2";"7.61";"BDBM236254";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2C)N(c2cccc(Cl)c2F)C3=O)c1";"IC50";"'='";"0.6";"nM";"9.22";"";"411594";"UO_0000065";"15.89";"0.31";"1.61";"14.51";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5179234";"";"None";"730.73";"2";"5.36";"15";"CCC[C@H]1N(C(=O)c2c(C(F)(F)F)ccc[n+]2[O-])CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"10.48";"0.21";"2.30";"6.99";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5199492";"";"None";"769.81";"2";"6.72";"17";"C=CCNc1nccc(C(F)(F)F)c1C(=O)N1CCC[C@@](Oc2csc(C(F)(F)F)c2)(C(=O)N2CCN(c3ccccc3OCCO)CC2)[C@H]1CCC";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"7.79";"0.15";"-0.72";"5.58";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL3935668";"";"None";"548.47";"2";"7.21";"BDBM236308";"COc1ccc(C(N)=O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.104";"nM";"9.98";"";"411692";"UO_0000065";"18.20";"0.36";"2.77";"12.87";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3920785";"";"None";"540.00";"2";"6.62";"BDBM236334";"COc1cnc(CC#N)cc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cccc(Cl)c1F)C2=O";"IC50";"'='";"0.359";"nM";"9.45";"";"411718";"UO_0000065";"17.49";"0.33";"2.82";"9.95";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4113117";"";"None";"581.56";"2";"5.78";"BDBM215217";"CC[C@@H](C(C)NS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"2.0";"nM";"8.70";"";"378598";"UO_0000065";"14.96";"0.31";"2.92";"8.38";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111025";"";"None";"583.58";"2";"6.03";"BDBM215219";"CC[C@@H](C(C)NS(=O)(=O)C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"378600";"UO_0000065";"14.60";"0.31";"2.49";"8.21";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3915542";"";"None";"477.43";"1";"5.53";"BDBM215071";"CCNC[C@@H](CC)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"490.0";"nM";"6.31";"";"378350";"UO_0000065";"13.22";"0.27";"0.78";"9.06";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4110652";"";"None";"473.40";"1";"6.22";"BDBM215079";"CC[C@@H](CCC#N)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"378358";"UO_0000065";"15.89";"0.32";"1.30";"9.24";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115223";"";"None";"525.48";"2";"6.95";"BDBM215081";"CC[C@@H](CCc1ccccn1)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"90.0";"nM";"7.05";"";"378360";"UO_0000065";"13.41";"0.27";"0.10";"9.99";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3963590";"";"None";"629.55";"2";"6.33";"BDBM215308";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CN(C(F)F)S(=O)(=O)C2CC2)C2CC2)C1=O";"IC50";"'='";"0.1";"nM";"10.00";"";"378677";"UO_0000065";"15.88";"0.33";"3.67";"10.53";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125527";"";"None";"568.56";"2";"6.52";"BDBM50448936";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378746";"UO_0000065";"17.59";"0.37";"3.48";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114575";"";"None";"579.55";"2";"5.34";"BDBM215426";"CCC(CN(C)S(=O)(=O)C1CC1)N1C(=O)[C@@]2(C[C@H](c3cccc(Cl)c3)C1c1ccc(Cl)cc1)C[C@H]2C(=O)O";"IC50";"'='";"23.8";"nM";"7.62";"";"378809";"UO_0000065";"13.15";"0.27";"2.28";"8.03";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3959586";"";"None";"630.64";"2";"6.52";"BDBM215437";"CC[C@@H](CN1CCCS1(=O)=O)N1C(=O)[C@@](C)(Cc2cccc(OC)n2)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"275.0";"nM";"6.56";"";"378820";"UO_0000065";"10.40";"0.21";"0.04";"8.22";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4796115";"";"None";"378.22";"0";"3.17";"Rac-5a";"O=C1Nc2cc(Cl)ccc2[C@]12NC[C@@H]([N+](=O)[O-])[C@@H]2c1cccc(Cl)c1";"IC50";"'='";"36500.0";"nM";"4.44";"";"";"UO_0000065";"11.73";"0.24";"1.27";"5.27";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3691738";"";"None";"520.46";"2";"7.68";"8";"COc1ccccc1-n1nc2c(c1C(C)C)[C@@H](c1ccc(Cl)cc1C)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"506000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4432632";"Inhibition of C-terminal biotin-tagged streptavidin labelled human MDM2 ( 2 to 188 residues)/Cy5-labelled p53 (18 to 26 residues)(unknown origin) interaction after 15 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4431357";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"None";"";""
"CHEMBL3649989";"";"None";"559.07";"2";"6.09";"59";"COCC(c1ccccc1)c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"15.56";"0.30";"2.61";"7.79";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5076274";"";"None";"538.57";"2";"6.38";"24";"CC(C)c1ccnc(-c2nc3nc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2Cc2ccc(C(F)(F)F)cc2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"15.59";"0.29";"2.02";"7.94";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5086781";"";"None";"554.57";"2";"5.34";"26";"C[C@@H](Nc1nc(C(=O)O)nc2nc(N[C@@H](CO)c3ccccc3)n(Cc3ccc(C(F)(F)F)cc3)c12)C1CCC1";"IC50";"'='";"1.5";"nM";"8.82";"";"";"UO_0000065";"15.91";"0.30";"3.48";"7.05";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5080429";"";"None";"490.65";"1";"6.14";"33";"CC(C)c1ccnc(-c2nc3nc(C(=O)O)nc(N[C@H](C)C4CCC4)c3n2C[C@H]2CC[C@H](C)CC2)c1";"IC50";"'='";"2.2";"nM";"8.66";"";"";"UO_0000065";"17.65";"0.33";"2.52";"8.18";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5092465";"";"None";"587.08";"2";"5.29";"41";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3nc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1";"IC50";"'='";"0.52";"nM";"9.28";"";"";"UO_0000065";"15.81";"0.30";"3.99";"7.26";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3925236";"";"None";"562.50";"2";"7.47";"BDBM236257";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)C(c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.9";"nM";"9.05";"";"411596";"UO_0000065";"16.08";"0.32";"1.58";"14.23";"0";"CHEMBL3888633";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 1: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL5203613";"";"None";"801.81";"2";"5.25";"23";"CCC[C@H]1N(C(=O)c2c(C(F)(F)F)ccnc2OCC(=O)NC)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"246.0";"nM";"6.61";"";"";"UO_0000065";"8.24";"0.16";"1.36";"4.94";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL3928665";"";"None";"553.42";"2";"7.64";"BDBM236303";"COc1ccc(C(=O)O)cc1-c1cc2c(n1C(C)C)C(c1ccc(Cl)cc1)N(c1ccc(F)c(Cl)c1)C2=O";"IC50";"'='";"0.351";"nM";"9.46";"";"411688";"UO_0000065";"17.08";"0.34";"1.81";"13.17";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3967086";"";"None";"517.45";"2";"5.54";"BDBM215074";"CC[C@H](CN1CCCC1=O)N1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"140.0";"nM";"6.85";"";"378353";"UO_0000065";"13.25";"0.27";"1.31";"8.80";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3907720";"";"None";"462.42";"1";"6.58";"BDBM215086";"CCC(CC)CN1C(=O)[C@@H](CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"378365";"UO_0000065";"15.62";"0.32";"0.64";"12.54";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3895600";"";"None";"600.59";"2";"5.86";"BDBM215147";"CC[C@@H](CN1CCN(C(=O)C2CC2)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378426";"UO_0000065";"13.32";"0.27";"2.14";"9.86";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111577";"";"None";"492.40";"0";"4.42";"BDBM215152";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@@H]2CC[C@H](O)[C@@H]2O)C1=O";"IC50";"'='";"280.0";"nM";"6.55";"";"378431";"UO_0000065";"13.31";"0.27";"2.13";"6.68";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4106459";"";"None";"470.36";"1";"5.53";"BDBM215157";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2cnccn2)C1=O";"IC50";"'='";"110.0";"nM";"6.96";"";"378436";"UO_0000065";"14.79";"0.30";"1.43";"8.34";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111096";"";"None";"504.80";"2";"6.18";"BDBM215160";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N(c2ccnc(Cl)n2)C1=O";"IC50";"'='";"610.0";"nM";"6.21";"";"378439";"UO_0000065";"12.31";"0.26";"0.03";"7.45";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4112050";"";"None";"535.47";"2";"6.05";"BDBM215174";"CC[C@@H](C(=O)OC(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(Cl)ccn2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378453";"UO_0000065";"14.38";"0.29";"1.65";"7.95";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4108551";"";"None";"546.41";"2";"6.62";"BDBM215203";"CC[C@H](N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1)C(C)(O)C(F)(F)F";"IC50";"'='";"10.0";"nM";"8.00";"";"378483";"UO_0000065";"14.64";"0.30";"1.38";"10.28";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3963132";"";"None";"581.56";"2";"5.04";"BDBM215251";"CC[C@@H](CN1CCS(=O)(=O)CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"378495";"UO_0000065";"13.24";"0.28";"2.66";"8.11";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4115598";"";"None";"567.54";"2";"8.29";"BDBM215267";"CC[C@@H](c1nc2ccccc2s1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"378509";"UO_0000065";"12.61";"0.26";"-1.14";"10.15";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4107995";"";"None";"518.44";"2";"5.87";"BDBM215290";"CCOC(=O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)C1c1ccc(Cl)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"378527";"UO_0000065";"15.43";"0.31";"2.13";"9.53";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3975518";"";"None";"490.43";"1";"5.69";"BDBM215297";"C[C@H](O)[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"80.0";"nM";"7.10";"";"378531";"UO_0000065";"14.47";"0.29";"1.41";"9.12";"0";"CHEMBL3888179";"Homogenous Time-Resolved Fluorescence Assay (HTRF1 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 2.5 nM GST-hMDM2 (aa 1-188), 5 nM biotinylated-p53 (aa 1-83), 1.8 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 200 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3125525";"";"None";"552.52";"2";"5.89";"BDBM50448938";"CC[C@@H](CS(=O)(=O)C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378744";"UO_0000065";"17.55";"0.37";"3.81";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3904145";"";"None";"586.55";"2";"6.66";"BDBM215410";"CC[C@@H](CS(=O)(=O)C(C)(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cc(F)cc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.1";"nM";"10.00";"";"378799";"UO_0000065";"17.05";"0.36";"3.34";"10.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4111986";"";"None";"621.61";"2";"6.35";"BDBM215302";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@@H](c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)c2cccs2)C2CC2)C1=O";"IC50";"'='";"0.2";"nM";"9.70";"";"378671";"UO_0000065";"15.60";"0.33";"3.35";"9.35";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4114867";"";"None";"630.59";"2";"5.82";"BDBM215324";"C[C@]1(CC(=O)O)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N([C@H](CNS(=O)(=O)Cc2ccccn2)C2CC2)C1=O";"IC50";"'='";"0.6";"nM";"9.22";"";"378693";"UO_0000065";"14.62";"0.30";"3.40";"7.90";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3940186";"";"None";"614.59";"2";"7.09";"BDBM215348";"Cc1ccccc1S(=O)(=O)C[C@H](C1CC1)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"2.9";"nM";"8.54";"";"378720";"UO_0000065";"13.89";"0.28";"1.45";"9.31";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3944399";"";"None";"568.56";"2";"6.52";"BDBM215369";"CC[C@@H](CS(=O)(=O)C(C)C)N1C(=O)[C@@](CC)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"0.2";"nM";"9.70";"";"378749";"UO_0000065";"17.06";"0.36";"3.18";"10.57";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3924621";"";"None";"538.54";"2";"6.47";"BDBM215386";"CC[C@@H](C[S@@+]([O-])C(C)C)N1C(=O)[C@@](C)(CC(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"1.9";"nM";"8.72";"";"378772";"UO_0000065";"16.19";"0.34";"2.25";"10.81";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"10";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"88.0";"nM";"7.06";"";"";"UO_0000065";"12.13";"0.24";"1.17";"8.45";"0";"CHEMBL5128491";"Inhibition of recombinant human MDM2/p53 interaction by Biacore's surface plasmon resonance analysis";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5126548";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"";"INHIBITOR"
"CHEMBL4786337";"";"None";"604.51";"2";"6.05";"Ib-240";"CNC(=O)c1ccc2c(c1)nc1n2CC[C@H]2[C@@H]1[C@H](c1cccc(Cl)c1F)[C@]1(C(=O)Nc3cc(Cl)ccc31)N2CC1CC1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"14.10";"0.28";"2.47";"10.75";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL4761571";"";"None";"685.59";"2";"6.56";"Ia-56";"CCOc1cccc(CN2[C@H]3Cc4c5cc(C)c(C(=O)NC)cc5nn4[C@H]3[C@H](c3cccc(Cl)c3F)[C@]23C(=O)Nc2nc(Cl)ccc23)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"12.11";"0.24";"1.74";"8.19";"0";"CHEMBL4725100";"Inhibition of GST-tagged MDM2 (23 to 117 residues) (unknown origin) assessed as inhibition of MDM2/biotinylated wild type human p53 (16 to 27 residues) interaction by measuring reactivation of p53 incubated for 15 mins by AlphaScreen assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4715930";"1";"Scientific Literature";"ACS Med Chem Lett";"2021";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL3916664";"";"None";"562.50";"2";"7.47";"BDBM236265";"CNC(=O)c1ccc(OC)c(-c2cc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)ccc2C)C3=O)c1";"IC50";"'='";"0.095";"nM";"10.02";"";"411650";"UO_0000065";"17.82";"0.35";"2.55";"15.77";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3892910";"";"None";"513.00";"2";"5.70";"BDBM236290";"COc1nc(N)ncc1-c1cc2c(n1C(C)C)C(c1ccc(C#N)cc1)N(c1cc(Cl)ccc1C)C2=O";"IC50";"'='";"0.401";"nM";"9.40";"";"411675";"UO_0000065";"18.32";"0.35";"3.70";"8.54";"0";"CHEMBL3888635";"Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay: Assay 2: The test is performed in white 384-well plates (Greiner Bio-One, reference 781207) in a total volume of 60 μL by adding 1 μL of compounds tested at different concentrations diluted in 100% DMSO (1.7% final DMSO concentration) in reaction buffer (PBS, 125 mM NaCl, 0.001% Novexin (consists of carbohydrate polymers), designed to increase the solubility and stability of proteins; Expedeon Ltd., Cambridgeshire, United Kingdom), 0.01% Gelatin, 0.01% 0.2%, Pluronic F-127 (block copolymer from ethylenoxide and propyleneoxide), 1 mM DTT). After addition of 1.25 nM MDM2-biotinylated or 2.5 nM MDM4-biotinylated (internal preparations), and 0.625 nM Europium labeled streptavidin (Perkin Elmer), the solution is pre-incubated for 15 minutes at room temperature, then 10 nM Cy5-p53 peptide (internal preparation) is added before an incubation at room temperature for 15 minutes prior to reading the plate. For measurement of samples, a Victor II microplate reader (Perkin Elmer) is used with the following settings: Excitation 340 nm, Emission Donor 620 nm and Emission Acceptor 665 nm. For selected compounds displaying IC50s between 0.05 and 5 nM on MDM2, a slightly modified assay is used with the following adaptations: 0.1 nM MDM2, 0.1 nM Europium labeled streptavidin and Tecan genios Pro is used as a microplate reader for the fluorescence measurements (p53-MDM2 Assay 2).";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886789";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL3958840";"";"None";"490.43";"1";"5.55";"BDBM215288";"CC[C@@H](CO)N1C(=O)[C@@](C)(C2CC2C(=O)O)C[C@H](c2cccc(Cl)c2)[C@H]1c1ccc(Cl)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"378657";"UO_0000065";"14.27";"0.29";"1.45";"8.99";"0";"CHEMBL3888180";"Homogenous Time-Resolved Fluorescence Assay (HTRF2 Assay): The standard assay conditions for the in vitro HTRF assay consisted of a 50 ul total reaction volume in black 384-well Costar polypropylene plates in 1xPBS buffer pH 7.4, 1 mM DTT, 0.1% BSA, 0.2 nM GST-hMDM2 (aa 1-188), 0.5 nM biotinylated-p53 (aa 1-83), 0.18 nM SA-XLent (Cisbio; Bedford, Mass.), 0.6 nM anti-GST cryptate monoclonal antibody (Cisbio; Bedford, Mass.) and 100 mM KF. Amino acid residues 1-188 of human MDM2 were expressed as an amino-terminal glutathione-5-transferase (GST) fusion protein (GST-hMDM2) in Escherichia coli. Residues 1-83 of human p53 were expressed as an amino-terminal AviTag-TrxA-6×His fusion protein (biotinylated p53) in E. coli. Each protein was purified from cell paste by affinity chromatography. Specifically, 10 uL of GST-hMDM2 was incubated with 10 ul of diluted compound (various concentrations, serially diluted) in 10% DMSO for 20 minutes at room temperature. 20 uL of biotinylated-p53 was added to the GST-hMDM2+compound mixture, and then incubated at room temperature for 60 min. 10 uL of detection buffer consisting of SA-XLent, anti-GST cryptate antibody and KF was added to GST-hMDM2, biotinylated-p53 and compound reaction and left at room temperature to reach equilibrium for >4 hrs. The final concentration of DMSO in the reaction was 2%. Time-resolved fluorescence readings were measured on a microplate multilabel reader. Percentage of inhibition was calculated relative to nutlin-3.";"B";"BAO_0000224";"protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL3886611";"37";"BindingDB Database";"";"2016";"None";"";""
"CHEMBL4744488";"";"None";"476.38";"0";"4.68";"8";"CC(=O)N[C@@H]1[C@H](C)N(CC2CC2)[C@@]2(C(=O)Nc3cc(Cl)ccc32)[C@H]1c1cccc(Cl)c1F";"IC50";"'='";"229.0";"nM";"6.64";"";"";"UO_0000065";"13.94";"0.28";"1.96";"10.81";"0";"CHEMBL4681440";"Inhibition of GST-tagged MDM2 (amino acids 17 to 111 residues)/p53 (unknown origin) interaction incubated for 15 mins by";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL4680091";"1";"Scientific Literature";"J Med Chem";"2016";"None";"TIME = 0.25 hr";"INHIBITOR"
"CHEMBL5180348";"";"None";"532.79";"2";"6.16";"2q";"CCOC(=O)C1=NN(c2ccc(Cl)cc2)C2(C(=O)Nc3cc(Cl)ccc32)C1c1cccc(Cl)c1F";"IC50";"'='";"70.7";"nM";"7.15";"";"";"UO_0000065";"13.42";"0.28";"0.99";"10.07";"0";"CHEMBL5110382";"Inhibition of MDM2/p53 interaction in human U-87 MG cells preincubated for 10 mins under shaking condition and measured after 1.5 hrs by immuno-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5108018";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 1.667 hr";"INHIBITOR"
"CHEMBL5191434";"";"None";"660.76";"2";"5.41";"8";"CCC[C@H]1N(C(=O)c2cnccc2C)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"11.30";"0.22";"2.06";"7.83";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL191334";"NUTLIN-3";"None";"581.50";"2";"5.89";"Nutilin-3a; 9";"COc1ccc(C2=N[C@@H](c3ccc(Cl)cc3)[C@@H](c3ccc(Cl)cc3)N2C(=O)N2CCNC(=O)C2)c(OC(C)C)c1";"IC50";"'='";"18.7";"nM";"7.73";"";"";"UO_0000065";"13.29";"0.26";"1.84";"9.26";"0";"CHEMBL5164646";"Inhibition of GST-tagged MDM2/Biotin-tagged p53 interaction (unknown origin) incubated for 40 mins by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.6667 hr";"INHIBITOR"
"CHEMBL5094473";"";"None";"566.67";"1";"4.94";"40";"Cc1cncc(-c2nc(-c3noc(=O)[nH]3)nc3nc(N4CCOC[C@H]4c4ccccc4)n(C[C@H]4CC[C@H](C)CC4)c23)c1";"IC50";"'='";"3.9";"nM";"8.41";"";"";"UO_0000065";"14.84";"0.27";"3.47";"6.58";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5191746";"";"None";"684.70";"2";"6.76";"24";"CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OC)CC1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"10.99";"0.22";"0.76";"10.00";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5179820";"";"None";"772.77";"2";"6.70";"27";"CCC[C@H]1N(C(=O)c2c(C(F)(F)F)ccnc2O)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCCC(=O)O)CC1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"10.30";"0.21";"1.26";"6.00";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5207199";"";"None";"788.76";"2";"5.59";"22";"CCC[C@H]1N(C(=O)c2c(C(F)(F)F)ccnc2OCC(=O)O)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCN(c2ccccc2OCCO)CC1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"9.64";"0.19";"2.01";"5.35";"0";"CHEMBL5135142";"Inhibition of HDM2-p53 (unknown origin) protein-protein interaction by fluorescence polarization peptide displacement assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5131494";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"DISRUPTING AGENT"
"CHEMBL5079411";"";"None";"516.57";"2";"5.94";"25";"C[C@@H](Nc1nc(C(=O)O)nc2nc(NC3CCCCC3)n(Cc3ccc(C(F)(F)F)cc3)c12)C1CCC1";"IC50";"'='";"7.6";"nM";"8.12";"";"";"UO_0000065";"15.72";"0.30";"2.18";"7.74";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL5090666";"";"None";"551.65";"2";"5.24";"38";"C[C@H]1CC[C@H](Cn2c(N3CCOC[C@H]3c3ccccc3)nc3nc(-c4noc(=O)[nH]4)nc(-c4ccccc4)c32)CC1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"14.50";"0.27";"2.76";"6.96";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL3647064";"";"None";"538.05";"1";"4.93";"55";"C[C@@H]1COC[C@@H](C)N1c1nc2cc(-c3noc(=O)[nH]3)nc(-c3cncc(Cl)c3)c2n1C[C@H]1CC[C@H](C)CC1";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"16.25";"0.31";"3.81";"7.61";"0";"CHEMBL5030008";"Inhibition of N-terminal thioredoxin-His6 tagged HDM2 (17 to 125 residues)/p53 protein-protein interaction (unknown origin) incubated for 2 hrs by TR-FRET assay";"B";"BAO_0000224";"protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5029175";"1";"Scientific Literature";"J Med Chem";"2021";"None";"TIME = 2.0 hr";"INHIBITOR"
"CHEMBL4169540";"";"None";"516.56";"2";"1.59";"11";"N=C(N)Nc1cccc(C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)NC(c2ccccc2)c2ccccc2)c1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"13.83";"0.26";"5.55";"3.83";"0";"CHEMBL5164630";"Inhibition of MDM2/p53 interaction in human U-87 MG cells incubated for 10 mins by immuno-enzymatic assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"U-87 MG";"None";"";"";"";"CHEMBL1907611";"Tumour suppressor p53/oncoprotein Mdm2";"Homo sapiens";"PROTEIN-PROTEIN INTERACTION";"CHEMBL5154862";"1";"Scientific Literature";"J Med Chem";"2022";"None";"TIME = 0.1667 hr";"INHIBITOR"
